ADVANCES IN
FOOD AND NUTRITION RESEARCH VOLUME 52
ADVISORY BOARD KEN BUCKLE University of New South Wales, Australia
MARY ELLEN CAMIRE University of Maine, USA
BRUCE CHASSY University of Illinois, USA
DENNIS GORDON North Dakota State University, USA
ROBERT HUTKINS University of Nebraska, USA
RONALD JACKSON Quebec, Canada
DARYL B. LUND University of Wisconsin, USA
CONNIE WEAVER Purdue University, USA
RONALD WROLSTAD Oregon State University, USA
SERIES EDITORS GEORGE F. STEWART
(1948–1982)
EMIL M. MRAK (1948–1987) C. O. CHICHESTER (1959–1988) BERNARD S. SCHWEIGERT (1984–1988) JOHN E. KINSELLA STEVE L. TAYLOR
(1989–1993) (1995– )
ADVANCES IN
FOOD AND NUTRITION RESEARCH VOLUME 52
Edited by
STEVE L. TAYLOR Department of Food Science and Technology University of Nebraska Lincoln, Nebraska USA
AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier
Academic Press is an imprint of Elsevier 525 B Street, Suite 1900, San Diego, California 92101-4495, USA 84 Theobald’s Road, London WC1X 8RR, UK
This book is printed on acid-free paper. Copyright ß 2007, Elsevier Inc. All Rights Reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the Publisher. The appearance of the code at the bottom of the first page of a chapter in this book indicates the Publisher’s consent that copies of the chapter may be made for personal or internal use of specific clients. This consent is given on the condition, however, that the copier pay the stated per copy fee through the Copyright Clearance Center, Inc. (www.copyright.com), for copying beyond that permitted by Sections 107 or 108 of the U.S. Copyright Law. This consent does not extend to other kinds of copying, such as copying for general distribution, for advertising or promotional purposes, for creating new collective works, or for resale. Copy fees for pre-2007 chapters are as shown on the title pages. If no fee code appears on the title page, the copy fee is the same as for current chapters. 1043-4526/2007 $35.00 Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone: (þ44) 1865 843830, fax: (þ44) 1865 853333, E-mail:
[email protected]. You may also complete your request on-line via the Elsevier homepage (http://elsevier.com), by selecting ‘‘Support & Contact’’ then ‘‘Copyright and Permission’’ and then ‘‘Obtaining Permissions.’’ For information on all Academic Press publications visit our Web site at www.books.elsevier.com ISBN-13: 978-0-12-373711-3 ISBN-10: 0-12-373711-7 PRINTED IN THE UNITED STATES OF AMERICA 07 08 09 10 9 8 7 6 5 4 3 2
1
CONTENTS
Contributors to Volume 52. . . . . . . . . . . . . . . . . . . . . . .
ix
Sweet Potato: A Review of Its Past, Present, and Future Role in Human Nutrition Adelia C. Bovell-Benjamin I. Introduction . . . . . . . . . . . . . . . . . . . . . . . . II. Sweet Potato in Human Diets . . . . . . . . . . . . . . . III. Biochemical and Nutritional Composition of the Sweet Potato . . . . . . . . . . . . . . . . . . . . . . . . IV. Sweet Potato Utilization as Value-Added Products in Human Food Systems . . . . . . . . . . . . . . . . . . . V. Sweet Potato Starch Utilization in Human Food Systems VI. Advances in SPF Production and Utilization for Human Food Systems . . . . . . . . . . . . . . . . . . . . . . . VII. Other Potential Sweet Potato Products . . . . . . . . . . VIII. Potential of Sweet Potato in the Ugandan Food System . IX. Sweet Potato Processing and Utilization EVorts in Kenya X. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . XI. Recommendations . . . . . . . . . . . . . . . . . . . . . Acknowledgments . . . . . . . . . . . . . . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . .
3 6
. . .
7
. . . . . .
17 18
. . . . . . . .
. . . . . . . .
28 38 42 44 47 48 48 48
I. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . II. Canine distemper virus . . . . . . . . . . . . . . . . . . . . . . III. Rous-Associated Virus-7 . . . . . . . . . . . . . . . . . . . . .
62 63 73
. . . . . . . .
Infectobesity: Obesity of Infectious Origin Magdalena Pasarica and Nikhil V. Dhurandhar
vi
CONTENTS
IV. V. VI. VII. VIII. IX. X. XI. XII. XIII. XIV. XV. XVI.
Chlamydia pneumoniae . . . . . . . . . . . . Scrapie Agent . . . . . . . . . . . . . . . . Borna disease virus . . . . . . . . . . . . . . Gut Microbiota . . . . . . . . . . . . . . . Adenoviruses . . . . . . . . . . . . . . . . . SMAM-1 . . . . . . . . . . . . . . . . . . . Adenovirus Type 36 . . . . . . . . . . . . . Adenovirus Type 5 . . . . . . . . . . . . . . Adenovirus Type 37 . . . . . . . . . . . . . Adipogenic Potential of Other Adenoviruses Role of Pathogens in Human Obesity . . . . Infection, Inflammation, and Obesity . . . . Conclusions . . . . . . . . . . . . . . . . . Acknowledgments . . . . . . . . . . . . . . References . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
77 78 81 83 84 85 87 90 91 91 92 92 93 94 94
Refrigerated Fruit Juices: Quality and Safety Issues Maria Jose Esteve and Ana Frı´gola I. Introduction . . . II. Review . . . . . . Acknowledgments References . . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
104 108 132 132
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
142 145 156 208 220 221
Tetrodotoxin Poisoning Deng-Fwu Hwang and Tamao Noguchi I. II. III. IV. V.
Introduction . . . . . . TTX Poisoning . . . . . Causative Agent: TTX . Highlight of Viewpoint. Summary . . . . . . . . References . . . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
Marine Biotechnology for Production of Food Ingredients Rosalee S. Rasmussen and Michael T. Morrissey I. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . II. Sources of Marine-Derived Food Ingredients . . . . . . . . . .
238 244
CONTENTS
vii
III. Marine-Derived Food Ingredients . . . . . . . . . . . . . . . . IV. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . . . . .
257 283 284
Fruits of the Actinidia Genus Ichiro Nishiyama I. II. III. IV. V. VI.
Introduction . . . . . . . . . . Actinidia Species and Cultivars Fruit Components . . . . . . . Allergenic Properties . . . . . . Health Benefits . . . . . . . . . Perspectives. . . . . . . . . . . Acknowledgments . . . . . . . References . . . . . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
294 295 299 317 317 318 319 319
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
325
CONTRIBUTORS TO VOLUME 52
Numbers in parentheses indicate the pages on which the authors’ contributions begin.
Adelia C. Bovell-Benjamin, Department of Food and Nutritional Sciences, Tuskegee/NASA Center for Food and Environmental Systems for Human Exploration of Space (CFESH), Tuskegee University, Tuskegee, Alabama 36088 (1) Nikhil V. Dhurandhar, Department of Infections and Obesity, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana 70808 (61) Maria Jose Esteve, Department of Food Chemistry and Nutrition, University of Valencia, Avda. Vicent Andres Estelles, s/n. 46100, Burjassot, Spain (103) Ana Frı´gola, Department of Food Chemistry and Nutrition, University of Valencia, Avda. Vicent Andres Estelles, s/n. 46100, Burjassot, Spain (103) Deng-Fwu Hwang, Department of Food Science, National Taiwan Ocean University, Taiwan, Republic of China (141) Michael T. Morrissey, Seafood Laboratory, Department of Food Science and Technology, Oregon State University, Astoria, Oregon 97103 (237) Ichiro Nishiyama, Department of Food and Nutrition, Komazawa Women’s Junior College, Inagi, Tokyo 206-8511, Japan (293) Tamao Noguchi, Department of Food Science, National Taiwan Ocean University, Taiwan, Republic of China; Tokyo Healthcare University, Setagaya, Tokyo, Japan (141) Magdalena Pasarica, Department of Infections and Obesity, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana 70808 (61) Rosalee S. Rasmussen, Seafood Laboratory, Department of Food Science and Technology, Oregon State University, Astoria, Oregon 97103 (237)
SWEET POTATO: A REVIEW OF ITS PAST, PRESENT, AND FUTURE ROLE IN HUMAN NUTRITION ADELIA C. BOVELL-BENJAMIN Department of Food and Nutritional Sciences, Tuskegee/NASA Center for Food and Environmental Systems for Human Exploration of Space (CFESH) Tuskegee University, Tuskegee, Alabama 36088
I. Introduction II. Sweet Potato in Human Diets III. Biochemical and Nutritional Composition of the Sweet Potato A. Protein: Sweet Potato Leaves B. Protein: Sweet Potato Roots C. b-Carotene D. Mineral Contents E. Dietary Fiber F. Anthocyanins IV. Sweet Potato Utilization as Value-Added Products in Human Food Systems V. Sweet Potato Starch Utilization in Human Food Systems A. Bulk Ingredients from Three Cv. of Sweet Potatoes: Composition and Properties (Bovell-Benjamin et al., 2004) B. EVects of Processing Technology on SPS Yield and Quality (Jianjun, 2004) C. Physicochemical and Viscometric Properties of an SPS Syrup (Miller et al., 2003) D. EVects of pH and Concentration Times on Selected Functional Properties of a Sweet Potato Syrup (Yousif-Ibrahim et al., 2003) E. Influence of a-Amylase on the Physical Properties and Consumer Acceptability of SPS Syrup (Bovell-Benjamin et al., 2005) F. Sensory and Consumer Evaluation of SPS Syrup (Miller et al., 2003) VI. Advances in SPF Production and Utilization for Human Food Systems A. Breadmaking Properties of SPF (Greene et al., 2003) B. Macroscopic and Sensory Evaluation of Bread Supplemented with SPF (Greene and Bovell-Benjamin, 2004) C. Development and Storage Stability of Breads Supplemented with SPF and Dough Enhancers (Hathorn et al., 2005)
ADVANCES IN FOOD AND NUTRITION RESEARCH VOL 52 # 2007 Elsevier Inc. All rights reserved
ISSN: 1043-4526 DOI: 10.1016/S1043-4526(06)52001-7
2
A. C. BOVELL-BENJAMIN
VII.
VIII. IX. X. XI.
D. Sensory Characterization of a Ready-to-Eat Sweet Potato Breakfast Cereal by Descriptive Analysis (Dansby and Bovell-Benjamin, 2003b) E. Physical Properties and Sixth Graders’ Acceptance of an Extruded Ready-to-Eat Sweet Potato Breakfast Cereal (Dansby and Bovell-Benjamin, 2003c) F. Preparation of SPF and Its Fermentation to Ethanol (Reddy and Basappa, 1997) G. Genetic Variation in Color of SPF Related to Its Use in Wheat-Based Composite Flour Products (Collado et al., 1997) H. Quality Evaluation of SPF Processed in DiVerent Agroecological Sites Using Small-Scale Processing Technologies (Owori and Hagenimana, 2000) I. SPF-Like Products Other Potential Sweet Potato Products A. Consumer Acceptance of Vegetarian Sweet Potato Products Intended for Space Missions (Wilson et al., 1998) B. Sweet Potato ‘‘Kunuzaki’’ (Tewe et al., 2003) C. Sweet Potato Beverage D. Selected Patents Regarding Sweet Potato Products E. Preparation, Evaluation, and Analysis of a French-Fry-Type Product from Sweet Potatoes F. Textural Measurements and Product Quality of Restructured Sweet Potato French Fries (Walter et al., 2002) Potential of Sweet Potato in the Ugandan Food System Sweet Potato Processing and Utilization EVorts in Kenya Conclusions Recommendations Acknowledgments References
The overall objective of this chapter is to review the past, present, and future role of the sweet potato (Ipomoea batatas [L.] Lam) in human nutrition. Specifically, the chapter describes the role of the sweet potato in human diets; outlines the biochemical and nutritional composition of the sweet potato with emphasis on its b-carotene and anthocyanin contents; highlights sweet potato utilization, and its potential as value-added products in human food systems; and demonstrates the potential of the sweet potato in the African context. Early records have indicated that the sweet potato is a staple food source for many indigenous populations in Central and South Americas, Ryukyu Island, Africa, the Caribbean, the Maori people, Hawaiians, and Papua New Guineans. Protein contents of sweet potato leaves and roots range from 4.0% to 27.0% and 1.0% to 9.0%, respectively. The sweet potato could be considered as an excellent novel source of natural health-promoting compounds, such as b-carotene and anthocyanins, for the functional food market.
SWEET POTATO: A REVIEW
3
Also, the high concentration of anthocyanin and b-carotene in sweet potato, combined with the high stability of the color extract make it a promising and healthier alternative to synthetic coloring agents in food systems. Starch and flour processing from sweet potato can create new economic and employment activities for farmers and rural households, and can add nutritional value to food systems. Repositioning sweet potato production and its potential for value-added products will contribute substantially to utilizing its benefits and many uses in human food systems. Multidisciplinary, integrated research and development activities aimed at improving production, storage, postharvest and processing technologies, and quality of the sweet potato and its potential value-added products are critical issues, which should be addressed globally. I. INTRODUCTION Currently, in some developed countries, overnutrition rather than undernutrition presents a major public health challenge. However, from a global perspective, undernutrition, food insecurity issues, droughts, and limited agricultural technologies are major problems. In developing countries, many farmers are highly dependent on root and tuber crops, as contributing, if not principal, sources of food, nutrition, and cash income (Scott et al., 2000). From this standpoint, there is need to critically reevaluate versatile, locally available, hardy root and tuber crops with wide ecological adaptability for their usefulness in human nutrition. The sweet potato (Ipomoea batatas [L.] Lam) is one such crop because it is high yielding and drought tolerant, with wide adaptability to various climates and farming systems (Diop, 1998; Jiang et al., 2004). Furthermore, a single sweet potato plant may produce 40–50 roots ranging in length from a few to 30 cm, and weighing between 100 and 1000 g, and the roots, leaves, and shoots are all edible (CIAD et al., 1996). It has been emphasized that the sweet potato roots and leaves (greens or tips) can support more people per unit hectare than any other food (Woolfe, 1992). The leaves of the sweet potato are dark green and are expected to have nutritive values comparable to common dark green leafy vegetables (Ishida et al., 2000). Regular consumption (100 g or half-cup daily) of yellow- or orange-fleshed sweet potato roots having about 3 mg/100 g b-carotene on a fresh weight basis provide the recommended daily amount of vitamin A for children less than 5 years old (Tsou and Hong, 1992). Jalal et al. (1998) reported that incorporation of orange-fleshed sweet potato into meals eaten by 3- to 6-year olds improved vitamin A status. Weight for weight, some orange-fleshed sweet potato cultivars (cv.) contains 20–30 times more b-carotene than Golden Rice
4
A. C. BOVELL-BENJAMIN
(Ye et al., 2000). Also, sweet potato is a typical food security crop because it can be harvested little by little over several months. It is because of these unique features and nutritional value of the sweet potato that the National Aeronautics and Space Administration (NASA) has selected it as a candidate crop to be grown and incorporated into the menus for astronauts on space missions. The sweet potato has immense potential and has a major role to play in human nutrition, food security, and poverty alleviation in developing countries. Sweet potato is a creeping dicotyledonus plant with the following scientific classification (Kingdom: Plantae; Division: Magnoliophyta; Class: Magnoliopsida; Order: Solanales; Family: Convolvulaceae; Genus: Ipomoea, and Species: batatas). The sweet potato, its leaves and roots are shown in Figure 1. Common names for the root include: sweet potato (English); batata, boniato, camote (Spanish); kumar (Peru); kumara (Polynesian); and cilera abana, ‘‘protector of the children’’ (eastern Africa); kara-imo, ‘‘Chinese potato’’ (southern Kyushu, Japan); Ubhatata (South Africa); and satsuma-imo, ‘‘Japanese potato’’ (most of the other parts of Japan). The sweet potato is said to have originated in the New World; however, the exact origin has not been well defined. Austin (1988) proposed the origin of the sweet potato as being between the Yucata´n Peninsula of Mexico and the Orinoco River in Venezuela. In 1514, nine sweet potato cv. were identified in Honduras. Currently, hundreds of cv. are grown throughout the world and are unique to countries or smaller regions within countries. All cv. are more or less sweet flavored. In developed countries, limited numbers of sweet potato cv. are grown. In the United States, producers tend to grow only one or two major cv. for regional and national markets, but may grow several cv. in small amounts for local markets. The two cv., which account for most of the current US acreage, are ‘‘Jewel’’ and ‘‘Beauregard.’’ There is a need to diVerentiate between the sweet potato and yam because of some confusion that exists regarding them in the United States. Sweet potatoes and yams are both angiosperms (flowering plants), however, they are botanically diVerent. Sweet potatoes, often called ‘‘yams’’ in the United States, are dicotyledons (having two embryonic seed leaves) and are from the Convolvulaceae or morning glory family. On the other hand, yams are monocotyledons (one embryonic seed leaf ) and are from the Dioscoreaceae or yam family. Also, the edible storage organ of the sweet potato is a true root, and for the yam it is a tuber. A tuber is a thickened part of the stem or rhizome (Kays et al., 1992). The root system of the yam is a rhizome, which is a thickened stem that grows horizontally underground. The appearance and shape of the sweet potato and yam are also diVerent. For example, the sweet potato is usually smaller, short, and blocky with tapered ends, while yams are usually long and cylindrical with some toes. b-Carotene content is usually high in orange-fleshed sweet potatoes
SWEET POTATO: A REVIEW
5
FIG. 1 Sweet potato leaves and roots. (A) Sweet potato leaves. (B) Orange-fleshed sweet potato roots. (C) White-fleshed sweet potato roots (http//encyclopedia.laborlawtalk.com).
but low in yams. The growing season is 90–150 and 180–360 days for the sweet potato and yam, respectively (http://www.loc.gov/rr/scitech/mysteries/sweetpotato.html). This chapter focuses on the sweet potato and not yams. The overall objective of this chapter is to review the past, present, and future role of the sweet potato in human nutrition. Specifically, the paper will: Describe the role of the sweet potato in human diets Outline the biochemical and nutritional composition of the sweet potato with emphasis on its b-carotene and anthocyanin contents
6
A. C. BOVELL-BENJAMIN
Highlight sweet potato utilization and its potential for incorporation into value-added products for use in human food systems Use case studies to demonstrate the potential of the sweet potato in the African context II. SWEET POTATO IN HUMAN DIETS The records left by early Europeans indicated that sweet potato provided a staple food source for many indigenous populations in southern Central America and South America (Sauer, 1950). Piperno and Holst (1998) reported that starch grain analysis revealed sweet potato as a staple food source for inhabitants in coastal Peruvian sites. The sweet potato or kumara was one of the most important crops in the diets of the Maori people, early New Zealand settlers of Polynesian descent, and was already an important staple food in Hawaii in 1778 (Huang et al., 1999). Commercial cultivation of sweet potato began in Hawaii in 1849, and since then many cv. have been introduced (Valenzuela et al., 1994). The sweet potato remains an important staple food in the diets of the Maori people, Papua New Guineans, and Hawaiians (Cambie and Ferguson, 2003; Huang et al., 1999; Sawer, 2001). Sweet potato, which is the commonest traditional root crop in Papua New Guinea, is consumed daily by 66% and 33% of the rural and urban population, respectively (Sawer, 2001). The Satamu sweet potato provides the largest part of the energy intake and contributes to self-suYciency in Okinawa in the Ryukyu Island (Sho, 2001). Sweet potato is also an important staple in countries such as the Solomon Islands, Tonga, and New Caledonia (Hijmans et al., 2002). In parts of West, Central, and East Africa, sweet potato is an important source of calories and is consumed by people of all age groups (Hagenimana et al., 1998a). For example, in Nigeria, the traditional utilization of sweet potatoes includes: (1) boiled and eaten with stew; (2) boiled and pounded with either boiled or fermented cassava as ‘‘foofoo’’ or boiled or pounded yam; (3) dried and milled for sweetening of gruel or ogi porridge; and (4) sliced into chips, dried, and fried in vegetable oil or boiled with beans or vegetables. Koreans value sweet potato leaves as a very nutritious and tasty vegetable. The leaves are usually cooked together with other ingredients in various Korean dishes or can be dried and stored for later use as a boiled or fried vegetable (www.agnet.org/library/article/ pt2001034.html). The sweet potato is also an important starch source in China, Vietnam, Korea and Taiwan, and the Philippines (Collado et al., 1999; Marter and Timmins, 1992). Although sweet potato may contribute essential nutrients, it is usually consumed for its sensory properties, as a substitute or supplement to corn, rice, or wheat or as the main ingredient of traditional, but infrequently consumed dishes in many developing countries (Shewry, 2003; Van Den and del Rosario, 1984).
SWEET POTATO: A REVIEW
7
In 1999, sweet potato accounted for approximately 20% of the total world production of root and tuber crops (FAO, 1999). Asia is the largest sweet potato-producing region in the world, with an annual production of 125 million tonnes. China produces roughly 65% of the world’s sweet potato, making it the leading supplier of sweet potatoes in the world (Hijmans et al., 2002). Latin America and North America produce about 1.9 million and 600,000 tonnes annually, respectively. In the United States, North Carolina and Louisiana each grow 40% of the total sweet potatoes, while California, Alabama, and Texas grow the bulk of the remainder (Burden, 2005). The only European country that produces considerable quantities of sweet potato is Portugal, at 23,000 tonnes annually (FAO, 1999). There are considerable concentrations of sweet potato in the Caribbean region; Indonesia; New Guinea, Papua New Guinea; and Vietnam (Hijmans et al., 2002). Production of sweet potato in Africa amounts to 6% of world production (Karyeija et al., 1998). The largest sweet potato growers in Africa are: Uganda, the third largest producer in the world (2.2 million metric tonnes); Rwanda (1.1 million metric tonnes); Kenya and Burundi (0.7 million metric tonnes each); Tanzania (0.4 million metric tonnes); and Ethiopia (0.2 million tonnes) (Diop, 1998; Karyeija et al., 1998; http://www.harvestplus.org/sweetpotato.html). The other African countries with annual sweet potato production (103) exceeding 100,000 tonnes are shown in Figure 2. However, over the last four decades, global sweet potato production has remained static, and demand for the crop is greatly decreased, possibly because of diversified eating habits and little knowledge about its nutritional and functional properties among other things (Kays, 2005; Yamakawa and Yoshimoto, 2002).
III. BIOCHEMICAL AND NUTRITIONAL COMPOSITION OF THE SWEET POTATO The sweet potato has immense potential to help prevent and reduce food insecurity and mal-, under-, and overnutrition in developing and developed countries because of its nutritional composition and unique agronomic features. However, paucity of information regarding the nutritional composition of the sweet potato greatly limits its exploitation. Improved awareness of the nutritional quality, utilization, and future economic importance of the crop has important implications for human food systems, nationally and internationally (Scott et al., 2000). The sweet potato contains many nutrients including protein, carbohydrates, minerals (calcium, iron, and potassium), carotenoids, dietary fiber, vitamins (especially C, folate, and B6), very little fat, and sodium. As described in the following sections, the nutrient composition of the sweet potato varies greatly according to genetic and environmental factors.
8
A. C. BOVELL-BENJAMIN
Egypt 160
Guinea 143
Uganda 2235 Ethiopia 155 Cameroon 180
Rwanda Kenya 1100 630 Zaire 407 Burundi Tanzania Madagascar 451 674 560 Angola 200
FIG. 2 The 12 African countries with an annual sweet potato production (103) exceeding 100,000 tonnes. Note the main production area concentrated around Lake Victoria (in black). Modified from Karyeija et al. (2000) and FAO (1995).
A. PROTEIN: SWEET POTATO LEAVES
In Africa and Japan, the leaves of the sweet potato are eaten, and the protein content has been reported to be as high as 27% protein on dry weight basis (dwb; Diop, 1998). Tewe et al. (2003) reported that the protein content of sweet potato leaves was 18.4%, while fiber content was between 3.3% and 6.0%. Ishida et al. (2000) studied two kinds of sweet potatoes and reported that the leaves contained high amounts of protein (3.8 and 3.7 g/100 g), total dietary fiber (5.9 and 6.9 g/100 g), and ash (1.9 and 1.5 g/100 g). Ishiguro et al. (2004) described a newly developed sweet potato cv. (Suioh) for utilization as vegetable greens. The nutritional composition of the greens is shown in Table I. The total polyphenol content and radical-scavenging properties of the Suioh were reported to be much higher than that of spinach, broccoli, cabbage, and lettuce (Ishiguro et al., 2004). Also, sweet
SWEET POTATO: A REVIEW
9
TABLE I NUTRITIONAL CONTENT OF SUIOH SWEET POTATO GREENS
Nutrient
Percentage (dwb)
Iron (mg/100 g) Calcium (g/100 g) Vitamin E (mg/100 g) Total carotenoid (mg/100 g)
2.6–26.4 1.2 15.8 34.7
Source: Ishiguro et al. (2004).
potato tea made from Suioh greens was more acceptable to sensory judges than other teas (Ishiguro et al., 2004). Pace et al. (1996) described the nutritional content of sweet potato greens as 4.0–6.0% protein, 8.0–12.0% carbohydrate, 60-mg/100 g calcium, and 80-mg/100 g phosphorus. Tewe et al. (2003) also reported that in some parts in Nigeria, sweet potato leaves were acceptable as soup ingredients in terms of flavor, appearance, palatability, softness, and acceptability. Islam (2006) reported that sweet potato leaves contain at least 15 biologically active anthocyanins, which are beneficial to human health and may also be useful as natural food colorants. B. PROTEIN: SWEET POTATO ROOTS
The crude protein content of sweet potato (Kjeldahl nitrogen 6.25) generally ranges from 1.3% to >10% dwb (Bradbury et al., 1985; Purcell et al., 1978). However, substantial variation has been shown to exist. Ishida et al. (2000) reported 2.1% and 1.3% protein for Koganesengan and Beniazuma sweet potato cv., respectively. Diop (1998) reported 1.0–2.4% protein in sweet potato while Bovell-Benjamin et al. (2001) and Dansby and Bovell-Benjamin (2003a) reported protein contents ranging from 1.2 0.05% to 1.8% (fresh weight) for hydroponically grown sweet potatoes. Oboh et al. (1989) analyzed 49 varieties of sweet potato sold in Nigerian markets and reported protein contents between 1.4% and 9.4%. The protein contents of sweet potato roots from 16 cv. grown in Sri Lanka ranged from 3.0% to 7.2% on dwb (Ravindran et al., 1995). Cambie and Ferguson (2003) reported 1.7% protein content for sweet potato while Gichuhi et al. (2004) reported 4.5%, 4.7%, and 9.0% protein (dwb) for cv. J6/66, Beauregard (commercial), and TU-82-155. Bovell-Benjamin et al. (2004) observed a wide variation in the protein content of three cv. of sweet potato with TU-82-155 containing almost twice as much protein (8.7 0.1%) on dwb as J6/66 (4.4 0.03%) and Beauregard (4.7 0.5%). Sporamins A and B, the major storage proteins in sweet potato, which account for more than 80% of the total protein, are also of importance (Gichuhi et al., 2004; Scott and Symes, 1996). It has been reported that sporamins A and B,
10
A. C. BOVELL-BENJAMIN
which are proteinase inhibitors, may have some anticarcinogenic properties (Maeshinia et al., 1985). Although the biological significance is still unclear, Hou and Lin (1997) reported that sporamins have antioxidant activity, acting as dehydroascorbate reductase and monodehydroascorbate reductase, which are associated with intermolecular thiol/disulfide exchange. Although regarded as a low-protein food in the United States, sweet potato serves as an important protein source to a large segment of the world’s population (Walter et al., 1984; Woolfe, 1992). For example, the highlanders of Papua, New Guinea rely on sweet potatoes as a major source of protein and for 60–90% of their energy requirements (Clark and Moyer, 1988).
C. b-CAROTENE
Globally, sweet potato has a significant role to play in the fight against vitamin A deficiency (VAD). VAD is of public health significance in developing countries, causing temporary and permanent eye impairments and increased mortality, especially among children, pregnant, and lactating women. It has been shown that more than 230 million of the world’s children have inadequate vitamin A intake, with 13 million of them being aVected by night blindness (Schweigert et al., 2003; Stephenson et al., 2000; Underwood and Arthur, 1996). Children in South Asia, eastern, western, central, and southern Africa have the highest prevalence of VAD (Mason et al., 2001). VAD is caused by habitual inadequate intake of bioavailable carotenoids (provitamin A) or vitamin A to meet physiological needs (Van Jaarsveld et al., 2005). Plant foods do not contain vitamin A, however, they contain precursors or provitamin A (b-carotene and other carotenoids), which the human body converts to vitamin A. One approach to controlling VAD is improving dietary quality and quantity through diversification. Dietary diversification includes the production of b-carotene-rich crops such as orange-fleshed sweet potato for human consumption (Van Jaarsveld et al., 2005). More than eight decades ago, Steenbock (1919) reported that sweet potato eliminated the symptoms of VAD in rats. Later, Ezell and Wilcox (1948) stressed the importance of sweet potato as a source of b-carotene. Haskell et al. (2004) concluded that daily consumption of cooked, pureed green leafy vegetables or sweet potatoes impacts positively on vitamin A stores in populations at risk for VAD. In Kenya, orange-fleshed sweet potatoes have been recognized as the least expensive year-round source of provitamin A (Low et al., 1997). Hagenimana et al. (1999) reported that consumption of orange-fleshed sweet potato increased the dietary vitamin A intake in Kenyan children and women. Another study indicated that consumption of orange-fleshed sweet potato could contribute substantially
SWEET POTATO: A REVIEW
11
to reducing VAD in sub-Saharan Africa (Low et al., 2001). The consumption of diets containing primarily orange-fleshed sweet potatoes as a source of b-carotene significantly increased serum retinol (vitamin A status) levels of Indonesian children with marginal VAD (Jalal et al., 1998). Van Jaarsveld et al. (2005) also concluded that increased consumption of orange-fleshed sweet potato could be a feasible food-based strategy for controlling VAD in children in developing countries. Sweet potato varieties exist in many colors of skin and flesh, ranging from almost pure white through cream, yellow, orange, or pink, to a very to deep purple, although white and yellow-orange flesh are the most common (Onwueme, 1978). For example, white- to cream-colored flesh sweet potatoes are common in the South Pacific, Africa, the Caribbean, and most other developing countries. In contrast, sweet potatoes commonly consumed in the United States and other developed countries, normally have yellow to orange flesh (Bradbury and Holloway, 1988). The commercial sweet potato varieties in Hawaii have white, cream, yellow to orange, and purple color flesh. The flesh colors and b-carotene content in sweet potato roots vary widely because they are aVected by genetic variety, maturity, growing conditions, postharvest storage, season, and which part of the vegetable is consumed (Hart and Scott, 1995; Hulshof et al., 1999). The intensity of the yellow or orange flesh color of the sweet potato is directly correlated to the carotenoid content (Ameny and Wilson, 1997). Sweet potato is an excellent source of carotenoid because its major carotenoid is all trans-b-carotene, which exhibits highest provitamin A activity among the carotenoids. Carotenoids, which can be red, yellow, or orange, are a diverse group of structurally related isoprenoids biosynthesized mainly by plants that have the capacity to trap lipid peroxyl radicals and singlet oxygen species (Ben-Amotz and Fishler, 1998). Provitamin A carotenoids are those which can be cleaved to yield retinaldehyde. b-Carotene, the primary carotenoid in sweet potato, is cleaved in the intestinal mucosa by carotene dioxygenase, yielding retinaldehyde, which is reduced to retinol (vitamin A). The total amount of vitamin A in foods is expressed as microgram retinol equivalents (Bender, 2002). Nutritionally, 6 mg of dietary b-carotene is equivalent to 1 mg of retinol (Bender, 2002). Provitamin A from orange-fleshed sweet potato appears to be more bioavailable than that from dark green leafy vegetables (de Pee et al., 1998; Jalal et al., 1998). Ben-Amotz and Fishler (1998) reported relatively high b-carotene content in sweet potato (Table II). Hagenimana et al. (1998a) reported varying b-carotene for orange, cream, and white flesh sweet potato roots, respectively, while Holland et al. (1991) reported b-carotene values for orange-fleshed sweet potatoes (Table II). Huang et al. (1999) reported b-carotene contents for 18 commercial varieties of sweet potato roots grown in Hawaii.
12
A. C. BOVELL-BENJAMIN
TABLE II b-CAROTENE CONTENTS OF SWEET POTATO REPORTED BY DIFFERENT RESEARCHERS
References
b-Carotene content (mg/100 g) unless otherwise indicated
Holland et al., 1991
1800–16,000
Simonne et al., 1993 Bhaskarachary et al., 1995 Hulshof et al., 1999 Ben-Amotz and Fishler, 1998 Hagenimana et al., 1998a
Dansby and Bovell-Benjamin, 2003a
100–19,000 1000 5.0 1.0 to 58.0 70.0 79.8 2130 109 to 7983 339 158 39 to 1071.3 101 19.6 6700–13,100 <0.1–0.6 7.9 0.2 4.5 0.3 1566 306
Namutebi et al., 2004 Bendech et al., 2005
6800–12,500 1911–2348
Huang et al., 1999 Sungpuag et al., 1999
Sweet potato type Orange-fleshed sweet potatoes on fresh weight basis dwb Yellow-fleshed variety ‘‘kiran’’ Indonesian sweet potato varieties dwb Orange flesh, cream flesh, white flesh Orange flesh, yellow, white, and purple flesh Raw, yellow-flesh cooked, yellow-flesh Raw, orange-flesh, hydroponic, fresh weight Orange-flesh Orange-flesh grown in Burkino Faso
The b-carotene content of raw orange-fleshed hydroponically grown sweet potato was reported by Dansby and Bovell-Benjamin (2003a). Simonne et al. (1993) reported the b-carotene content in blanched sweet potato roots from diVerent cv. (Table II). Bendech et al. (2005) reported mean b-carotene contents for orange-fleshed sweet potatoes grown in Burkino Faso as shown in Table II. Namutebi et al. (2004) and Sungpuag et al. (1999) detailed high b-carotene concentrations for orange-fleshed, and raw and cooked yellow sweet potato varieties (Table II). Traditional Indian sweet potato cv. are white fleshed and contain no carotenes, however, a new yellow-fleshed variety, ‘‘kiran’’ showed significant amounts of b-carotene, and mean b-carotene content for six samples was 1087 0.14 mg/100 g (Bhaskarachary et al., 1995). Cancer is not a rare disease in most developing countries. For example, in women, cancer cumulative mortality from cancer in developing countries is actually higher than in developed countries (Parkin et al., 2005). Several epidemiological studies have shown associations between carotenoids such as b-carotene, and decreased risk for cancer, heart disease, and age-related macula degeneration (Kohlmeier and Hastings, 1995; Niizu and Rodriguez-Amaya, 2005; Olson, 1996; Russell, 1998; van Poppel and Goldbohm, 1995). Using a case-control study, Pandey and Shukla (2002) evaluated the possible role of diet
SWEET POTATO: A REVIEW
13
in gallbladder carcinogenesis. The authors reported that a significant reduction in odds ratio (OR 0.33; 95% CI 0.13–0.83) was seen with the consumption of sweet potato, radish, and green chili. On the basis of its b-carotene content, there is a potential role for sweet potato in cancer prevention and risk reduction. D. MINERAL CONTENTS
It has been argued that the mineral content of agricultural products varies with geographic location. Makki et al. (1986) reported that in two Egyptian sweet potato cv., the mineral in highest concentration was calcium followed by magnesium, iron, copper, zinc, and manganese. However, older data reported by Ekpenyong (1984) from FAO (1972) cited phosphorous as the mineral in highest concentration for sweet potatoes. The data indicated 56-, 36-, 0.9-, 2.0-, and 387-mg/100 g for phosphorus, calcium, iron, zinc, and manganese, respectively. Olaofe and Sanni (1988) reported potassium (3617 mg/100 g) as the most abundant mineral in sweet potato roots followed by magnesium (580 mg/100 g) and calcium (112 mg/100 g). Manganese, iron, copper, and zinc were present in low amounts of 8.8, 14.0, 1–5.0, and 3.0 mg/100 g, respectively. A more extensive discussion of mineral occurrence in sweet potato is contained in Woolfe (1992). E. DIETARY FIBER
The importance of dietary fiber in noncommunicable disease prevention has been extensively discussed elsewhere (Guillon and Champ, 2000; Schneeman, 1998). Dietary fiber contains all the polysaccharides and lignin of the diet that are not digested by human enzymes (Brody, 1994). Dietary fibers include: resistant starches; cellulose; hemicellulose; b-glucans; pectins, nonstarch polysaccharides and lignin (Brody, 1994). For populations that consume sweet potato as a staple food, its dietary fiber contribution could be critical. Huang et al. (1999) reported that the total dietary fiber content of orangefleshed sweet potato cv. ranged from 2.0 to 3.2 g/100 g fresh weight, which is higher than the 0.7 g/100 g listed in the United States Department of Agriculture (USDA) database. Four purple-fleshed sweet potatoes had dietary fibers ranging from 2.3 to 3.9 g/100 g, while yellow/white-fleshed sweet potato cv. had values between 2.3 and 3.3 g/100 g (Huang et al., 1999). Crude dietary fiber ranged from 3.8% to 5.9% in 49 varieties of sweet potatoes analyzed by Oboh et al. (1989). Two Egyptian sweet potato cv., ‘‘Abees’’ and ‘‘Giza 69’’ studied by Makki et al. (1986) had crude dietary fiber contents of 5.6% and 5.7%, respectively, dwb. Total dietary fiber content of two kinds of sweet potato roots were reported as 3.4 and 2.3 g/100 g by Ishida et al. (2000).
14
A. C. BOVELL-BENJAMIN
However, in agreement with Tsou and Hong (1992), it should be noted that crude dietary fiber which consists of cellulose and lignin does not adequately express the role of sweet potato as a dietary fiber provider in human nutrition. Research is being conducted to provide consumers with a sweet potato, which is low in cellulose and lignin but high in other components of dietary fiber (Tsou and Hong, 1992).
F. ANTHOCYANINS
Until the mid-1800s, the only external sources of colorants used in food systems were natural (Gilbert, 2005). Over the next 50 years, synthetic organic dyes became the most common type of food coloring (Gilbert, 2005). However, during the last decade, the demand for food colorants from natural sources has increased because of legislative and consumer pressure to reduce the use of synthetic additives in foods (Giusti and Wrolstad, 2003). Evidence of this trend is reflected in food industry’s replacement of synthetic dyes such as FD&C red 40 and the banned FD&C red 2 with natural plant colorants (Fabre et al., 1993). Additionally, most natural colorants are bioactive, and they add status to food products marketed as ‘‘natural’’ and ‘‘organic.’’ Anthocyanins are a large group of water-soluble pigments responsible for the attractive orange, red, purple, and blue colors of fruits and vegetables (Plata et al., 2003). Anthocyanins extracted from plants are commonly used in soft drinks, jams, confectioneries, and bakery products as a natural colorant (Plata et al., 2003). Deep purple sweet potato flour (SPF) and paste are also used as coloring materials for bread, snacks, and noodles (KNAES, 1995). Cevallos-Casals and Cisneros-Zevallos (2002) reported Peruvian, purple sweet potato colorant as having much higher color retention and more stability than commercial red grape colorant. Additionally, there is an increasing demand for carotenoids, such as b-carotene, as food colorants because of their natural origin, lack of toxicity, and flexibility of providing both lipo- and hydrosoluble colorants (Ben-Amotz and Fishler, 1998; Cinar, 2005). Consumption of the sweet potato has always been associated with good health and enhanced human nutrition. However, limited research has addressed the role of sweet potato in human nutrition and health. In human life, cell damage from oxygen free radicals (OFRs) is ubiquitous. OFRs are known to have carcinogenic potential (Dreher and Junod, 1996). Dietary or natural antioxidants such as carotenoids are said to be protective against the eVects of OFRs. Antioxidants exert their eVect on OFRs by neutralizing them (Scheibmeir et al., 2005). It has been reported that white, yellow, orange, and purple-fleshed sweet potato cv. have antioxidative and radical-scavenging activities, with the purple
SWEET POTATO: A REVIEW
15
Ayamurasaki
FIG. 3 Ayamurasaki sweet potato with high-antioxidative and radical scavenging activities (Cevallos-Casals and Cisneros-Zevallos, 2002; Furuta et al., 1998).
ones such as cv. Ayamurasaki (Figure 3) having the highest activity (CevallosCasals and Cisneros-Zevallos, 2002; Furuta et al., 1998). Antioxidant activity of purple sweet potato was observed to be 3.2 times higher than that of a blueberry variety (Cevallos-Casals and Cisneros-Zevallos, 2002). Interestingly, the antioxidant activity in sweet potato skin was found to be almost three times higher than in the rest of the tissue. Animal studies have shown that when purple sweet potato juice from cv. Ayamurasaki was fed to rats it reduced liver injury induced by carbon tetrachloride (Suda et al., 1998). Persons consuming cv. Ayamurasaki juice daily for 44 days eVectively decreased the blood serum levels of l-guinidine triphosphate (GTP), glutamin-oxaloactive transaminase (GOT), and glutamin-pyruvic transaminase (GPT) (indicators of liver injury) (Suda et al., 1998). Suda et al. (2003) reported that purple-fleshed sweet potato is a good source of anthocyanin. Some foods contain mutagens, which are associated with carcinogenesis. Purple-fleshed sweet potato roots were reported to have high antimutagenic activity (Yoshimoto et al., 1999). Various studies have reported the relationship between consumption of anthocyanin-rich foods and improved health. Health benefits associated with anthocyanin extracts include chemopreventive activities such as antimutagenicity and antioxidative potential (Table III). It has also been shown that a glycolipid (ganglioside) found in sweet potato juice reduces the multiplication of cultured human cells in cancers of the womb neck and melanoma (Shimozono et al., 1996). Sweet potato juice has been associated with antihypertensive and antidiabetic properties (Kusano and Abe, 2000; Matsui et al., 2001; Suda et al., 1998). Further, the anthocyanins, chlorogenic acid, and other polyphenolic compounds in sweet potato have the capability to inhibit carcinogens generated during food processing and cooking.
16
A. C. BOVELL-BENJAMIN
TABLE III POSSIBLE HEALTH BENEFITS ASSOCIATED WITH ANTHOCYANINS
Possible health benefit
References
Chemopreventive activities (e.g., antimutagenicity) Vasoprotective and antiinflammatory properties Enhancement of sight acuteness Antidiabetic, controlling diabetes, and antineoplastic agents Hepatoprotective Vasotonic agents Radiation-protective agents Antioxidant capacity
Karaivanova et al., 1990; Morazzoni and Magistretti, 1986 Lietti et al., 1976
Antihypertension Fibrocystic disease of the breast
Politzer, 1997; Timberlake and Henry, 1988 Kamei et al., 1995; Matsui et al., 2002, 2004; Scharrer and Ober, 1981 Mitcheva et al., 1993 Colantuoni et al., 1991 Akhmadieva et al., 1993; Minkova et al., 1990 Islam et al., 2002, 2003; Prior et al., 1998; Rice-Evans and Miller, 1996; Tamura and Yamagami, 1994; Wang et al., 1997 Suda et al., 1998; Yoshimoto, 2001 Leonardi, 1993
Sweet potato also contains the coumarins scopoletin (3, R —H), aesculetin (3, R —OH), and umbelliferone (3, R —OMe) compounds, which have anticoagulation properties and are postulated to inhibit HIV replication (Weiss and Finkelmann, 2000). The sweet potato could be considered as an excellent novel source of natural health-promoting compounds, such as anthocyanins, for the functional food market. Ultimately, this could increase utilization and demand for the crop by consumers, and the food industry. In sum, the commonly consumed white to cream-colored-flesh sweet potatoes in the South Pacific, Africa, the Caribbean, and most other developing countries contain less b-carotene than the orange-fleshed sweet potato. Orange-fleshed sweet potato is one of the most promising plant sources of b-carotene (Hagenimana and Low, 2000). However, it should be noted that although orange-fleshed sweet potato roots contain abundant amounts of b-carotene, the content decreases over time with processing (van Hal, 2000). Sungpuag et al. (1999) also demonstrated that boiling yellow-fleshed sweet potato resulted in further loss (43%) of b-carotene. Increased consumption of fresh orange-fleshed sweet potato roots and sweet potato-based processed foods in developing countries could contribute substantially toward improving vitamin A nutrition and enhancing food security. Sweet potato contains b-carotene and other dietary carotenoids, which have anticancer properties. The high concentration of anthocyanin and b-carotene in sweet potato combined with the high stability of the color extract make it a promising and healthier alternative to synthetic coloring agents in food systems.
SWEET POTATO: A REVIEW
17
IV. SWEET POTATO UTILIZATION AS VALUE-ADDED PRODUCTS IN HUMAN FOOD SYSTEMS Over the last 40 years, utilization of the sweet potato has shifted from being a ‘‘subsistence,’’ ‘‘food security,’’ or ‘‘famine relief’’ crop in some developing countries. Although traditional uses are still important in many countries, new uses are emerging, especially in China and parts of sub-Saharan Africa. Average annual per capita consumption of fresh roots for 1994–1996 was estimated at: 73, 18, 9, 7, 5, and 2 kg in Oceania, Asia, Africa, Japan, Latin America, and United States, respectively (FAO, 1997). In contrast to potato, per capita sweet potato consumption in Canada, Europe, and Australia is extremely limited and often confined to immigrant populations. In the developing world, sweet potato consumption varies by countries, regions, season of year, and income. For example, in Africa annual per capita sweet potato consumption in Rwanda is estimated at 160 kg; Burundi, 102 kg; and Uganda 85 kg. In northeast Uganda (one of the poorest parts of that country), sweet potato becomes a seasonal staple during the dry season when most other foodstuVs are in short supply. Currently, US per capita consumption is roughly 9.5 kg down from a recorded high of 30.6 kg in 1949. Several years ago, Carver (1918) recognized and demonstrated the importance of processing the sweet potato into value-added products by encouraging economically deprived farmers in the southern United States to grow and process it. Approximately 100 new products were processed from the sweet potato in Carver’s era, including flour, starch, sugar bread, mock coconut, tapioca, and vinegar (Carver, 1918). Additionally, SPF has been fermented to make products such as soy sauce and alcohol, or if immediately cooked, could be further processed into wine, vinegar, and ‘‘Nata de coco.’’ ‘‘Nata de coco’’ is a popular dessert or ‘‘on-the-go’’ food in the Philippines, and adjacent Asian countries, and is becoming very popular in Japan. It is a chewy, translucent, ready-to-eat mixture of coconut, sweet potato, and fruit, which resembles the American canned ‘‘fruit cocktail.’’ Today, long after Carver’s era, most of the global sweet potato production is marketed as cleaned, but otherwise unprocessed roots (Burden, 2005). Unprocessed sweet potato roots have a short shelf life compared to carrots, white potatoes, and so on, and they are diYcult to store. In developing countries, where limited transport infrastructure exists, processing the sweet potato into value-added products provides an alternative to the diYculties associated with storage and transport of the raw roots (Dansby and Bovell-Benjamin, 2003a). Furthermore, vegetable industry data suggest that 15% of all vegetables marketed in the United States are now in more consumer-friendly, convenient forms (Burden, 2005). If the sweet potato is to gain increased market visibility
18
A. C. BOVELL-BENJAMIN
and play a more important role in human nutrition, some of the total production must be converted into more consumer-friendly, convenient forms such as: (1) ‘‘minimally processed’’(ready-to-use—peeled and packaged or peeled, cut, and packaged); (2) ‘‘intermediate processed’’ (bulk ingredients such as flour and starch for use in other products, and so on); and (3) ‘‘preprocessed’’ (readyto-eat products). The following sections discuss some potentially feasible value-added products from the sweet potato. V. SWEET POTATO STARCH UTILIZATION IN HUMAN FOOD SYSTEMS In developing countries, sweet potato oVers much potential for income generation through small-scale processing because they are eYcient producers of carbohydrate. Carbohydrates could be converted into stable intermediate bulk ingredients (starch and flour) that are suitable for diverse markets in the food industry (Wheatley et al., 1996). Bulk ingredients from the sweet potato can be incorporated into the menus for astronauts and human food systems by further processing them into convenient, ready-to-use products. For example, sweet potato starch (SPS) can be enzymatically processed into diVerent products such as glucose syrup, which have a wide range of applications in the food and pharmaceutical industries (Sarikaya et al., 2000). Starch is very versatile with a number of uses in most major industries, but in developing countries, it is used predominantly to make processed foods. Worldwide, the biggest user of starch is the sweetener industry. In the food industry, starch is used to impart ‘‘functional’’ properties to processed foods such as thickening, binding, and filling. Starch is also used in canned soups, instant desserts, ice creams, noodles, processed meats, sauces, and bakery products. It can be processed into sweeteners and syrups, and in the manufacture of monosodium glutamate, a taste enhancer (Fuglie and Oates, 2002; Zhang and Oates, 1999). About 5% of total SPS production is used for making distilled spirit ‘‘shochu’’ in Japan as well as lactic acid, butanol, acetone, vinegar, and yeast (Woolfe, 1992). SPS has been successfully used to thicken chocolate pudding at Tuskegee University (HoVman and BovellBenjamin, 2001). Major users of starch in nonfood industries include the textile, paper, plywood, and adhesive industries and pharmaceuticals. Starch is a naturally occurring biopolymer in which glucose is polymerized into amylose, an essentially linear polysaccharide, and amylopectin, a highly branched polysaccharide. Starch occurs in plant tissues in the form of discreet granules whose size, shape, and form are unique to each botanical species (Woolfe, 1992). Sweet potato roots contain approximately 80–90%
SWEET POTATO: A REVIEW
TCAM-SB
0000
30 kv 10 µm
19
×2.000
FIG. 4 Scanning electron micrographs of sweet potato starch granules (Miller et al., 2003).
carbohydrate, mainly starch, making it a good raw material for the starch industry (Garcia and Walter, 1998; Lu and Sheng, 1990; Miller et al., 2003). Brabet et al. (1998) evaluated 106 sweet potato clones and reported an average total starch content of 61.5% dwb. Miller et al. (2003) reported 81% starch content on dwb in SPS. According to Woolfe (1992), sweet potato starches occur in oval-, round-, or polygonal-shaped granules, and mean granule size ranges from 12.3 to 21.5 mm. Bovell-Benjamin et al. (2004) isolated SPS and reported granule sizes in the range of 9.0–34.2, 2.6–15.8, and 5.3–21.8 mm for J6/66, Beauregard, and TU-82-155 cv., respectively (Figure 4). These findings were consistent with those of Mandamba et al. (1975) and Chen et al. (2003) who reported the same phenomenon for the granule size of three Chinese sweet potato cv. Kays (1992) also reported a range from 1 to 30 mm for SPS granules. Starch processing from sweet potato can create new economic and employment activities for farmers and rural households and can add nutritional value to food systems. Conversion of sweet potato to starch should be especially attractive to developing countries because it can help to lessen the need for imported materials, which reduces import bills (Garcia and Walter, 1998). For example, sweet potato accounted for 26% of starch production in Asia, and the global SPS production of 4.15 million metric tonnes in the early 1990s came from Asia (Ostertag, 1993). SPS is widely used in a variety of food and industrial applications in Asia (Tian et al., 1991). An industry based on SPS extraction has been developed in several regions in China (Li et al., 1991) and may account for more than two million tonnes annually, but the statistics are not quite precise (Wheatley and Bofu, 2000). The starch is utilized primarily
20
A. C. BOVELL-BENJAMIN
for the production of traditional noodles, although some factories use it for production of derived products such as maltose. For noodles, starch quality is an important factor, and starch from sweet potato is preferred over starch from other crops such as corn and cassava (Fuglie and Oates, 1990). Vietnam exports about 840 tonnes of sweet potato annually to China for production of maltose and glucose syrups, which are used in the manufacture of baby foods in some developed countries. Recently, SPS has emerged as a commercially important value-added product in the Philippines with the institution of three starch plants in the last 9–10 years (Collado et al., 1999). CIAD et al. (1996) assessed the potential demand for SPS in both food and nonfood industries in China, and industry estimated starch demand at over 200,000 million tonnes versus 100,000 million tonnes of maize starch actually supplied to the industrial sector. This situation reflects a great potential for SPS in human food systems, although some uncertainties have been reported. Researchers have reported that starches from diVerent sweet potato cv. exhibit a variety of nutritive, physical and sensory properties, such as higher starch content and more extractable starch (Madhusudhan et al., 1996). Maximizing starch yield from the sweet potato requires varieties with high dry matter and starch contents; however, these genetic characteristics can be manipulated. Ideally, for most food products SPS should have a smooth texture, which is consistently soft and flexible at low temperature and must be able to retain its thickening power at high temperature (Garcia and Walter, 1998). In SPS production, quality of the fresh root and the amount of extractable starch are important because of their influence on final product quality and eVects on process eYciency. The key issue in SPS production is product quality, especially the chemical (ash, protein, fiber, and so on) and functional properties of the starch itself. Wheatley and Bofu (2000) reported that SPS has low viscosity values on pasting when compared with potato starch, and it may not be suYciently white in color. However, Miller et al. (2003) reported L* color values of SPS, which are comparable to those of cornstarch. Excessive moisture content, as high as 15%, has been reported for SPS, but Miller et al. (2003) and Bovell-Benjamin et al. (2004) reported a 4.4 0.2%, 5.0 0.2%, and 6.0 0.3% moisture contents for starch extracted from three sweet potato cv. (J6/66, TU-82-155, and Beauregard, respectively). Garcia and Walter (1998) extracted starch from seven sweet potato cv. and reported moisture levels extending from 9.8% to 15.3%. The limited chemical properties (impurities) reported could be addressed through process improvements such as more eVective separation, additional purification steps, and more eYcient drying. For example, in China, Timmins and Marter (1992) added ‘‘sour liquid’’ from a traditional fermentation process (liquid fermentate from peas or
SWEET POTATO: A REVIEW
21
beans) at the separation stage to remove impurities, which produce oV-colors in the SPS (Figure 5). The process of starch isolation from the sweet potato using a modified technology with more eYcient drying is shown in Figure 5. The functional properties of SPS can be manipulated by processing (milling, sifting) as well as by cv. selection and chemical or enzymatic modifications. The seasonal nature of the sweet potato harvest limits the processing period,
A Freshly harvested sweet potato roots Water Washing Washed roots Water Grinding SP slurry (mash) Water
Extraction
Sieving SP starch slurry Sweet potato residue (pig feed)
Aqueous solution (drain)
Sour liquid solution (1st liquid)
Sour liquid solution (2nd liquid)
(Mix) Sedimentation (1) Wet starch (Mix) Sedimentation (2) Wet starch
Sour liquid Purification Water
(Mix) Sedimentation (3) Wet starch
Dewatering Moist starch
Aqueous solution (drain) Drying (sun)
Dry sweet potato starch
FIG. 5 (continued )
Final preparation
22
A. C. BOVELL-BENJAMIN B
Water
Sweet potato roots
Wash, peel, weigh
Water, dirt
Homogenize (2:1 water to sweet potato ratio)
Centrifuge (3000 rpm, 5 minutes)
Decant
Repeat last two steps Moist starch
Dehydrate (708C, 12 hours)
Grind
Mill
Sweet potato starch
FIG. 5 Procedures for sweet potato starch production. (A) Sweet potato starch production by the sour-liquid method (Timmins and Marter, 1992). (B) Sweet potato starch isolation (Miller et al., 2003).
and such constraints help to make large-scale investment in production of SPS uneconomic. However, small- and medium-scale enterprises may not suVer from this drawback. The summaries of the following studies demonstrate the potential usefulness of SPS in human food systems in space and on Earth.
SWEET POTATO: A REVIEW
23
A. BULK INGREDIENTS FROM THREE CV. OF SWEET POTATOES: COMPOSITION AND PROPERTIES (BOVELL-BENJAMIN ET AL., 2004)
The study processed three sweet potato cv. into starch and evaluated the suitability of the starch for use as a bulk ingredient on space flights and on Earth. Starch was isolated from TU-82-155, Beauregard, and J6/66 cv. as shown in Figure 5B, and X-ray diVraction (XRD) was used to determine starch crystallinity level. The protein, ash, moisture, carbohydrate, and fat contents of starch from the three diVerent cv. were similar (Table IV). Figure 6 shows the XRD patterns of the three sweet potato starches, as well as that for TU-82-155 hydroponically grown sweet potato. The Beauregard, J6/66, and the hydroponic sweet potato starches had similar XRD patterns. However, the field grown TU-82-155 exhibited only one XRD peak, indicating that the sample was almost entirely amorphous. According to Morris et al. (2005), the strong ˚ spacings are consistent with the presence of crystallites character3.8- to 5.8-A ized by a hexagonal array of sixfold amylase double helices, whose central channel is occupied by another double helix. This structure, which is typical of cereal starch crystallites, was also recognized in SPS. These results suggest that it is possible to relate the functional properties of the SPS to the XRD patterns, and hence predict their potential use in human food systems. B. EFFECTS OF PROCESSING TECHNOLOGY ON SPS YIELD AND QUALITY (JIANJUN, 2004)
The eVect of processing technologies that aVect the quality and extraction rate of SPS was examined by orthogonal design. An orthogonal test was made with nine trials which included three combinations of technologies on milling method, separating fineness, and precipitation method of starch extraction from ‘‘Xushu 18’’ sweet potato cv. Two sets of technology to enhance starch quality and extraction rate were identified. Recommendations to improve
TABLE IV PROXIMATE COMPOSITION STARCH PROCESSED FROM THREE SWEET POTATO CV.
Cultivar
Moisture (%)
Carbohydrate (%)
Protein (%)
Ash (%)
Fat (%)
J6/66 TU-82-155 Beauregard
4.4 0.2 5.0 0.2 6.0 0.3
93.6 92.8 92.1
1.3 0.0 1.2 0.0 1.1 0.1
0.6 0.01 0.7 0.04 0.6 0.01
0.1 0.1 0.3 0.2 0.2 0.1
Source: Bovell-Benjamin et al. (2004).
24
A. C. BOVELL-BENJAMIN
FSST 100
50
0 BSS 100
Intensity (counts)
50
0 HSST 100
50
0 JSS 100
50
0 5
10
15
20 25 2-Theta (8)
30
35
40
FIG. 6 X-ray intensity curves for starch from three sweet potato cv. FSST, starch from TU-82-155 cv. (field grown); BSS, starch from Beauregard cv.; HSST, starch from TU-82155 cv. (hydroponic); JSS, starch from J6/66 cv. (Greene, 2003).
SWEET POTATO: A REVIEW
25
starch quality were the combination of saw tooth milling at 1000 rpm, separation using 120-size mesh, and precipitation with sour liquid. A combination of hammer mill in 4200 rpm, separation using 120-size mesh, and natural precipitation was recommended to improve extraction rate. C. PHYSICOCHEMICAL AND VISCOMETRIC PROPERTIES OF AN SPS SYRUP (MILLER ET AL., 2003)
This study processed syrup from SPS and determined its physicochemical [refractive index (RI) and color] and viscometric properties during storage at 21 3 and 4 C. SPS was isolated from field-grown Hillbilly sweet potato cv. (Figure 5B). The SPS was rehydrated, heated to 102 C, treated with a-amylase at 90 C for 5 hours, cooled, and further treated with glucoamylase at 62.5 C for 12 hours (Figure 7). The solutions were filtered, evaporated, and cooled. RI, color, and viscometric properties were measured. The RI of the sweet potato syrup was significantly higher (p < 0.01) than that reported in the literature (1.42 0.02 vs 0.66). The mean L*, a*, and b* values of the syrups were 68.8 0.6, 0.7 0.1, and 18.7 0.6, respectively.
Sweet potato starch and water L I Q
Heat to 1028C Thermostable bacterial α-amylase Incubate at 1028C
Dextrins (branched and linear) Cool adjust to pH 6.4
Glucoamylase S A C
300 µl, incubate at 62.58C, 12 hours Filtration and evaporation
High glucose syrup
FIG. 7 Overview of enzymatic hydrolysis of sweet potato starch into glucose syrup. LIQ ¼ Liquefaction, SAC ¼ Saccharification (Bovell-Benjamin et al., 2005).
26
A. C. BOVELL-BENJAMIN
The mean viscosity of the sweet potato syrup was 1.98 Pas at room temperature and 0.95 Pas at 4 C. The viscosity for the sweet potato syrup gradually increased as storage time increased. With syrups stored at both temperatures, increased shear stress decreased their viscosities. However, when a commercial corn syrup was tested under the same conditions, there was no decrease in viscosity as shear stress increased. Overall, the SPS syrup had RI, color, and viscosity comparable to that of the commercial corn syrup. D. EFFECTS OF pH AND CONCENTRATION TIMES ON SELECTED FUNCTIONAL PROPERTIES OF A SWEET POTATO SYRUP (YOUSIF-IBRAHIM ET AL., 2003)
The overall objective of this study was to optimize previously developed sweet potato syrup. Specifically, the study determined the eVect of varying pH and time at the liquefaction and concentration stages, respectively, on the moisture, RI, color, and yield of an SPS (Figure 10). SPS was used to process three syrups in which the protocol remained constant, except for the pH and concentration times. At the liquefaction stage, the pH was adjusted to 6.4, 7.0, and 8.0 for Syrup A (SPSA), Syrup B (SPSB), and Syrup C (SPSC), respectively. At the concentration stage, the syrups were exposed to 35, 40, and 43 minutes of heat. The moisture content of the syrups concentrated for 35 minutes was significantly (p < 0.05) diVerent, with the SPSC having the highest moisture. Similarly, the moisture content for the SPSC heated for 40 minutes was highest, but lowest when heated for >43 minutes. The mean refractive indices were similar for the syrups, ranging from 1.4 to 1.5. As the concentration time increased, the L* value decreased for the syrups, with SPSA being lightest in color at all concentration times. At all concentration times, the total syrup yield from 60-g SPS was highest for SPSC. The syrup with pH 8.0, and 40 minutes, at the liquefaction and concentration stages, respectively, had the most desirable RI, color, and overall yield. E. INFLUENCE OF a-AMYLASE ON THE PHYSICAL PROPERTIES AND CONSUMER ACCEPTABILITY OF SPS SYRUP (BOVELL-BENJAMIN ET AL., 2005)
Technology was developed on a laboratory scale for the production of SPS syrup, and the eVect of varying levels of a-amylase on syrup quality, storage stability, and consumer acceptance were evaluated. Three levels of thermostable bacterial a-amylases (1.5, 3.0, and 4.5 ml) were used for conversion of SPS into glucose syrup. The 1.5-ml a-amylase-treated SPS was dropped
SWEET POTATO: A REVIEW
27
from the experiment because there was no hydrolysis. The enzymatic conversion of SPS into glucose was significantly higher (p < 0.05) for the 4.5-ml a-amylase-treated compared to the 1.5 and 3.0 ml levels. The RI was 1.5 and 1.4 for the 4.5 and 3.0 ml a-amylase-treated syrups, respectively, while moisture content (16.7 vs 12.5) and Brix (65.0 vs 57.0) were higher for the 4.5 ml a-amylase-treated syrup. Syrups were stored at room (RSPSS) and refrigerated (RESPSS) temperatures. During storage, the L* color value for RESPSS was significantly higher ( p < 0.05) than that of RSPSS. Similarly, the Brix was 64.1 1.1 and 66.0 1.7 for the RSPSS and RESPSS, respectively. The RSPSS was stable for 12 weeks. The sweet potato starch syrup (SPSS) and two commercial syrups (maple and ginger) were evaluated by 112 children between the ages of 12 and 13 years on a nine-point hedonic scale with plain waZe as a ‘‘carrier.’’ For the younger children, there were no significant diVerences in liking between the SPSS (6.1) and maple syrup (5.8). However, the mean preference for the ginger syrup was significantly less (p < 0.001). Overall, the SPSS had acceptable physical and consumer properties, indicating the need for further research to convert it into a commercially viable product.
F. SENSORY AND CONSUMER EVALUATION OF SPS SYRUP (MILLER ET AL., 2003)
This study evaluated selected sensory attributes of SPS using a modified magnitude estimation (ME) procedure, and determined consumer acceptance using a nine-point hedonic scale. A syrup made from hydroponic sweet potato starch (HSPS) was tested against two commercial control (ginger and corn) syrups. For the ME, 11 undergraduate students on Tuskegee University campus were trained as judges to do ME scaling. The judges were trained in ratio scaling by contrasting a reference line with relative lengths of experimental lines in random order in proportion to the fixed modulus of 15 (Giovanni and Pangborn, 1983). The three syrups were evaluated in triplicate with the modulus anchored at ‘‘30.’’ Five attributes, namely, mouthfeel, pourability, aroma, sweetness, and color were evaluated. The samples were evaluated relative to the modulus, for example, if a sample was twice as sweet as the modulus, it would be assigned the value of ‘‘60.’’ For the consumer testing, 43 untrained judges evaluated the syrups for color, sweetness, aroma, viscosity, and overall preference. The pourability of the HSPS and corn syrups was significantly ( p < 0.05) higher than the ginger syrup, which is a more desirable feature for consumers. The ME judges scored the HSPS as having a more desirable color than both commercial syrups. Ratings for the HSPS and ginger syrups were similar for the aroma attribute, but significantly higher for the corn syrup. The ginger
28
A. C. BOVELL-BENJAMIN
and corn syrups were equally sweet, but the HSPS was significantly ( p < 0.05) less sweet. Consumers liked the color HSPS and corn syrups moderately (7.0 score on the hedonic scale), and this is promising because a 7.0 indicates that it is highly likely the particular attribute will be acceptable to consumers. The viscosity of the HSPS was also liked slightly and equally well as the commercial ginger syrup. However, the sweetness and aroma attributes were disliked slightly. Further optimization of the HSPS syrup such as isomerization into fructose syrup could help to improve the sweetness and aroma attributes. VI. ADVANCES IN SPF PRODUCTION AND UTILIZATION FOR HUMAN FOOD SYSTEMS Peters and Wheatley (1997) conducted an in-depth diagnostic assessment of the feasibility of establishing a household-level SPF processing industry in East Java. Their results identified SPF as a promising product to increase rural income with potential markets in bakery, noodle, and various snacks. This finding is also relevant to other developing countries such as Kenya, Uganda, and Nigeria where the potential for small-scale SPF production was identified as an alternative for traditional flours (Hagenimana and Owori, 1996; Hagenimana et al., 1995; Omosa, 1994). SPF could be marketed as a low-cost alternative to imported wheat flour, thus reducing bakery costs and foreign exchange bills. For example, Peters and Wheatley (1997) postulated that for a 5% substitution rate, the potential savings from wheat import reductions for Indonesia would be US$40,000,000 based on 1995 import volume and value. SPF can also serve as a source of carbohydrate, b-carotene, minerals; can add natural sweetness, color and flavor to processed products; and can prevent food allergies in some instances (van Hal, 2000). Food allergies have become a public health issue in many countries including the United States (Maleki, 2001). Cereals containing gluten are ranked among the eight most common causes of food allergy (Taylor and Hefle, 2001). It is estimated that up to 5% of the population has serious allergies to some foods, including the gluten in wheat (Mannie, 1999). Celiac disease aVects the small intestines due to sensitivity to gluten present in certain cereals including wheat, wheat starch, rye, barley, triticale, and probably oats, and the only eVective treatment is strict adherence to a 100% gluten-free diet for life (Caperuto et al., 2000). SPF can serve as an alternative for individuals diagnosed with celiac disease or with allergies to the gluten in wheat. Perhaps, more importantly, van Hal (2000) estimated that SPF could contribute 0–100%, 20%, 20–40%, 17%, and 10% of the daily nutrient needs [based on the recommended daily allowances (RDA)] for b-carotene, thiamin, iron, vitamin C, and protein, respectively. SPF can also be used
SWEET POTATO: A REVIEW
29
directly or as a raw material for processing into other products. A variety of products such as doughnuts, biscuits, muYns, cookies, fried sweet potato cakes, extruded sweet potato chips, ice creams, porridge, brownies, pies, breakfast foods, and weaning foods have been made from SPF (Fuglie and Hermann, 2004; Greene, 2003). In India, dried sweet potatoes grounded into flour are used to supplement flours in bakery products, chapatis, and puddings, while in the Philippines, dried sweet potato chips are pounded into flour for use in gruel (Nair et al., 1987). The steps involved in processing sweet potato into flour are shown in Figure 8. The ratio of the weight of the flour to the weight of the fresh sweet potato roots expressed as a percentage is termed the yield or conversion rate. Limited information regarding flour yields from sweet potato is available, but it is known that flour yield is dependent on factors such as sweet potato cv., technologies used, and the dry matter of the final flour. Dawkins and Lu (1991) reported a 13–18% yield in flour prepared from steam blanched, microwave blanched, and unblanched sweet potatoes. A flour yield ranging from 17% to 38% for diVerent sweet potato cv. was also reported by Gakonyo (1993a). Two Philippine sweet potato cv. Georgia Red and Ilocos Sur were reported to yield 12 and 37 kg, respectively, of flour from 100-g fresh roots (Van Den, 1984). Dansby and Bovell-Benjamin (2003a) calculated the mass balance for flour made from hydroponic sweet potato and reported a yield of 15%. Average sweet potato root:flour conversion rates ranging from 23% to 27% were reported by Peters et al. (2005). Suismono (1995) reported 24% fresh root:flour conversion rate, while Martin (1984) reported a 17–38% range. Peters and Wheatley (1997) calculated the data from two on-farm trials, and the fresh
Fresh sweet potato roots
Grind
Mill
Weigh, wash
Dehydrate, 708C, 12 hours
Peel, wash
Shred
Sweet potato flour
FIG. 8 Production of sweet potato flour (Dansby and Bovell-Benjamin, 2003a).
30
A. C. BOVELL-BENJAMIN
root:flour conversion rates were approximately 20%. Overall, the reported literature indicates that fresh sweet potato root:flour conversion rate ranges from 13% to 38%. Variations in yield could be aVected by factors such as drying times, cv., processing methods, and calculations. It is important to understand the functional, physical, and chemical characteristics of SPF if its suitability for use in value-added products has to be determined. Previous researchers have noted a lack of information on SPF quality. For example, Hagenimana and Owori (1996) mentioned that SPF is very convenient for utilization by the food industry, but its quality and shelf life are not documented. The quality characteristics of SPF include high starch content, white color, low acidity, crude fiber, and ash contents (Antarlina, 1990). The moisture content of SPF is especially important because high moisture can speedup chemical or microbial deterioration (van Hal, 2000). According to Woolfe (1992) and Collado and Corke (1999), the moisture content of SPF ranges from 4.4% to 13.2%. Reddy and Basappa (1997) prepared SPF using diVerent peeling methods: hand, lye, mechanical abrasive, no peeling, and no peeling and cooking. Final SPF had moisture contents between 9.3% and 12.6%. The sensory, nutritional, and microbiological quality of SPF processed from nonsoaked and soaked slices using minimum amounts of water were compared by Owori and Hagenimana (2000). The moisture contents of SPF soaked for 0, 30, 60, and 90 minutes are shown in Table V. Fuglie and Hermann (2004) and TABLE V MOISTURE, CARBOHYDRATE, PROTEIN, AND b-CAROTENE CONTENTS OF SWEET POTATO FLOUR
References
Moisture (%)
Carbohydrate
Protein (%)
b-Carotene (mg/100 g)
SWEET POTATO: A REVIEW
31
Dansby and Bovell-Benjamin (2003a) also evaluated the moisture contents of SPF processed from conventionally and hydroponically grown sweet potatoes (Table V). The hydroponic SPF had lower mean initial moisture than those reported by Woolfe (1992) and Collado and Corke (1999). However, the final moisture content is dependent on the drying method and time. The bulk of SPF is carbohydrate between 85% and 95% dwb, but this varies according to cv. Several researchers have reported the total carbohydrate content of SPF as ranging from 86.1% to 94.8% dwb (Gurkin-Ulm, 1988; Maneepun et al., 1992; Woolfe, 1992). Dansby and Bovell-Benjamin (2003a) reported carbohydrate values for hydroponic SPF stored for 5 months at room and refrigerated temperatures (Table V). Yadav et al. (2005) determined the eVect of drying methods (native, drum dried, and hot air-dried) on the functional properties of SPF from red- and white-skinned sweet potato. Fuglie and Hermann (2004) documented carbohydrate content for a complex instant SPF as shown in Table V. The protein content of SPF is usually low, ranging from 1.0% to 14.2% (Collado et al., 1997; Woolfe, 1992). Owori and Hagenimana (2000), Dansby and Bovell-Benjamin (2003a), Yadav et al. (2005), and Fuglie and Hermann (2004) reported protein values for SPF (Table V). The b-carotene content of SPF processed from hydroponically grown sweet potato reported by Dansby and Bovell-Benjamin (2003a) was within the range of that reported by Woolfe (1992) for field-grown sweet potatoes (Table V). Total dietary fiber of SPF was reported to range between 11.0 0.1% and 17.6 0.3% by Dansby and Bovell-Benjamin (2003a) and Yadav et al. (2005), respectively. Dietary fiber content of SPF is between 0.4% and 13.8% (van Hal, 2000). Fuglie and Hermann (2004) reported 2% crude dietary fiber in SPF. SPF has higher amounts of b-carotene than wheat products and is an eVective way of increasing dietary carotenoid intake. Although SPF is identified as one of the most promising sweet potato products, its quality and storage stability need to be further researched. Dansby and Bovell-Benjamin (2003a) evaluated the proximate composition and color of processed hydroponic SPF during storage. The researchers concluded that the storage temperatures and time (4 or 21 4 C for 5 months) did not significantly aVect the proximate composition and color of the SPF. However, although no discoloration or browning of the SPF was observed, the flour stored at 21 4 C lost more of the orange/yellow color than that stored at refrigerated temperature. Orbase and Autos (1996) found that there was no discoloration in flour from four sweet potato cv. stored for 6 months in polyethylene, cotton, and polyethylene/cotton packaging. No deterioration was observed in flour stored for 5–7 months in polyethylene and polypropylene bags (Woolfe, 1992). Similarly, Gurkin-Ulm (1988) reported that the proximate composition and dietary fiber of SPF stored for 1.5 month were
32
A. C. BOVELL-BENJAMIN
not aVected by storage time, temperature, or atmosphere. In general, the SPF retains most of the nutritional composition of fresh sweet potato roots, and many advances have been made in the technology of SPF production, its storage stability and nutrition, making the flour a highly feasible, commercial value-added product. Many studies have reported the feasibility of using SPF as an alternative to wheat especially in bakery products. Woolfe (1992) reported that at SPF substitution levels above 20%, bread became unacceptable in terms of loaf volume, flavor, and texture. In Peru, commercial bakeries are producing widely accepted bread supplemented with 15% and 30% sweeet potato (Huaman, 1992). The technology has advanced, and substitution levels as high as 65% SPF have resulted in bread with acceptable loaf volumes, flavor and texture. For example, breads supplemented with 50%, 55%, 60%, and 65% SPF had acceptable texture and loaf volumes (Greene et al., 2003). Marklinder et al. (1996) considered barley sourdough bread that yielded volumes >450 ml as acceptable, and 990-ml loaf volume for standard wheat bread as acceptable. The studies reported below illustrate the advances in utilization of SPF. A. BREADMAKING PROPERTIES OF SPF (GREENE ET AL., 2003)
There is limited research regarding the processing of sweet potato bread. The objectives of this research were to: (1) determine the chemical properties (moisture, loaf volume, and texture) of bread supplemented with diVerent levels of SPF, and (2) evaluate the structural properties of bread supplemented with diVerent levels of SPF using scanning electron microscopy (SEM) and diVerential scanning calorimetry (DSC). Whole-wheat bread formulations were supplemented with 50%, 55%, 60%, and 65% SPF. The maximum percentage strain required to cut the breads into two pieces was used to indicate texture (firmness). The Jeol 5800 SEM and DSC 2010 were used to determine the morphological structure and enthalpies of the breads, respectively. The moisture contents of sweet potato bread ranged from 36.8 0.7% to 40.4 0.7%. The bread supplemented with 50% SPF had the highest loaf volume, which was not significantly diVerent from the other breads. Loaf volumes ranged from 825 ml (bread with 65% SPF) to 1450 ml (bread with 50% SPF). The loaf volume of the bread containing 65% SPF was acceptable and contrary to Woolfe’s (1992) findings. All the sweet potato breads were less firm than the control (a 100% whole-wheat bread). The SEM showed that the 50% SPF bread had the most gelatinization of starch granules when compared with the others. The sweet potato breads had high enthalpies, possibly because of the presence of larger granules in the SPS. The chemical and structural properties of the sweet potato breads were similar. Overall, the sweet potato breads had similar loaf volume, texture, morphology, and
SWEET POTATO: A REVIEW
33
enthalpies. The moisture content of the breads supplemented with 55% and 60% SPF were similar, but significantly diVerent from those with 50% and 65% SPF. The SEM revealed that starch gelatinization was less in the breads supplemented with 55%, 60%, and 65% SPF. The DSC results indicated a high enthalpy in the bread with 50% SPF, which showed the most gelatinization. It can be concluded that sweet potato bread is a feasible option for incorporation into the diets of astronauts and consumers on Earth based on its chemical and structural properties. B. MACROSCOPIC AND SENSORY EVALUATION OF BREAD SUPPLEMENTED WITH SPF (GREENE AND BOVELL-BENJAMIN, 2004)
The macroscopic and sensory properties of bread supplemented with 50%, 55%, 60%, and 65% SPF were evaluated. Trained judges evaluated 10 samples of freshly baked and 5 samples of day-old breads supplemented with 50%, 55%, 60%, 65% SPF, and two commercial controls (100% wholewheat bread and potato bread). The proximate analysis showed that increasing percentages of SPF increased the b-carotene contents of the breads, while decreasing their protein contents. Twelve perceived sensory attributes, which could be used to diVerentiate the appearance (color, cell size, uniformity), texture (chewy, soft, gritty, denseness), and flavor (fresh bread smell, strong wheaty smell, strong sweet potato smell, wheaty taste, aftertaste) of breads supplemented with SPF were generated. The judges’ perceptions for color and texture were in agreement with those from the instrumental measures used in the study. SPF could be used to substitute whole-wheat flour at 50%, 55%, 60%, and 65% levels in bread making. C. DEVELOPMENT AND STORAGE STABILITY OF BREADS SUPPLEMENTED WITH SPF AND DOUGH ENHANCERS (HATHORN ET AL., 2005)
Sweet potato and hard red spring wheat (HRSW) have been selected by the NASA to be grown in space. The objective of this study was to determine the storage stability of bread supplemented with SPF. Sweet potato and HRSW were processed into flour, and two dough enhancers, with and without SPS, were developed. Six breads, with two levels of SPF (50% and 65%) with and without dough enhancers were made. The breads were stored at room temperature (22 2 C) for 7 days. Samples were randomly withdrawn every 24 hours, and the proximate composition, color, loaf volume, texture, and mold and yeast growth measured. Moisture contents ranged from 30% to 41% in all breads. The color of the breads lightened as storage time increased.
34
A. C. BOVELL-BENJAMIN
FIG. 9 (A and B) Loaf volumes of breads supplemented with 50% and 65% sweet potato flour, respectively.
Loaf volumes were highest in breads containing 50% SPF and dough enhancers (Figure 9). Breads containing 65% SPF and no dough enhancer had the lowest loaf volume. Texture (firmness) was similar for all breads during the storage period. Yeast counts were low, but higher than mold counts throughout the storage. During storage, mold counts were <4 CFU/ml for all breads. On the seventh day, the breads deteriorated, and yeasts were too numerous to count. The findings indicate that sweet potato bread can be stored for 6 days at room temperature without deterioration in texture and adverse growth of yeasts and molds. D. SENSORY CHARACTERIZATION OF A READY-TO-EAT SWEET POTATO BREAKFAST CEREAL BY DESCRIPTIVE ANALYSIS (DANSBY AND BOVELL-BENJAMIN, 2003b)
A trained panel evaluated the sensory attributes of extruded, sweet potato ready-to-eat breakfast cereals (RTEBC) using sensory descriptive analysis. Three cereal formulations with varying amounts of processed hydroponic SPF and/or wheat bran [100% SPF, 75%/25% SPF/whole-wheat bran (SPFWWB), and 100% whole-wheat bran (WWB)] were developed. Ten panelists evaluated the sensory attributes of the three RTEBC, and a commercial cereal, Fiber OneÒ (the control). The intensity of 12 sensory attributes of the four RTEBC was rated. The appearance attributes evaluated were color, gloss, and sticklike; the flavor attributes were blandness, sweetness, sharp smell, cinnamon aftertaste; and the texture attributes were crunchiness, grittiness, hardness, chewiness, and dryness. Descriptive analysis revealed that the samples were significantly diVerent for all attributes. Fiber OneÒ had a significantly (p < 0.05) lighter brown color than the sweet potato RTEBC, but the 100%
SWEET POTATO: A REVIEW
35
SPF and SPFWWB were the crunchiest. The WWB was the sweetest cereal and significantly diVerent to all the others. For the sweetness attribute, the SPFWWB and the Fiber OneÒ were not significantly (p < 0.05) diVerent, but the 100% SPF cereal was sweeter and significantly diVerent from them. The sweet potato RTEBC was chewier than the control. The underlying principle of descriptive analysis is the development of a descriptive language to be used for scoring the product. In this study, a descriptive language for sweet potato RTEBC was developed, and 12 terms could be used to describe and diVerentiate the appearance, texture, and flavor of sweet potato RTEBC. The data collected could be used to facilitate future training of similar panels and to enhance sensory communication regarding sweet potato RTEBC. Stone and Sidel (1993) and Pal et al. (1995) noted that descriptive analysis could contribute directly or indirectly to other activities such as cost reduction, determination of consumer reaction, quality maintenance, and evaluation in product development. Therefore, the data collected in this could be useful for further optimization of the sweet potato RTEBC and help to increase utilization of SPF. Finally, the data can be used in the design of follow-up consumer studies of the sweet potato RTEBC with the relevant population groups. E. PHYSICAL PROPERTIES AND SIXTH GRADERS’ ACCEPTANCE OF AN EXTRUDED READY-TO-EAT SWEET POTATO BREAKFAST CEREAL (DANSBY AND BOVELL-BENJAMIN, 2003c)
This study was a continuation of the authors’ earlier investigations in a broader project to develop palatable, nutritious food ingredients and value-added products from the sweet potato. The nutritive, physical properties and sixth graders’ acceptance of a newly developed RTEBC were determined. Extruded RTEBC were made from 100% and 75% SPF, 100% WWB, and extrusion cooking. The proximate composition, bulk density, expansion ratio, color, morphology, water absorption index, and water solubility index of the RTEBC were determined. Seventy-three sixth grade students evaluated three sweet potato RTEBC on a nine-point hedonic scale, with the nine structural levels ranging from 9 ‘‘supergood’’ through 5 ‘‘maybe good or bad’’ to 1 ‘‘superbad.’’ The samples were: (1) 100% SPF cereal, (2) 75% SPF/25% WWB cereal, (3) 100% WWB cereal, and (4) Fiber OneÒ (a commercial ready-to-eat breakfast cereal, made from wheat and corn bran was the control). Wheat bran was chosen as a control because the main ingredient in Fiber OneÒ is wheat bran, and it is the commercial ready-to-eat breakfast cereal, which is similar in appearance to the sweet potato cereals. The mean moisture content was similar for both sweet potato RTBC, but significantly higher for the 100% WWB. The crude ash content was significant (p < 0.05) for all the RTEBC, being highest in the 100% WWB and lowest in the
36
A. C. BOVELL-BENJAMIN
100% SPF. All the RTEBC had similar fat contents. As expected, carbohydrate and ascorbic acid contents were higher in the 100% SPF. The b-carotene content in the 100% SPF was significantly (p < 0.05) higher than that of the 100% WWB, which had negligible amounts (6495 mg/100 g compared with 280 mg/100 g). However, the dietary fiber in the 100% WWB was almost three times as high as that of the 100% SPF (29% vs 10%), not surprising because wheat is a richer source of dietary fiber than sweet potato. The vitamins thiamin and riboflavin contents were similar for the cereals. The bulk density and expansion ratio of extruded products describe the degree of puYng of the extrudates. The bulk densities and water absorption index were similar for the cereals. However, expansion ratio was highest in the 100% SPF cereal. The 100% WWB had the lightest color and most fibrous morphology. For the consumer testing, degree of liking (DOL) among the RTEBC diVered significantly (p < 0.05). Fiber OneÒ was liked significantly more than the other cereals. The 100% WWB was the least-liked cereal and was significantly diVerent from all other cereals. The extruded RTEBC containing 100% SPF and 75%/25% SPFWWB received high ratings 6.7 1.7 and 6.2 1.7, respectively. In hedonic ratings, scores 5 reflect liking of the product by the consumers. The 100% WWB was unacceptable to the sixth graders which was not surprising because sensory descriptive analysis done earlier confirmed that it was the blandest, most gritty, most chewy cereal. Extruded RTEBC containing 100% SPF and 75% SPF are promising products to be included in human diets because they were well liked and acceptable to sixth graders. However, further work is continuing to decrease the chewiness of the sweet potato RTEBC and evaluate its stability during long-term storage studies. F. PREPARATION OF SPF AND ITS FERMENTATION TO ETHANOL (REDDY AND BASAPPA, 1997)
The economic preparation of SPF and eYcient conversion to ethanol were studied. SPF was prepared using abrasive peeling, hand peeling, lye peeling, and drum drying. The SPF was treated with pectinase, and then with culture filtrate (a-amylase and glucoamylase) of Endomycopsis fibuligera. The inoculated samples were fermented for 3 days. A winelike product with ethanol up to 8.6% (w/v), desirable aroma and color was processed. G. GENETIC VARIATION IN COLOR OF SPF RELATED TO ITS USE IN WHEAT-BASED COMPOSITE FLOUR PRODUCTS (COLLADO ET AL., 1997)
SPFs vary widely in color depending on genotype, and when used in wheatbased composite flours they will impart characteristic colors, which may be favorable or unfavorable for particular food products. SPF was prepared from
SWEET POTATO: A REVIEW
37
44 genotypes and analyzed for proximate composition and biochemical properties. The Hunter color L*, a*, b* values of the dry SPF and their modified Pekar slicks (PS) with water and alkali were measured. Polyphenol oxidase activity, a-amylase activity, and total sugar were significantly correlated to L* values of dry SPF and of their PS tests with water and alkali. The yellow pigment level was significantly correlated to the yellowness (b*) of the dry flour and of the PS test with water, but less correlated to b* of the PS test with alkaline. The results indicated a complex biochemical basis to SPF color, and no single biochemical factor examined was adequate to predict the color of a food product made from SPF. However, the PS color parameters were highly correlated with the color of dough sheets for white-salted and yellow-alkaline noodles made from wheat and sweet potato composite flour (75:25). Thus, the simple modified PS test could be used in screening of genotypes for color stability and suitability for a specific end-use. SPF genotypes conferred a wide range of colors on composite flour dough preparations. Some colors, particularly the range of greens and bright orange, may be useful in specialty product development. H. QUALITY EVALUATION OF SPF PROCESSED IN DIFFERENT AGROECOLOGICAL SITES USING SMALL-SCALE PROCESSING TECHNOLOGIES (OWORI AND HAGENIMANA, 2000)
Owori and Hagenimana (2000) developed appropriate processes for smallscale production of SPF with the desired degree of odor, color, and nutritional and microbiological quality. It was reported that slicing and soaking the sweet potato roots for 1.5 hours prior to sun drying reduced the odor of the flour. For the color, as the soaking time increased, browning in the SPF decreased. There was a decrease in the total sugars, reducing sugars, starch, and proteins in flour processed from sweet potatoes soaked for 90 minutes. There were no diVerences in the microbial quality of SPFs made from soaked and nonsoaked sliced roots. The researchers concluded that soaking sliced sweet potato roots for 90 minutes prior to sun drying could be a suitable method for small-scale production of flour. I. SPF-LIKE PRODUCTS
In Uganda, drying is the traditional way to preserve sweet potato. Women crush and sun dry chunks of the fresh root to prepare a coarse inginyo. For amukeke chips, the men slice up the roots into round, flat pieces, which the women then spread out to dry; both keep for 4–5 months (CIP, 1998). The inginyo or amukeke are ground into a coarse flour, which is rehydrated with water, boiled, mashed, and then eaten directly as a thick porridge known as atapa, starchy staple (CIP, 1998). The dried sweet potato is also boiled in
38
A. C. BOVELL-BENJAMIN
sauces along with beans and vegetables. The recovery rate of fresh roots to amukeke dried chips is from 40% to 45%, and for every 45 kg of fresh sweet potato roots about 18 kg of dried chips (at 14% moisture) are produced. The nutritional composition of sweet potato chips has been reported as 5.2%, 0.1%, and 2.6% for crude protein, crude fiber, and ash, respectively (Tewe et al. 2003). Equally suitable as a human snack food, amukeke dried chips can be found in the marketplace, but command little consumer interest (CIP, 1998). In Mali, West Africa, sweet potatoes are peeled, cut into small pieces, and sun-dried. The dehydrated sweet potatoes can be stored for several months. They are usually rehydrated and added to a sauce with other condiments and eaten with a stiV cereal porridge or rice (Scheuring et al., 1996). Researchers have indicated that shade-dried sweet potato pieces still had high levels of b-carotene (Scheuring et al., 1996). Sweet potato is processed into two local products called Michembe (the roots are withered, cut into slices, and dried) and Matobolwa (the roots are boiled, sliced, and dried) in Tanzania. These products can last for 5–8 months (Gichuki et al., 2005). Other products that have been prepared in Tanzania include cakes, chapatis, donates, kaimati, and buns (Gichuki et al., 2005). VII. OTHER POTENTIAL SWEET POTATO PRODUCTS Potential sweet potato products (some with limited commercialization) include sweet potato bread pudding, casserole, tart, muYns, scalloped sweet potato, and refrigerated sweet potato pieces (Figure 10). Other value-added, commercial SPF products sold in supermarkets in the United States include sweet potato pancake mixes and sweet potato chips. Some east coast restaurants in the United States, especially in New York and Florida now feature sweet potato fries (Adam, 2005). An extensive sweet potato recipe list including dishes from China, Ghana, Guyana, India, Japan, and the United States is available elsewhere (Hill et al., 1992). The following section gives a more detailed description of selective potential sweet potato products. A. CONSUMER ACCEPTANCE OF VEGETARIAN SWEET POTATO PRODUCTS INTENDED FOR SPACE MISSIONS (WILSON ET AL., 1998)
The study determined consumer acceptability of products containing from 6% to 20% sweet potato on dwb. Vegetarian products made with sweet potato were developed for use in nutritious and palatable meals for future space explorers. Sensory (appearance/color, aroma, texture, flavor/taste, and overall acceptability) studies were conducted using panelists at NASA/Johnson Space Center, Houston, Texas. All the products were vegetarian with the exception of a
SWEET POTATO: A REVIEW
39
FIG. 10 Potential sweet potato products (some with limited commercialization). (A) Bread pudding, (B) casserole, (C) bran muYns, (D) scalloped sweet potato, (E) refrigerated sweet potato pieces, and (F) tart.
sweet potato pie. A nine-point hedonic scale (9 ¼ like extremely, 5 ¼ neither like nor dislike, and 1 ¼ dislike extremely) was used to evaluate 10 products and similar commercially available products (controls). The products tested were sweet potato pancakes, waZes, tortillas, bread, pie, pound cake, pasta, vegetable patties, doughnuts, and pretzels. All the products were liked either
40
A. C. BOVELL-BENJAMIN
moderately or slightly with the exception of the sweet potato vegetable patties, which were neither liked nor disliked. Because of their consumer acceptability, these products were recommended to NASA’s Advanced Life Support Program for inclusion in a vegetarian menu plan designed for lunar/Mars space missions. B. SWEET POTATO ‘‘KUNUZAKI’’ (TEWE ET AL., 2003)
In the northern part of Nigeria, sweet potato is processed into a local drink called kunuzaki. Fresh sweet potato is peeled, blended/grated or ground, sifted separated into boiled and unboiled portions, mixed, and left overnight to ferment and sugar added. C. SWEET POTATO BEVERAGE
Van Den (1992) reported two beverages from orange-fleshed sweet potato. One of the beverages, which were highly acceptable to consumers, was fruity and resembled fruit juice drinks. Sweet potato roots were processed into precooked powder, which was sieved and mixed with cocoa powder. The sweet potato–cocoa (85:15) hot drink was also acceptable to consumers. In the United States, Gladney (2005) reformulated and processed a sweet potato beverage. Selected chemical and physical properties of the beverage (color, Brix, pH, and ascorbic acid) were evaluated. The beverages contained 19%, 22%, and 26% sweet potato puree and other fruit juices. The results indicated that the color was similar for all beverages; however, those with higher amounts of sweet potato were darker. In general, the Brix was higher than those reported for a fruity beverage developed by Van Den (1992). D. SELECTED PATENTS REGARDING SWEET POTATO PRODUCTS
A technology with methods for producing cooked sweet potato products was patented in 2001 (Walter et al., 2001). The patent, docket, and serial numbers are: 6197363, 22696, and 9216518, respectively. The invention is a process for converting sweet potatoes into convenient and nutritional finished products for consumers and the food service industry. Similar to frozen Idaho potatoes and fries, the invention uses a method that combines cooked and pureed sweet potatoes with approximately 25% dry matter such as potato flakes or starch. Gelling agents such as alginate, methylcellulose and hydroxypropylmethyl cellulose, sucrose, calcium, and water are added. The final mixture can either be spread or injected into a rectangular mold or extruded and could be cut into bite-sized pieces, strips, wafers, and patties, frozen and packed for distribution. The resulting products have low-fat content and can be adjusted by food processors for desired fat levels.
SWEET POTATO: A REVIEW
41
Products made using the invention also contain a high degree of b-carotene to meet or exceed RDA. US patent 5,204,137, which describes processes for products from sweet potato, was issued in 1993. The invention is concerned with the utilization of orange sweet potato roots, with the purpose of producing various flours, other valuable edible products, and industrial products from them. The invention is best described by reference to certain specific examples given in this patent. A partial listing of these examples includes orange sweet potato bread, orange sweet potato imitation corn bread, orange sweet potato cake dough, orange sweet potato muYns, orange sweet potato pancake mix, orange sweet potato pizza dough, orange sweet potato waZes, orange sweet potato dumplings, and so on (http://patft.uspto.gov). Patent 5,204,137 also reports earlier patents, which are described here. Dried, ground orange sweet potatoes were patented for use as an ingredient in coVee blends (US patent 100,587 issued in 1870; http://patft.uspto.gov); uncooked orange SPF was patented by Marshall (US patent 77,995; http://patft.uspto.gov) and Baylor (US patent 100,587; http://patft.uspto.gov). E. PREPARATION, EVALUATION, AND ANALYSIS OF A FRENCH-FRY-TYPE PRODUCT FROM SWEET POTATOES
The researchers prepared a French-fry-type product from Jewel and Centennial sweet potatoes. The sweet potato roots were washed, lye peeled, sliced into strips, and blanched in hot water containing 1% sodium acid pyrophosphate. The blanched strips were partially dried at 121 C. The dehydrated strips were frozen until fried at 175 C. Panelists evaluated the color, flavor, and texture of the products on a five-point scale. The flavor and texture results indicated that a good product could be prepared from both cv. of sweet potato. F. TEXTURAL MEASUREMENTS AND PRODUCT QUALITY OF RESTRUCTURED SWEET POTATO FRENCH FRIES (WALTER ET AL., 2002)
The study investigated: (1) the applicability of using alginate–calcium gelling system to produce a high-quality sweet potato French-fry-type product from sweet potato puree, (2) the physical and sensory properties of the product, and (3) the relationship between measured instrumental texture parameters and sensory properties of this product. Cooked, pureed sweet potatoes were mixed with potato flakes, sucrose, tetrasodium pyrophosphate, alginate, and calcium sulfate, formed and gelled, cut into strips, frozen, and fried. The sweet potato fries containing 0.35-g alginate/100 g and 0.5 g-CaSO4/100 g
42
A. C. BOVELL-BENJAMIN
were most acceptable to consumers who evaluated them. The researchers concluded that restructured sweet potato fries with consistent texture and consumer acceptability can be made from sweet potato puree using the alginate–calcium gelling system. VIII. POTENTIAL OF SWEET POTATO IN THE UGANDAN FOOD SYSTEM Uganda is the biggest sweet potato producer in the Africa and third largest producer in the world (Scott and Maldonado, 1999). In the 1900s, sweet potato was already an important crop in the western part of Uganda (McMaster, 1962). Winter et al. (1992) noted that the crop was traditionally grown in appreciable quantities by the Arube tribe and Konjo of the Ruwenzori slopes. Sweet potato cultivation spread to northern Uganda during the early part of the nineteenth century (Drisberg, 1923). In the 1950s, sweet potatoes ranked as the most important crop after millet, bananas, and cassava (Hakiza et al., 2000). Today in Uganda, sweet potato is a major staple food and the fifth most important food crop, with regard to land area (after bananas, beans, maize, and finger millet), but is rated third in importance on a fresh weight basis (Ministry of Agriculture, Animal Industries and Fisheries, 1992). In districts such as Lira, Pallisa, and Soroti, sweet potato is ranked as one of the three most important crops grown. The crop is an important source of carbohydrates because of rapid population growth, and its ability to produce massive amount of energy in short periods of time (Odongo et al., 2004). Additionally, the importance of sweet potato increased over the last two decades because of the serious decline of cassava production subsequent to attack by the cassava mosaic disease, cassava green mite, and cassava mealy bug (Odongo et al., 2004). Also from the mid-1980s, the region has experienced increased food insecurity, and the people have relied on the sweet potato for their nutritive requirements. In Uganda, sweet potato production, which is mainly concentrated in the densely populated, mid-altitude regions, has increased from 231,000 ha in 1980 to 560,000 ha in 1999 with outputs of 1.2 and 1.9 metric tonnes, respectively (Hakiza et al., 2000). During the last 5 years, sweet potato production trends have increased in the northeastern region of Uganda (Owori and Hagenimana, 2000). Bashasha et al. (2001) ranked sweet potato as second to banana in the western and central regions, and after finger millet in the northern and eastern regions in terms of food preference. Smith et al. (1996) reported that sweet potato ranks first and third as a food crop and cash crop, respectively, in Soroti District, Uganda. However, the postharvest technologies and outlets have not kept pace with the increased production.
SWEET POTATO: A REVIEW
43
Researchers, policymakers, and other stakeholders have become increasingly interested in the role of sweet potato in the Ugandan food system and its potential to improve nutrition, reduce food insecurity, and generate rural incomes (Bashasha et al., 2001). With this recognition, the government of Uganda has given high priority to research directed at enriching the nutrient contents of the sweet potato through the development of orange-fleshed cv. and diversifying sweet potato-based products and fortification. In Ugandan food systems, the sweet potato assumes five roles, of which four are unique to rural areas and one mainly to urban areas. According to Hall et al. (1998) and Mwesigwa (1995), these roles are: (1) a predominant staple providing the majority of calories for most of the year, although sweet potato production is seasonal; (2) it is a major complementary staple eaten throughout the year but with seasonal peaks; (3) a famine reserve staple typically consumed only in significant quantities during shortages of the dominant staple; (4) a source of cash income either produced strictly for sale or more commonly as a source of revenue from petty trading; and (5) a low-priced complementary staple for the poor and lower-income urban groups. As with other developing countries, the marketing of sweet potato in Uganda is influenced by its bulkiness, perishability, transportation issues, poor physical infrastructure such as roads, poor storage, and marketing information systems, limited availability of adapted sweet potato-processing technologies, and limited demand for traditionally processed products (Owori and Hagenimana, 2000). However, the adaptation of sweet potato processing technologies and value-added products can enhance consumption among consumers. Some researchers have concluded that it is not profitable for Ugandan farmers to engage in sweet potato processing, while others have reported otherwise. For example, in Soroti, the sweet potato is consumed year-round as boiled roots; traditionally processed food products, such as dried chips; flour primarily for domestic use; household food security; and on a more limited scale for sale in rural markets (Owori and Hagenimana, 2000). EVorts are being made to expand the SPF market, and there is a potential for SPF in Uganda’s baking industry. Collaborative research in Lira and Soroti districts has also demonstrated that there is a market for common snack products such as mandazi (doughnut), chapati, buns, and cakes, which have been supplemented with 30% SPF (Owori et al., 2000). Bashasha and Scott (2001) conducted a study in northeastern Uganda to assess the status and market potential of processed sweet potato, namely, inginyo and amukeke. Their results indicated that sweet potato was processed primarily for household food security. Respondents reported lack of time, high labor cost, and lack of market as the main bottlenecks, while peeling and slicing were the most labor-intensive activities. Owori and Hagenimana (2000) conducted research to improve the quality (odor, color, sensory, nutritional, and
44
A. C. BOVELL-BENJAMIN
microbiological) of SPF processed from nonsoaked and soaked slices and recommended appropriate processing techniques for small-scale production. Soaking the sweet potatoes for 90 minutes decreased the odor intensity of the flour, and browning reduced with increased soaking time. The nutrient content of the SPF reduced slowly as soaking time increased, moisture content increased, ash, starch, protein, total and reducing sugars decreased. The research demonstrated that routine microbiological analysis of SPF was needed to control the production process, and soaking sliced sweet potato roots for 90 minutes before sun drying is the most suitable method for small-scale production. In another research process, Mudiope et al. (2000) conducted a survey in Kumi subcounty, Uganda to evaluate the role of sweet potato in the farming system by measuring the production, marketing, and processing constraints facing the crop. Production constraints such as labor shortage and lack of planting materials were the major limitations in the sweet potato farming system. Constraints in processing of sweet potatoes included lack of processing tools. Peters (1998) examined related aspects of sweet potato production, processing, utilization, and marketing to set postharvest research strategies for addressing food security and income generation in Uganda. The relevant findings indicated the need for more research focused on planting material, appropriate technology for processing, storage of fresh or processed roots, and the commercial potential for SPF as a substitute for wheat flour. Peters (1998) also indicated that SPF could be marketed as ‘‘atap’’ (a low-quality flour consumed by the general population as a staple). The outcomes of the above-mentioned studies stress the need for further research eVorts to address the production and processing aspects of the sweet potato to enable it to play a greater role in ensuring food security in Uganda. Over the last decade or more, sweet potato production has increased in Uganda while the decline in cassava production has allowed the crop to play a role in food security. However, the sweet potato has the potential to play a much more substantial role in the Ugandan food system. Further fundamental research is needed to upgrade the quality of sweet potato production, processing and product development, and identify ways to eVectively educate Ugandans regarding exploitation of the nutritional benefits of the sweet potato, and how it can play a role in eradicating VAD and food insecurity. IX. SWEET POTATO PROCESSING AND UTILIZATION EFFORTS IN KENYA In Kenya, East Africa, sweet potato is an important secondary and ‘‘food security’’ crop when maize supply is low and in times of drought (Gakonyo, 1993b; Mutuura et al., 1992). For example, Mutuura et al. (1992) reported
SWEET POTATO: A REVIEW
45
that in western Kenya, 40–60% of households ate sweet potatoes more than four times weekly, while 65–95% consumed them once per week during the ‘‘hunger season’’ and when maize was plentiful, respectively. Alumira and Obara (1997) reported that sweet potato is not a main dietary staple in Nairobi. In their 1997 survey, the majority of participants (from middle- and low-income groups) indicated that they ate less sweet potato than 5 years ago because of changes to more ‘‘urban/modern-type’’ foods. Other reasons given for the decreased consumption include unavailability of sweet potato, unreliable sweet potato harvests, less land space available for production of sweet potato, and high cost for sweet potatoes. On the other hand, 37% of the participants indicated that eating habits have changed in favor of the sweet potato because they are cheap and easy to cook, they serve as an alternative when maize price is high, and they are preferred to bread at breakfast time because of the sugar content and low price. The production of sweet potato in Kenya has increased from 55,000 ha in 1988 to 65,000 ha in 1996 (FAO, 1997). The average annual per capita sweet potato consumption is approximately 24 kg (Scott and Ewell, 1992). In the western part of Kenya, including the Lake Victoria basin and Nyanza Province, sweet potato is grown widely and is mostly a woman-tended crop (Nungo et al., 2000; Oyunga-Ogubi et al., 2005). In the Nyanza Province, 82% of households grow sweet potato (Oyunga-Ogubi et al., 2005). VAD is widespread in Kenya, and most of the dietary vitamin A is supplied by carotenoids (GoK and UNICEF, 1995). Plant foods such as the sweet potato with concentrated provitamin A can contribute to decreasing food insecurity and VAD in Kenya. However, full exploitation of the sweet potato is limited by its bulkiness, perishability, high cost per unit sold, poor consumers’ perceptions, and the varieties cultivated (GTZ, 1998). The predominant sweet potato cv. grown and consumed in Kenya are white or pale-yellow flesh types, which are low in b-carotene (Hagenimana et al., 1998b). In contrast, orange-fleshed varieties, which are rich in b-carotene, are not so popular. The orange-fleshed sweet potato is an aVordable, rich, yearround source of b-carotene, therefore, eVorts are being made to adopt it in Kenya. If farmers and consumers switch from nonorange to orange-fleshed sweet potato cv., it is hypothesized that this could have a substantial impact on vitamin A status. Hagenimana et al. (1998b) concluded that the high carotenoid level of orange-fleshed sweet potato cv. would provide an excellent and appropriate mechanism for combating VAD. In an 18-month village-level study in western Kenya, Low et al. (1997) and Hagenimana et al. (1999) confirmed that potential exists to successfully substitute orange-fleshed sweet potatoes for the commonly used white-fleshed varieties. In Kenya, SPF was consumed in large quantities in the 1950s when some families used the flour to make porridge mixed with sorghum of finger millet
46
A. C. BOVELL-BENJAMIN
flour (GTZ, 1998). However, with the introduction of maize, utilization of SPF declined as it became an inferior crop associated with poverty (GTZ, 1998). According to Nungo et al. (2000) and Gakonyo (1993a), processing and utilization of sweet potato in Kenya have been limited to washing, roasting, boiling, and mashing with other foods. Since 1995, the Allendu Women Group from Allendu location has been processing and marketing sweet potato products including chapati, mandazi, crisps, chips, and cakes. However, accurate data on the volume of sweet potato processed are unavailable. Oyunga-Ogubi et al. (2005) reported that improved provitamin A content was seen in population groups when SPF was incorporated into traditional products such as buns, chapatis, and mandazis in Rongo, Ndhiwa, and Kendu Bay districts in Nyanza Province. Nungo et al. (2000) prepared, tested, and evaluated several recipes made from sweet potato leaves and roots for color, taste, texture, and acceptability, and compared them to other recipes from cassava, rice, and carrots. The products were scored on a five-point scale where 5 ¼ very desirable; 3 ¼ moderately desirable; and 1 ¼ undesirable. Overall, 10 sweet potato products mshenye, doughnuts, relish, porridge, chips, ugali, cake, bread, mandazi, and chapati were selected as suitable and marketable products. Mshenye and relish were very acceptable to 90% of the consumers. Oyunga-Ogubi et al. (2005) investigated the adoption of an intervention technology for increasing vitamin A intake through the use to high-b-carotene sweet potatoes in the Siaya district, Kenya. They reported on the fresh roots, SPF, and novel products from traditional dishes (mandazis, chapati, ugali, porridge, chips, and crisps). Consumer tests showed high acceptability of the novel products. Mandazis and chips were preferred by males, while all products except ugali were highly acceptable to females. Children of diVerent ages and gender had variable preferences. Method of preparation of products was acceptable to women. However, on increased SPF processing, equipment was an issue. Men preferred most equipment as presented, but women and children suggested changes. For example, in flour production, cleaning and peeling were tedious, and the large amount of wash water resulted in increased workload. Also, women and children felt that the rotary slicer should be modified to allow a sitting position, the drying should fit under their normal practice, and there should be education on storage of chips and flour. The researchers also concluded that there is insignificant sweet potato processing in Siaya, but there is potential for adoption of this technology particularly by women. Hagenimana et al. (1999) identified orange-fleshed sweet potato varieties with high acceptability of appearance and taste that are appropriate for consumption by adults and young children in Kenya. In both Ndhiwa/Nyarongi and Rongo districts, consumer evaluation of the taste and appearance of cooked sweet potatoes indicated that cv. of orange-fleshed sweet potatoes
SWEET POTATO: A REVIEW
47
were acceptable to community members. Pumpkin cv. was preferred for use in weaning foods. Local cv. ranked high in terms of taste and appearance in all districts. Also processed food products, such as mandazis made from new sweet potato cv. were acceptable to food processors and consumers. Mashed and flour products were preferred over grated products. The processing of modified food products did not require additional labor or production costs. A cost analysis indicated that substituting sweet potato for wheat flour in mandazis made the product more profitable for market vendors, and substituting sweet potato for other ingredients increased the b-carotene content of processed food products. Mandazis, chapatis, and buns with and without sweet potato contained approximately 100- and 800- to 3200-mg b-carotene/100 g, respectively (Hagenimana et al., 1999). As part of the promotion of orange-fleshed sweet potato, farmers in some parts of Kenya have received hands-on demonstrations to make various sweet potato products, including vegetable stew (relish), mashed food (mshenye/Irio), chapati, samosa, and biscuits (Gichuki et al., 2005). In sum, preliminary studies indicate that orange-fleshed sweet potatoes are available and acceptable to western Kenyans and are a good addition to the diets to reduce VAD. Processing of the orange-fleshed sweet potato into value-added products for yearround consumption and to increase provitamin A intake is limited. However, encouraging processing and expanding the use of the orange-fleshed sweet potato in the Kenyan food system will help to meet food requirements, improve nutritional status, enhance food security, and reduce poverty. X. CONCLUSIONS The sweet potato combines a number of advantages from nutritional to socioeconomic to environmental, which makes it a potentially good candidate for reducing the increasing food insecurity, VAD, and the under- and overnutrition that is occurring globally, especially in developing countries. However, consumers’ poor perception of the sweet potato in many developing countries, its static production, lack of storage technology for fresh sweet potato, lack of processing equipment, scarcity of data on the demand for fresh sweet potato or its products, inadequate processing and postharvest technology, and lack of knowledge regarding its nutritional benefits must be overcome. Repositioning sweet potato production and its potential for value-added products will contribute substantially to utilizing its benefits and many uses. Accurate estimates of the market demand for value-added sweet potato-based products have not been established, but advertisement and promotion will enhance their utilization.
48
A. C. BOVELL-BENJAMIN
XI. RECOMMENDATIONS Multidisciplinary, integrated research and development activities aimed at improving production, storage, postharvest and processing technologies, and quality of the sweet potato and its potential value-added products are critical issues, which should be addressed globally. Additionally, widespread, eVective farmer and consumer education (awareness) regarding the exploitation of the nutritional, health and economical benefits of the sweet potato, and how it can play a role in eradicating VAD and food insecurity should be undertaken. Other important issues that need to be addressed urgently include: (1) research that will lead to the development of nutritious, consumer-acceptable valueadded products from the roots and leaves of the sweet potato; (2) determination of the critical physical and chemical factors modulating the acceptance of sweet potato by consumers; (3) more urgent collaborative eVorts by plant breeders, horticulturists, sensory scientists, and nutritionists to characterize and improve the starch and flour properties of sweet potato cv.; (4) although SPF is one of the most promising sweet potato products, its quality and storage stability need to be further researched; (5) providing farmers and consumers with acceptable recipes and samples of value-added products are also necessary approaches to increase production and consumption of the crop; and (6) low-cost, appropriate sweet potato processing technologies, and policies for their transfer to developing countries should be developed. Finally, governments, policy makers, and stakeholders should adopt food-based strategies that encourage and expand utilization of the orange-fleshed sweet potato cv. instead of the white-fleshed cv. Such strategies will assist in meeting food requirements, improve nutritional status, enhance food security, reduce poverty, and could eVectively improve vitamin A status of young children in particular, and populations in general. ACKNOWLEDGMENTS This chapter is, in part, an output from the sweet potato research work experiences of the author at Center for Food and Environmental Systems for Human Exploration of Space (CFESH), Tuskegee University funded by NASA; therefore, the author also wishes to acknowledge NASA, the team members of the Food Processing and Product Development Team in particular, and the rest of the CFESH team. REFERENCES Adam, K.L. 2005. ‘‘Sweetpotato: Organic Production’’. ATTR (http://www.attra.ncat.org). Akhmadieva, A.K., Zaichkina, S.I., Ruzieva, R.K., and Ganassi, E.E. 1993. The protective action of a natural preparation of anthocyanin (Pelargonidin-3-5-diglucoside). Radiobiologiia 33, 433–435.
SWEET POTATO: A REVIEW
49
Alumira, J.D. and Obara, C.M. 1997. Post-Harvest Consumption Analysis of Sweetpotato in Kenya—Survey. (http://www.fao.org/Wairdocs/X5420E/x5420e0f.htm) Ameny, M.A. and Wilson, P.W. 1997. Relationship between hunter color values and b-carotene contents in white-fleshed African sweetpotato (Ipomoea batatas Lam). J. Sci. Food Agric. 73, 301–306. Antarlina, S. 1990. UPWARD Proceedings of the Inaugural Planning Workshop on the User’s Perspective with Agricultural Research and Development, Baguio City, Philippines, April 3–5, 1990, Los Ban˜os, Laguna, Philippines, UPWARD, CIP Reg. OYce Region VII, Philippines p. 68. Austin, D.F. 1988. The taxonomy, evolution and genetic diversity of sweetpotatoes and related wild species. In ‘‘Exploration, Maintenance, and Utilization of Sweetpotato Genetic Resources’’ (P. Gregory, ed.), pp. 27–60. CIP, Lima, Peru. Bradbury, H.J. and Holloway, W.D. 1988. ‘‘Chemistry of Tropical Root Crops’’, p. 201. ACIAR, Canberra. Bashasha, B.B., Mwanga, R., Ocitti, P.C., and Ewell, P.T. 2001. Sweetpotato in the farming and food systems of Uganda: A Farm Survey Report. International Potato Center (CIP), National Agricultural Organization (NARO). Bashasha, B.B. and Scott, G. 2001. Processed sweetpotato in the household economy of north-eastern uganda. East Afr. J. Rural Dev. 17, 35–50. Ben-Amotz, A. and Fishler, R. 1998. Analysis of carotenoids with emphasis on 9-cis b-carotene in vegetables and fruits commonly consumed in Israel. Food Chem. 62, 515–520. Bendech, M.A., Vebamba, O., Tarini, A., and Baker, S.K. 2005. Orange-fleshed sweetpotato dissemination process in the Gourma Province (Burkina Faso). Sight and Life Newsletter 2/2005 29–31. Bender, D.A. 2002. The vitamins. In ‘‘Introduction to Human Nutrition’’ (M.J. Gibney, H.H. Vorster, and F. Kok, eds), pp. 125–176. Blackwell Science, Malden, MA. Bhaskarachary, K., Rao, D.S., Deosthale, Y.G., and Reddy, V. 1995. Carotene content of some common and less familiar foods of plant origin. Food Chem. 54, 189–193. Bovell-Benjamin, A.C., Bromfield, E., Pace, R., and Wang, B. 2001. Chemical and sensory characteristics of a hydroponic sweetpotato during storage. Technical Paper 2001-01-2278. Society for Automative Engineers, Warrendale, PA. Bovell-Benjamin, A.C., Gichuhi, P., Abdalla, M., Biswas, M., Bromfield, E., Alvarea, M., Kpomblekou, A.K., and Dean, D. 2004. Bulk ingredients from three cultivars of sweetpotatoes: Composition and properties. Technical Paper 2004-01-2527. Society for Automative Engineers, Warrendale, PA. Bovell-Benjamin, A.C., Yousif-Ibrahim, S., Gichuhi, P., and Bromfield, E. 2005. Influence of a-amylase on the physical properties and consumer acceptability of sweetpotato starch syrup. Technical Paper 2005-01-3113. Society for Automative Engineers, Warrendale, PA. Brabet, C., Reynoso, D., Dufour, D., Mestres, C., Arredondo, J., and Scott, G. 1998. Starch content and properties of 106 sweetpotato clones from the world germplasm collection held at CIP, Peru. CIP Program Report 1997–1998, CIP, Lima, Peru. Bradbury, J.H., Hammer, B., Nguyen, T., Anders, M., and Millar, J.S. 1985. Protein quantity and quality, and trypsin inhibitor content of sweetpotato cultivars from the Highlands of Papua, New Guinea. J. Agric. Food Chem. 33, 281–285. Brody, T. 1994. ‘‘Nutritional Biochemistry’’, pp. 113–116. Academic Press, San Diego, CA. Burden, D. 2005. Sweetpotato profile. http://www.agmrc.org (accessed 02/16/2006). Cambie, R.C. and Ferguson, L.R. 2003. Potential functional foods in the traditional Maori diet. Mutat. Res. 523–524, 109–117. Caperuto, L., Amaya-Farfan, J., and Camargo, C. 2000. Performance of quinoa (Chenopodium quinoa Wild) flour in the manufacture of gluten-free spaghetti. J. Sci. Food Agric. 81, 95–101. Carver, G.W. 1918. How to make sweetpotato flour, starch, sugar bread and mock cocoanut. Bulletin 37. Experiment Station. Tuskegee Normal and Industrial Institute, Tuskegee, AL.
50
A. C. BOVELL-BENJAMIN
Cevallos-Casals, B.A. and Cisneros-Zevallos, L.A. 2002. Bioactive and functional properties of purple sweetpotato (Ipomoea batatas [L.] Lam). Acta Hort. (ISHS) 583, 195–203. Chen, Z., Schols, H.A., and Voragen, A.G.J. 2003. Starch granule size strongly determines starch noodle processing and noodle quality. J. Food. Sci. 68, 1584–1589. CIAD, SAAS, SAHVRI 1996. Social and economic assessment of the small scale sweetpotato base pig production system in Suining Municipality, Sichuan Province. Center for Integrated Agricultural Development (CIAD), Sichuan Academy of Agricultural Sciences (SAAS) and Sichuan Animal Husbandry and Veterinary Research Institute (SAHVRI); CIAD, Beijing Agricultural University, Beijing, China, p. 54. Cinar, I. 2005. EVects of cellulose and pectinase concentrations on the colour yield of enzyme extracted plant carotenoids. Process Biochem. 40, 945–949. CIP (International Potato Center). 1998. Food security in East Africa: A battle on many fronts. CIP Annual Report’98. http://www.cipotato.org/market/ARs/Ar98/Food.htm (accessed 02/02/ 2005). Clark, C.A. and Moyer, J.W. 1988. ‘‘Compendium of Sweetpotato Diseases’’. APS (American Phytopathological Society) Press, St Paul, MN. Colantuoni, A., Bertuglia, S., Magistretti, M.J., and Donato, L. 1991. Effects of Vaccinium myrtillus anthocyanosides on arterial vasomotion. Arzneim-Forsch/Drug Res. 41(9), 905–909. Collado, L.S. and Corke, H. 1999. Accurate estimation of sweet potato amylase activity by flour viscosity analysis. J. Agric. Food Chem. 47, 832–835. Collado, L.S., Mabesa, L.B., and Corke, H. 1997. Genetic variation in color of sweetpotato flour related to its use in wheat-based composite flour products. Cereal Chem. 74, 681–686. Collado, L.S., Mabesa, R.C., and Corke, H. 1999. Genetic variation in the physical properties of sweetpotato starch. J. Agric. Food Chem. 47, 4195–4201. Dansby, M.Y. and Bovell-Benjamin, A.C. 2003a. Production and proximate composition of a hydroponic sweetpotato flour during extended storage. J. Food Process Preserv. 27, 153–164. Dansby, M.Y. and Bovell-Benjamin, A.C. 2003b. Sensory characterization of a ready-to-eat sweetpotato breakfast cereal by descriptive analysis. J. Food. Sci. 68, 706–709. Dansby, M.Y. and Bovell-Benjamin, A.C. 2003c. Physical properties and sixth graders’ acceptance of an extruded a ready-to-eat sweetpotato breakfast cereal. J. Food. Sci. 68, 2607–2612. Dawkins, N.L. and Lu, J. 1991. Physico-chemical properties and acceptability of flour prepared from microwave blanched sweetpotatoes. J. Food Process Pres. 15, 115–124. de Pee, S., Bloem, M.W., Gorsteen, J., Sari, M., Satoto, A., Yip, R., Shrimpton, R., and Muhilal, R. 1998. Reappraisal of the role of vegetables in the vitamin A status of mothers in Central Java, Indonesia. Am. J. Clin. Nutr. 68, 1068–1074. Diop, A. 1998. Storage and processing of roots and tubers in the tropics. In ‘‘Food and Agriculture Organization of the United Nations, Agro-Industries and Post-Harvest Management Service’’ (D.J.B. Calverley, ed.), pp. 38–50. Agricultural Support Systems Division. Food and Agriculture Organization, Rome, Italy. Dreher, D. and Junod, A.F. 1996. Role of oxygen free radicals in cancer development. Eur. J. Cancer 32A, 30–38. Drisberg, J.H. 1923. The Lango: A Nilotic tribe of Uganda. In ‘‘A Subsistence Crop Geography of Uganda. The World Land Uses Survey’’ (D. McMaster, ed.), Occasional papers No. 5, Dudley Stamp, L. Ed. Geographical Pub. Ltd., London, England. Ekpenyong, T.E. 1984. Composition of some tropical tuberous foods. Food Chem. 15, 31–36. Ezell, B.D. and Wilcox, M.S. 1948. Effect of variety and storage on carotene and total carotenoid pigments in sweet potatoes. Food Res. 13, 203. Fabre, C.E., Santerre, M.O., Baberian, R., Peteilleaux, A., Goma, G., and Blance, P.J. 1993. Production and food applications of the red pigments of Monascus ruber. Monascus ruber. J. Food Sci. 58, 1099–1110.
SWEET POTATO: A REVIEW
51
FAO (Food and Agricultural Organization) 1995. ‘‘Production Yearbook’’. FAO, Rome. FAO (Food and Agricultural Organization). 1972. Food composition tables for use in East Asia, FAO. US Department of Health, Education and Welfare. FAO (Food and Agricultural Organization). 1997. ‘‘Production Yearbook’’. FAO, Rome. FAO (Food and Agricultural Organization). 1999. ‘‘Production Yearbook’’, Vol. 53. FAO, Rome. Fuglie, K.O. and Oates, C.G. 1990. Starch markets in Asia. http://www.eseap.cipotato.org/MFESEAP/F1-Library/StarchMarketsAsia-Keith.pdf Fuglie, K.O. and Hermann, M. (eds.). (2004). Sweetpotato post-harvest research and development in China. In ‘‘Proceedings of an International Workshop held in Chengdu, Sichuan, PR China, November 7–8, 2001’’. International Potato Center (CIP), Bogor, Indonesia. Fuglie, K.O. and Oates, C.G. 2002. ‘‘Starch Markets in Asia’’. Paper presented in CIP-Indonesia Research Review Workshop, Bogor, Indonesia, March 26–27, 2002. Furuta, S., Suda, I., Nishiba, Y., and Yamakawa, O. 1998. High tert-butylperoxyl radical scavenging activities of sweetpotato cultivars with purple flesh. Food Sci. Technol. Int. Tokyo 29, 33–35. Gakonyo, N. 1993a. Sweet potato post-harvest system. In ‘‘Product Development for Root and Tuber Crops’’ (G. Scott, P. Fergusun, and J. Herere, eds), p. 317. CIP and IITA, Lima, Peru, and Ibadan, Nigeria. Gakonyo, N. 1993b. Processed sweetpotato. Responding to Kenya’s urban needs. Working Paper in agricultural economics, July 1993, Cornell University, Ithaca, New York. Garcia, A.M. and Walter, W.M. 1998. Physicochemical characterization of starch from Peruvian sweetpotato selections. Starch/Sta¨rke 50, 331–337. Gichuhi, P., Bromfield, E., Alvarez, N., Dean, D., Biswas, M., and Bovell-Benjamin, A.C. 2004. Electrophoretic and morphological characteristics of three sweetpotato [Ipomoea batatas (L.) Lam] cultivars. Technical Paper No. 04ICES-291. Society for Automotive Engineers, Warrendale, PA. Gichuki, S.T., La Bonte, D., Burg, K., Kapinga, R., and Simon, J.C. 2005. Assessment of genetic diversity, farmer participatory breeding, and sustainable conservation of Eastern African Sweetpotato germplasm (Grant No. o2–476). Annual Report April 2004–March 2005. (http://mcknight.ccrp.cornell.edu/ projects/spk/kenya_sweetpotato.html) Gilbert, J.C. 2005. Coloring foods and beverages. Food Technol. 59, 38–44. Giovanni, M.E. and Pangborn, R.M. 1983. Measurement of taste intensity and degree of liking of beverages by graphic scales and magnitude estimation. J. Food. Sci. 48, 1175–1182. Giusti, M.M. and Wrolstad, R.E. 2003. Acylated anthocyanins from edible sources and their applications in food systems. Biochem. Eng. J. 14, 217–225. Gladney, D. 2005. Evaluation of a beverage made from hydroponic sweetpotatoes. MS Thesis, available at Tuskegee University Library, Tuskegee, AL. GoK and UNICEF. 1995. A program of cooperation 1994–1998: Master plan operations, final draft, Nairobi, Kenya. Greene, J.L. 2003. Production and evaluation of hydroponic sweetpotato bread using macroscopic, spectroscopic, and thermal analyses. MS Thesis, available at Tuskegee University Library. Tuskegee Unversity, Tuskegee, AL. Greene, J.L. and Bovell-Benjamin, A.C. 2004. Macroscopic and sensory evaluation of bread supplemented with sweetpotato flour. J. Food. Sci. 69, 167–173. Greene, J.L., Bromfield, E., Dean, D., Abdalla, M., and Bovell-Benjamin, A.C. 2003. Breadmaking properties of sweetpotato flour. Technical Paper No. 2003–01–2617. Society for Automotive Engineers (SAE), Warrendale, PA. GTZ (Ministry of Agriculture and Deutsche Gesellschaft fu¨r Technische Zusammenarbeit [GTZ] GmbH). 1998. Post-harvest systems of potato and sweetpotato in Kenya—Final report, Nairobi, Kenya. Guillon, F. and Champ, M. 2000. Structural and physical properties of dietary fibres, and consequences of processing on human physiology. Food Res. Int. 33, 233–245.
52
A. C. BOVELL-BENJAMIN
Gurkin-Ulm, S. 1988. The eVect of storage conditions on selected quality attributes of sweetpotato flour. Ph.D Thesis, available from University of Tennessee Library, Knoxville, TN. Hagenimana, V. and Low, J. 2000. Potential of orange-fleshed sweetpotato for raising vitamin A intake in Africa. Food Nutr. Bull. 21, 414–418. Hagenimana, V. and Owori, C. 1996. Feasibility, acceptability, and production costs of sweetpotato baked products in Lira Municipality, Uganda. Study Report, International Potato Center/Natural Resources Institute. Hagenimana, V., Hall, A.J., and Low, J. 1995. The potential for sweetpotato processed products in Kampala city markets—a feasibility study on bread, chapatti, and mandazi. International Potato Center/Natural Resources Institute. Hagenimana, V., K’osambo, L.M., and Carey, E.E. 1998a. Potential of sweetpotato reducing vitamin A deficiency in Africa. CIP Program Report 1997–98, pp. 287–294. Hagenimana, V., Carey, E.E., Gichuki, S.T., Oyunga, M.A., and Imungi, J.K. 1998b. Replacing pills with sweetpotatoes to combat vitamin A deficiency. Post Harvest Newsletter. No. 3, October 1998 (http://www.iita.org/info/ph3/oct983.htm). Hagenimana, V., Oyunga, M.A., Low, J., Njoroge, S.M., Gichuki, S.T., and Kabira, J. 1999. ‘‘The EVects of Women Farmers’ Adoption of Orange-Fleshed Sweetpotatoes: Raising Vitamin A Intake in Kenya’’. International Center for Research on Women, June 1999, Research Report Series 3, Washington, D.C. Hakiza, J.J., Turyamureeba, G., Kakuhenzire, R.M., Odongo, B., Mwanga, R.M., Kanzikwera, R., and Adipala, E. 2000. Potato and sweetpotato improvement in Uganda: A historical perspective. African Potato Association Conference Proceedings 5, 47–58. Hall, A., Bocket, G., and Nahdy, S. 1998. Sweetpotato postharvest systems in Uganda: Strategies, constraints, and potentials. Social Science Department Working Paper No. 1998–7. International Potato Center (CIP), Lima, Peru. Hart, D. and Scott, K.J. 1995. Development and evaluation of an HPLC method for the analysis of carotenoids in foods and measurement of the carotenoid content of vegetables and fruits commonly consumed in the UK. Food Chem. 54, 101–111. Haskell, M.J., Jamil, K.M., Hassan, F., Peerson, J.M., Hossain, M.I., Fuchs, G.J., and Brown, K.H. 2004. Daily consumption of Indian spinach (Basella alba) or sweetpotatoes has a positive eVect on total-body vitamin A stores in Bangladeshi men. Am. J. Clin. Nutr. 80, 705–714. Hathorn, C., Gichuhi, P., and Bovell-Benjamin, A.C. 2005. ‘‘Development and Storage Stability of Breads Supplemented with Sweetpotato Flour and Dough Enhancers’’. A53-3. Institute of Food Technologists Annual Meeting and Food Expo, New Orleans, LA. Hijmans, R.J.L., Huaccho, L., and Zhang, D. 2002. Description and analysis of a geo-referenced database of the global distribution of sweetpotato area. Acta Hort. 583, 41–49. Hill, W.A., Bonsi, C.K., and Loretan, P.A. (eds), (1992). Photo journal/recipes. In ‘‘Sweetpotato Technology for the 21st Century’’ (W.A. Hill, C.K. Bonsi, and P.A. Loretan, eds), pp. 577–596. Tuskegee University, Tuskegee, AL. HoVman, C. and Bovell-Benjamin, A.C. 2001. Isolation and utilization of sweetpotato starch in chocolate puddings. Unpublished data. Holland, B., Unwin, I.D., and Buss, D.H. 1991. Vegetables, herbs and spices. In ‘‘The Fifth Supplement to McCance and Widdowson’s the Composition of Foods’’, 4th Ed. Royal Society of Chemistry, Cambridge. Hou, W.-C. and Lin, Y-H. 1997. Dehydroascorbate reductase and monodehydroascorbate reductase activities of trypsin inhibitors, the major sweetpotato (Ipomoea batatas [L.] Lam) root storage protein. Plant Sci. 149, 151–156. Huaman, Z. 1992. The use of sweetpotato in bread making. In ‘‘Sweetpotato Technology for the 21st Century’’ (W.A. Hill, C.K. Bonsi, and P.A. Loretan, eds), pp. 460–461. Tuskegee University, Tuskegee, AL.
SWEET POTATO: A REVIEW
53
Huang, A.S., Tanudjaja, L., and Lum, D. 1999. Content of alpha-, beta-carotene, and dietary fiber in 18 sweetpotato varieties grown in Hawaii. J. Food Compost. Anal. 12, 147–151. Hulshof, P.J.M., Xu, C., van de Bovenkamp, P., Muhilal, and West, C.E. 1999. Application of a validated method for the determination of provitamin A carotenoids in Indonesian foods of diVerent maturity and origin. J. Agric. Food Chem. 45, 1174–1179. Ishida, H., Suzuno, H., Sugiyama, N., Innami, S., Tadokoro, T., and Maekawa, A. 2000. Nutritive evaluation on chemical components of leaves, stalks and stems of sweetpotatoes (Ipomoea batatas poir). Food Chem. 68, 359–367. Ishiguro, K., Toyama, J., Islam, S., Yoshimoto, M., Kumagai, T., Kai, Y., Nakazawa, Y., and Yamakawa, O. 2004. Suioh, a new sweetpotato cultivar for utilization in vegetable greens. Acta Hort. (ISHS) 637, 339–345. Islam, S. 2006. Sweetpotato (Ipomoea batatas L.) leaf: Its potential eVect on human health and nutrition. J. Food Sci. 71, R13–R21. Islam, S., Yoshimoto, M., Terahara, N., and Yamakawa, O. 2002. Anthocyanin compositions in sweetpotato leaves. Biosci. Biotechnol. Biochem. 66, 2483–2486. Islam, S., Yoshimoto, M., Ishiguro, K., Okuno, S., and Yamakawa, O. 2003. EVect of artificial shading and temperature on radical scavenging activity an polyphenol compositions in sweetpotato leaves. J. Am. Hortic. Sci. 128, 182–187. Jalal, F., Nesheim, M.C., Agus, Z., Sanjur, D., and Habicht, J.P. 1998. Serum retinol concentrations in children are aVected by food sources of beta-carotene, fat intake, and antehelminthic drug treatment. Am. J. Clin. Nutr. 68, 623–629. Jiang, X., Jianjun, H., and Wang, Y. 2004. Sweetpotato processing and product research and development at the Sichuan Academy of Agricultural Sciences. In ‘‘Sweetpotato Post-Harvest Research and Development in China’’ (K.O. Fuglie and M. Hermann, eds), Proceedings of an International Workshop held in Chengdu, Sichuan, PR China, November 7–8, 2001, International Potato Center (CIP), Bogor, Indonesia. Jianjun, H. 2004. The eVects of processing technology on sweetpotato starch yield and quality. In ‘‘Sweetpotato Post-Harvest Research and Development in China’’ (K.O. Fuglie and M. Hermann, eds), Proceedings of an International Workshop held in Chengdu, Sichuan, PR China, November 7–8, 2001, International Potato Center (CIP), Bogor, Indonesia. Kamei, H., Kojima, T., Hasegawa, T., Koide, T., Umeda, T., Yukawa, T., and Terabe, K. 1995. Suppression of tumor cell growth by anthocyanins in vitro. Cancer Invest. 13, 590–594. Karaivanova, M., Drenska, D., and Ovcharov, R.A. 1990. Modification of the toxic eVects of platinum complexes with anthocyanins. Eksp. Med. Morfol. 29, 19–24. Karyeija, R.F., Gibson, R.W., and Valkonen, J.P.T. 1998. The significance of sweetpotato feathery mottle virus in subsistence sweetpotato production in Africa. Plant Dis. 82, 4–15. Karyeija, R.F., Kreuze, J.F., Gibson, R.W., and Valkonen, J.P.T. 2000. Synergistic interactions of a potyvirus and a phloem-limited crinivirus in sweet potato plants. Virology 269, 26–36. Kays, S.J. 1992. The chemical composition of the sweetpotato. In ‘‘Sweetpotato Technology for the 21st Century’’ (W.A. Hill, C.K. Bonsi, and P.A. Loretan, eds), pp. 201–262. Tuskegee University, Tuskegee, AL. Kays, S.J. 2005. Sweetpotato production worldwide: Assessment, trends and the future. Acta Hort. (ISHS) 670, 19–25. Kays, S.J., Collins, W.W., and Bouwkamp, J.C. 1992. A response: The sweetpotato storage organ is a root, not a tuber. In ‘‘Sweetpotato Technology for the 21st Century’’ (W.A. Hill, C.K. Bonsi, and P.A. Loretan, eds), pp. 307–313. Tuskegee University, Tuskegee, AL. Kohlmeier, L. and Hastings, S. 1995. Epidemiological evidence of a role of carotenoids in cardiovascular disease prevention. Am. J. Clin. Nutr. 62, 1370S–1376S. Kusano, S. and Abe, H. 2000. Antidiabetic activity of white-skinned sweetpotato (Ipomoea batatas L.). Biosci. Biotechnol. Biochem. 65, 109–114.
54
A. C. BOVELL-BENJAMIN
KNAES 1995. (Kyushu National Agricultural Experiment Station), No. 1, December 1995, Tokyo, Japan. Leonardi, M. 1993. Treatment of fibrocystic disease of the breast with Vaccinium myrtillus anthocyanins. Our experience. Minerva Ginecol. 45, 617–621. Li, W.G., Wu, X., Cai, H., and Du, R. 1991. Sweetpotato in China. In ‘‘Product Development for Root and Tuber Crops, Volume 1—Asia’’ (G.J. Scott, S. Wiersema, and P.I. Ferguson, eds), pp. 41–50, Proceedings of the International Workshop, April 22–May 1, 1991, ViSCA, Baybay, Leyte, Philippines. CIP, Lima, Peru. Lietti, A., Cristoni, A., and Picci, M. 1976. Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and anti-inflammatory activity. Arzneimittel-Forschung 26, 829–832. Low, J., Kinyae, P., Gichuki, M.A., and Tana, P. 1997. Combating vitamin A deficiency through the use of sweetpotato. Results from Phase I of an action research project in South Nyanza, Kenya. International Potato Center, Lima, Peru. Low, J., Walker, T., and Hijmans, R. 2001. The potential of orange-fleshed sweetpotatoes on vitamin A intake in Sub-Saharan Africa. Paper presented at a regional workshop on food-based approaches to human nutritional deficiencies. The VITAA Project, vitamin A and orange-fleshed sweetpotatoes in Sub-Saharan Africa, 9–11 May 2001, Nairobi, Kenya. Lu, G.Q. and Sheng, J.L. 1990. Application of near infrared reflectance spectroscopy (NIRS) in sweetpotato quality breeding. Scientia Agricultura Sinica 23, 76–81. Madhusudhan, B., Gowda, L.R., and Tharanathan, R.N. 1996. Studies on sweetpotatoes III. Distribution of unit chains of branched and unbranched molecules of starch. Food Chem. 57, 201–204. Maeshinia, M., Sasak, T., and Asahi, T. 1985. Characterization of major proteins in sweetpotato tuberous roots. Phytochemistry 24, 1899–1902. Makki, H.M., Abdel-Rahman, A.Y., Khalil, M.K.M., and Mohamed, M.S. 1986. Chemical composition of Egyptian sweetpotato. Food Chem. 20, 39–44. Maleki, S. 2001. The big eight food allergens. Dietitian’s Edge 57, 60. Mandamba, L.S.P., Bustrillos, A.R., and San Pedro, E.L. 1975. Sweetpotato starch: Physicochemical properties of whole starch. Philippine Agric. 58, 338–350. Maneepun, S., Reungmaneepaitoon, S., and Yunchalad, M. 1992. In ‘‘Product Development for Root and Tuber Crops, Volume I—Asia’’ (G.J. Scott, S. Wiersema, and P.I. Fergusun, eds), p. 229. CIP, Lima, Peru. Mannie, E. 1999. Breakfast cereal, kid-style. Food Prod Design 119, 1–7. Marklinder, I., Haglund, A., and Johansson, L. 1996. Influences of lactic acid bacteria on technological, nutritional and sensory properties of barley sour dough bread. Food Qual. Pref. 7, 285–292. Marter, A.D. and Timmins, W.H. 1992. Small scale processing of sweetpotato in Sichuan province, People’s Republic of China. J. Trop. Sci. 32, 241–250. Mason, J.B., Mahshid, L., Dalmiya, N., Sethuraman, K., and Deitchler, M. 2001. The micronutrient report: Current progress and trends in the control of vitamin A, iodine, and iron deficiencies. Ottawa, Canada: The Micronutrient Initiative/International Development Research Centre. Internet: http://www.micronutrient.org/frame_HTML/resource_text/publication/mm_report.pdf. (accessed May 20, 2005). Martin, F.W. 1984. Techniques and problems in small scale production of flour from sweetpotato. J. Agric. Univ. Puerto Rico 68, 423–432. Matsui, T., Ueda, T., Oki, T., Sugita, K., Terahara, N., and Matsumoto, K. 2001. a-Glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity. J. Agric. Food Chem. 49, 1948–1951. Matsui, T., Ebuchi, S., Kobayashi, M., Fukui, K., Sugita, K., Terahara, N., and Matsumoto, K. 2002. Anti-hyperglycemic eVect of diacylated anthocyanin derived from Ipomoes batatas cultivar Ayamurasaki can be achieved through the a-glucosidase inhibitory action. J. Agric. Food Chem. 50, 7244–7248.
SWEET POTATO: A REVIEW
55
Matsui, T., Ebuchi, S., Fujise, T., Abesundara, K.J.M., Doi, S., Yamada, H., and Matsumoto, K. 2004. Strong hyperglycemic eVects of water-soluble fraction of Brazilian propolis and its bioactive constituent, 3,4,5-tri-O-caVeoylquinic acid. Biol. Pharm. Bull. 27, 1797–1803. McMaster, D.N. 1962. ‘‘A Subsistence Crop Geography of Uganda’’, pp. 72–76. Geographical Pub. Ltd., England. Miller, S.-A., Dean, D., Ganguli, S., Abdalla, M., and Bovell-Benjamin, A.C. 2003. Physicochemical and viscometric properties of a sweetpotato syrup. Paper presented at ARD 2003. Association of Research Directors, Inc., 13th Biennial Research Symposium, March 29–April 2, Atlanta, GA. Ministry of Agriculture, Animal Industries and Fisheries 1992. Kampala, Uganda. Minkova, M., Drenska, D., Pantev, T., and Ovcharov, R. 1990. Antiradiation properties of alpha tocopherol, anthocyans, and pyracetam administered combined as a pretreatment course. Acta Physiol. Pharmacol. Bulg. 16, 31–36. Mitcheva, M., Astroug, H., Drenska, D., Popov, A., and Kassarova, M. 1993. Biochemical and morphological studies on anthocyans and vitamin E on carbon tetrachloride induced liver injury. Cell. Mol. Biol. 39, 443–448. Morazzoni, P. and Magistretti, M.J. 1986. EVects of Vaccinium myrtillus anthocyanosides on prostacyclin-like activity in rat arterial tissue. Fitoterapia 57, 11–14. Morris, V.J., Ridout, M.J., and Parker, M.L. 2005. AFM of starch: Hydration and image contrast. Prog. Food Biopolymer. Res. 1, 28–42. Mudiope, J., Kindness, H., and Haigenemana, V. 2000. Socio-economic constraints to the production, processing, and marketing of sweetpotato in Kumi District, Uganda. African Potato Association Conference Proceedings 5, 449–453. Mutuura, J., Ewell, P., Abubaku, A., Mungu, T., Ajarga, S., Irunga, S., Owori, F., and Masbe, S. 1992. Sweet Potatoes in the food system of Kenya. Results of a socio-economic survey. In ‘‘Current Research for the Improvement of Potato and Sweetpotato in Kenya’’ (J. Kabira and P. Ewell, eds). International Potato Centre, Nairobi, Kenya. Mwesigwa, T.W. 1995. Sweetpotato consumption levels and patterns in urban household with particular reference to Kampala city. B.Sc. Thesis, available at Library, Department of Agriculture, Makerere University, Kampala, Uganda. Nair, G.M., Ravindran, C.S., Moorthy, S.N., and Ghosh, S.P. 1987. Sweetpotato research and development for small farmers. International Sweetpotato Symposium, Baybay, Philippines, May 20–26, (K.T. Mackay, M.K. Palomar, and R.T. Sanico, eds), p. 301. SAEMEO-SEARCA, Philippines. Namutebi, A., Natabirwa, H., Lemaga, B., Kapinga, R., Matovu, M, Tumwegamire, S., Nsumba, J., and Ocom, J. 2004. Long-term storage of sweetpotato by small-scale farmers through improved post harvest technologies. Uganda J. Agric. Sci. 9, 922–930. Niizu, P.Y. and Rodriguez-Amaya, D.B. 2005. New data on the carotenoid composition of raw salad vegetables. J. Food Compost. Anal. 18, 739–749. Nungo, R.A., Ndolo, P.J., and Hagenemana, V. 2000. Promoting sweeetpotato processing and utilization: Experience in Western Kenya. African Potato Association Conference Proceedings 5, 481–482. Oboh, S., Ologhobo, A., and Tewe, O. 1989. Some aspects of the biochemistry and nutritional value of the sweetpotato (Ipomoea batatas). Food Chem. 31, 9–18. Odongo, B., Mwanga, R.O.M., and Niringiye, N. 2004. Promoting improved sweet potato varieties and processing technologies in Lira, Pallisa and Soroti Districts. Final Technical Report, October 2004-12-09. NAARI, Kampala, Uganda. Olaofe, O. and Sanni, C.O. 1988. Mineral contents of agricultural products. Food Chem. 30, 73–77. Olson, J.A. 1996. Benefits and liabilities of vitamin A and carotenoids. J. Nutr. 126, 1208S–1212S. Omosa, M. 1994. Current and potential demand for fresh and processed sweetpotato products in Nairobi and Kisumu, Kenya. International Potato Center, Nairobi, Kenya.
56
A. C. BOVELL-BENJAMIN
Onwueme, I.C. 1978. ‘‘The Tropical Root Crops: Yam, Cassava, Sweetpotato and Cocoyam’’. Wiley, New York. Orbase, B.R. and Autos, N.B. 1996. Sweetpotato. In ‘‘Selected Research Papers. July 1994–June, 1995. Volume 2, Sweetpotato’’ (E. Rasco and V.R. Amante, eds), p. 167. SAPPRAD, Manila, Philippines. Ostertag, C.F. 1993. ‘‘World Production and Marketing of Starch Mimeo’’. CIAT, Cali, Colombia. Owori, C. and Hagenimana, V. 2000. Quality evaluation of sweetpotato flour processed in diVerent agro-ecological sites using small scale processing technologies. African Potato Association Conference Proceedings 5, 483–490. Owori, C., Kigozi, J., and Mwesigye, A. 2000. Standardization and development of recipes for processing sweetpotato products. PRAPACE/CIP/NARO Annual Progress Report, CIP/ NARO, Kampala, Uganda. Oyunga-Ogubi, M.A., Ng’ang’a, N.M., and Olayo, J.A. 2005. Sweetpotato processing for improved vitamin A intake: Gender implications and potential for sustainable technology adoption in Siaya District, Kenya. http://www.asareca.org (accessed 11/11/05). Pace, R.D., Phillips, B.W., Adeyeye, S.O., and Gilliard, F.M. 1996. Eat smart menus and recipes with sweetpotato greens. Publication No. 110–196. Tuskegee University, Tuskegee, AL. Pal, S., Sachdeva, S., and Singh, S. 1995. Methods for determination of sensory quality of foods. A critical appraisal. J. Food. Sci. Technol. 32, 357–367. Pandey, M. and Shukla, V.K. 2002. Diet and gallbladder cancer: A case-control study. Eur. J. Cancer Prev. 11, 365–368. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. 2005. Global cancer statistics. CA Cancer J. Clin. 55, 74–108. Peters, D. 1998. ‘‘Setting Post-Harvest Strategies for Food Security and Income Generation in Soroti, Uganda’’. International Potato Center (CIP), Lima, Peru. Peters, D. and Wheatley, C. 1997. Small scale agro-enterprises provide opportunities for income generation: Sweetpotato flour in East Java, Indonesia. Q. J. Int. Agric. 36, 331–352. Peters, D., Wheatley, C., Heriyanto, C., and Antarlina, S.S. 2005. Participatory process improvement for small scale sweetpotato flour production in East Java, Indonesia. International Potato Center (CIP), Bogur, Indonesia http://www.eseap.cipotato.org/MF-ESEAP/Fl-Library/KNGTRIAL. pdf#search¼‘dai%20peters%20participatory%20process%20sweetpotato%20flour’ (accessed 09/ 12/2005). Piperno, D.R. and Holst, I. 1998. The presence of starch grains on prehistoric stone tools from the humid neotropics: Indications of early tuber use and agriculture in Panama. J. Archaeol. Sci. 25, 765–776. Plata, N., Konczak-Islam, I., Jayram, S., McClelland, K., Woolford, T., and Franks, P. 2003. EVect of methyl jasmonate and p-coumaric acid on anthocyanin composition in a sweetpotato cell suspension culture. Biochem. Eng. J. 14, 171–177. Politzer, M. 1997. Experience in the medical treatment of progressive myopia. Klin. Monatsbl. Augenheilkd. 171, 616–619. Prior, R.L., Cao, G., Martin, A., Sofic, E., McEwen, J., O’Brien, C., Lischner, N., Ehlenfeldt, M., Kalt, W., Krewer, G., and Mainland, C.M. 1998. Antioxidant capacity as influenced by total phenolic and anthocyanin content, maturity, and variety of Vaccinium species. J. Agric. Food Chem. 46, 2686–2693. Purcell, A.E., Walter, W.M., and Giesbrecht, F.G. 1978. Root, hill, and field variance in protein content of North Carolina sweetpotatoes. J. Agric. Food Chem. 26, 362–364. Ravindran, V., Ravindran, G., Sivakanesan, R., and Rajaguru, S.B. 1995. Biochemica assessment of tubers from 16 cultivars of sweetpotato (Ipomoea batatas L.). J. Agric. Food Chem. 43, 2646–2651. Reddy, O.V.S. and Basappa, S.C. 1997. Preparation of sweetpotato flour and its fermentation to ethanol. J. Food. Sci. Technol. 34, 108–112.
SWEET POTATO: A REVIEW
57
Rice-Evans, C.A. and Miller, N.J. 1996. Antioxidant activities of flavonoids as bioactive compounds of food. Transactions 24, 790–795. Russell, R.M. 1998. Physiological and clinical significance of carotenoids. Int. J. Vitam. Nutr. Res. 68, 349–353. Sarikaya, E., Higasa, T., Adachi, M., and Mikama, B. 2000. Comparison of degradation abilities of a and b-amylases on raw starch granules. Process Biochem. 35, 711–715. Sauer, J.D. 1950. Cultivated plants of South and Central America. In ‘‘Handbook of South American Indians’’ (J. Steward, ed.), pp. 487–543. Bureau of American Ethnology Bulletin 143, Vol. 6. Washington, DC: U.S. Government Printing Office. Sawer, W. 2001. The rocky road from roots to rice: A review of the changing food and nutrition situation in Papua New Guinea. P.N.G. Med. J. 44, 151–163. Scharrer, A. and Ober, M. 1981. Anthocyanisides in the treatment of retinopathies. Klin. Monatsbl. Augenheilkd. 178, 386–389. Scheibmeir, H.D., Christensen, K., Whitaker, S.H., Jegaethesan, J., Clancy, R., and Pierce, J.D. 2005. A review of free radicals and antioxidants for critical care nurses. Intensive Crypt Care Nurs. 21, 24–28. Scheuring, J.F., Schierie, J., and Frigg, M. 1996. Orange-fleshed sweetpotatoes bring vitamin A to Malians. Sight and Life Newsletter 4/1996, 6–7. Schneeman, B.O. 1998. Dietary fiber and gastrointestinal function. Nutr. Res. 18, 632–652. Schweigert, F.J., Klingner, J., Hurtienne, A., and Zunft, H.J. 2003. Vitamin A, carotenoid and vitamin E plasma concentrations in children from Laos in relation to sex and growth failure. Nutr. J. 2, 17 (available from http://www.nutritionj.com/content/2/1/17). Scott, G.J. and Ewell, P. 1992. ‘‘Sweet Potato in African Food Systems’’. International Potato Centre (CIP), Lima, Peru. Scott, G.J. and Maldonado, L. 1999. ‘‘CIP Sweetpotato Facts: A Compendium of Key Figures and Analysis for 33 Important Sweetpotato-Producing Countries’’. International Potato Center (CIP), Lima, Peru (brochure). Scott, G.J. and Symes, C.W. 1996. Isolation, characterization and cell growth-regulatory properties of kumara (sweetpotato) trypsin inhibitors. Biochem. Mol. Biol. Int. 38, 333–344. Scott, G.J., Rosegrant, M.W., and Ringler, C. 2000. Global projections for root and tuber crops to the year 2020. Food Policy 25, 561–597. Shewry, P.R. 2003. Tuber storage proteins. Ann. Bot. 91, 755–769. Shimozono, H., Kobori, M., Shinmoto, H., and Tsushida, T. 1996. Suppression of the melanogenesis of mouse melanoma B-16 cells by sweetpotato extract. Nippon Shokuhin Kagaku Kaishi 43, 313–317 (in Japanese). Sho, H. 2001. History and characteristics of Okinawan longevity food. Asia Pacific J. Clin. Nutr. 10, 159–164. Simonne, A.H., Kays, S.J., Koehler, P.E., and Eitenmiller, R.R. 1993. Assessment of b-carotene content in sweetpotato breeding lines in relation to dietary requirements. J. Food Composit. Anal. 6, 336–345. Smith, N., Odongo, B., and Okoth, J. 1996. Baseline data collection emphasizing on sweetpotato production in Gweri sub-county, Soroti, Uganda. PRA Progress Report. CIP/NARO, Kampala, Uganda. Steenbock, H. 1919. White corn vs. yellow corn and a probable relation between the fat-soluble vitamin and yellow plant pigments. Science 50, 352–353. Stephenson, L.S., Latham, M.C., and Ottesen, E.A. 2000. Global malnutrition. Parasitology 121 (Suppl.), S5–S22. Stone, H.H. and Sidel, J. 1993. ‘‘Sensory Evaluation Practices’’, pp. 50–56, 204–235. Redwood City, Academic Press, California.
58
A. C. BOVELL-BENJAMIN
Suda, I., Yamakawa, O., Matsugano, K., Sugita, K., Takuma, Y., Irisa, K., and Tokumaru, F. 1998. Changes of l-GTP, GOT and GPT levels in hepatic function-weakling subjects by ingestion of high anthocyanin sweetpotato juice. Nippon Shokuhin Kagaku Kogaku Kaishi 45, 611–617 (in Japanese). Suda, I., Tomoyki, O., Masuda, M., Kobayashi, M., Nishiba, Y., and Furuta, S. 2003. Physiological functionality of purple-fleshed sweetpotatoes containing anthocyanins and their utilization in foods. JARQ 37, 167–173 (http://www.jircas.aVrc.go.jp). Suismono, I. 1995. Sweetpotato processing for flour and noodles. M.Sc. Thesis, Bogor Agricultural University (IPB), Bogor, Indonesia, p. 137. Sungpuag, P., Tangchitpianvit, T., Chittchang, U., and Wasantwisut, E. 1999. Retinol and beta carotene content of indigenous raw and home-prepared foods in Northeast Thailand. Food Chem. 64, 163–167. Tamura, H. and Yamagami, A. 1994. Antioxidative activity of monoacylated anthocyanins from Muscat Bailey A grape. J. Agric. Food Chem. 42, 1612–1615. Taylor, S.L. and Hefle, S.L. 2001. Food allergies and other sensitivities. Food Technol. 55, 68–83. Tewe, O.O., Ojeniyi, F.E., and Abu, O.A. 2003. ‘‘Sweetpotato Production, Utilization and Marketing in Nigeria’’. Social Sciences Department, International Potato Center (CIP), Lima, Peru. Tian, S.J., Rickard, J.E., and Blanshard, J.M.V. 1991. Physicochemical properties of sweet potato starch. J. Sci. Food Agric. 57, 459–491. Timberlake, C.F. and Henry, B.S. 1988. Anthocyanins as natural food colorants. Prog. Clin. Biol. Res. 280, 107–121. Timmins, W.H. and Marter, A.D. 1992. Aspects of sweetpotato processing in Sichuan Province, People’s Republic of China. In ‘‘Product development for root and tuber crops, Volume I— Asia’’ (G. Scott, S. Wiersema, and P.I. Fergusun, eds), pp. 217–228. Proceedings of an International Workshop, held April 22–May 1 at Visayas State College of Agriculture, ViSCA, Baybay, Leyte, Phillipines. CIP, Lima, Peru. Tsou, S.C.S. and Hong, T.L. 1992. The nutrition and utilization of sweetpotato. In ‘‘Sweetpotato Technology for the Twenty-First Century’’ (W.A. Hill, C.K. Bonsi, and P.A. Loretan, eds), pp. 359–366. Tuskegee University Press, Tuskegee, AL. Underwood, B.A. and Arthur, P. 1996. The contribution of vitamin A to public health. FASEB J. 10, 1040–1048. Valenzuela, H., Fukuda, S., and Arakaki, A. 1994. Sweetpotato production guide for Hawaii. Research Extension Series 146. Institute of Tropical Agriculture and Human Resources, University of Hawaii, Honolulu, Hawaii. Van Den, T. 1984. Drying cassava and sweetpotato for food. PCARRD Monitor 12, 8–9. Van Den, T. 1992. Sweetpotato beverages: Product development and technology transfer. In ‘‘Sweetpotato Technology for the 21st Century’’ (W.A. Hill, C.K. Bonsi, and P.A. Loretan, eds), pp. 389–399. Tuskegee University, Tuskegee, AL. Van Den, T. and del Rosario, E.J. 1984. ‘‘Sweetpotato Starch Research, State-of-the-Art’’. Philippine Council for Agriculture and Resources Research, Los Banos. van Hal, M. 2000. Quality of sweetpotato flour during processing and storage. Food Rev. Internat. 16, 1–37. Van Jaarsveld, P.J., Faber, M., Tanumihardjo, S.A., Nestel, P., Lombard, C.J., and Benade´, 2005. b-Carotene-rich orange-fleshed sweetpotato improves the vitamin A status of primary school children assessed with the modified-relative-dose-response test. Am. J. Clin. Nutr. 81, 1080–1087. van Poppel, G. and Goldbohm, R.A. 1995. Epidemiological evidence for b-carotene and cancer prevention. Am. J. Clin. Nutr. 62, 13938–14028. Walter, W.M., Collins, W.W., and Purcell, A.E. 1984. Sweetpotato protein: A review. J. Agric. Food Chem. 32, 695–699.
SWEET POTATO: A REVIEW
59
Walter, W.M., Van Den, T., and Espinel, K.R. 2001. Patent Number 6,197,363. Methods for Producing Cooked Sweetpotato Products and Compositions. Issued March 6, 2001. Walter, W.M., Van Den, T., and Espinel, K.R. 2002. Textural measurements and product quality of restructured sweetpotato French fries. Lebensm.-Wiss. U.-Technol. 35, 209–215. Wang, H., Cao, G., and Prior, R.L. 1997. Oxygen radical absorbing capacity of anthocyanins. J. Agric. Food Chem. 45, 304–309. Weiss, R.F. and Finkelmann, A. 2000. ‘‘Herbal Medicine’’, 2nd Ed. Thieme, Stuttgart. Wheatley, C.C. and Bofu, S. 2000. Sweetpotato starch in China: Current status and future prospects. In ‘‘Cassava, Starch and Starch Derivatives’’ (R.H. Howeler, C.G. Oates, and G.M. O’Brien, eds), pp. 201–205. Proceedings of the International Symposium held in Nanning, Guangxi, China, November 11–15, 1996, A CIAT Publication, CIAT Regional Cassava Program for Asia. Wheatley, C.C., Scott, G.J., Best, R., and Wiersema, S. 1996. ‘‘Adding Value to Root and Tuber Crops’’, p. 166. CIAT, Cali, Colombia. Wilson, C., Pace, R.D., Bromfield, E., and Lu, J. 1998. Consumer acceptance of vegetarian sweet potato products intended for space missions. Life Support Biosph Sci. 5, 339–346. Winter, S., Purac, A., Leggett, F., Frison, E.A., Rossel, H.W., and Hamilton, R.I. 1992. Partial characterization and molecular cloning of a closeterovirus from sweetpotato aVected with the sweetpotato virus disease complex from Nigeria. Phytopathology 82, 869–875. Woolfe, J.A. 1992. ‘‘Sweetpotato: An Untapped Food Resource’’, pp. 41–117. Cambridge University Press, New York, NY. Yadav, A.R., Guha, M., Tharanathan, R.N., and Ramteke, R.S. 2005. Changes in characteristics of sweet potato flour prepared by diVerent drying techniques. LWT—Food Sci. Technol. 39, 152–158. Yamakawa, O. and Yoshimoto, M. 2002. Sweetpotato as food material with physiological functions. Acta Hort. (ISHS) 583, 179–185. Ye, X.S., Babili, A.L., Kloti, A., Zhang, J., Lucca, P., Beyer, P., and Potrykus, I. 2000. Engineering the provitamin A (b-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science 287, 303–305. Yoshimoto, M. 2001. New trends of processing and use of sweetpotato in Japan. Farming Jpn. 35, 22–28. Yoshimoto, M., Okuno, S., Suwa, K., Sugawara, T., and Yamakawa, O. 1999. Antimutagenicity of sweetpotato (Ipomoea batatas) roots. Biosci. Biotechnol. Biochem. 63, 537–541. Yousif-Ibrahim, S., Miller, S.-A., and Bovell-Benjamin, A.C. 2003. EVects of pH and concentration times on selected functional properties of a sweetpotato syrup. Paper presented at ARD 2003. Association of Research Directors, Inc., 13th Biennial Research Symposium. March 29–April 2, Atlanta, GA. Zhang, T. and Oates, C.G. 1999. Relationship between a-amylase degradation and physico-chemical properties of sweetpotato starches. Food Chem. 65, 157–163.
This page intentionally left blank
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN MAGDALENA PASARICA AND NIKHIL V. DHURANDHAR Department of Infections and Obesity, Pennington Biomedical Research Center Louisiana State University System, Baton Rouge, Louisiana 70808
I. Introduction II. Canine distemper virus A. CDV General Information B. CDV-Induced Obesity C. Mechanisms of CDV-Induced Obesity III. Rous-Associated Virus-7 A. RAV-7 General Information B. RAV-7-Induced Obesity C. Specificity of RAV-7-Induced Obesity D. Mechanism of RAV-7-Induced Changes IV. Chlamydia pneumoniae A. CP General Information B. CP Association with Higher BMI C. Mechanism of CP EVects V. Scrapie Agent A. General Information B. Scrapie-Induced Obesity C. Mechanism of Scrapie-Induced Obesity VI. Borna disease virus A. General Information B. Borna disease virus-Induced Obesity C. Mechanism of BDV-Induced Obesity VII. Gut Microbiota A. General Information B. Microbiota-Induced Obesity C. Mechanism of Microbiota-Induced Obesity VIII. Adenoviruses IX. SMAM-1 A. SMAM-1 General Information B. SMAM-1-Induced Obesity C. Mechanism of SMAM-1-Induced Obesity X. Adenovirus Type 36 A. Ad-36 General Information B. Ad-36-Induced Adiposity C. Mechanism of Ad-36-Induced Obesity
ADVANCES IN FOOD AND NUTRITION RESEARCH VOL 52 # 2007 Elsevier Inc. All rights reserved
ISSN: 1043-4526 DOI: 10.1016/S1043-4526(06)52002-9
62
M. PASARICA AND N. V. DHURANDHAR XI. Adenovirus Type 5 A. Ad-5 General Information B. Ad-5-Induced Obesity C. Mechanism of Ad-5-Induced Obesity XII. Adenovirus Type 37 XIII. Adipogenic Potential of Other Adenoviruses XIV. Role of Pathogens in Human Obesity XV. Infection, Inflammation, and Obesity XVI. Conclusions Acknowledgments References
The rapid increase in obesity and the associated health care costs have prompted a search for better approaches for its prevention and management. Such efforts may be facilitated by better understanding the etiology of obesity. Of the several etiological factors, infection, an unusual causative factor, has recently started receiving greater attention. In the last two decades, 10 adipogenic pathogens were reported, including human and nonhuman viruses, scrapie agents, bacteria, and gut microflora. Some of these pathogens are associated with human obesity, but their causative role in human obesity has not been established. This chapter presents information about the natural hosts, signs and symptoms, and pathogenesis of the adipogenic microorganisms. If relevant to humans, ‘‘Infectobesity’’ would be a relatively novel, yet extremely significant concept. A new perspective about the infectious etiology of obesity may stimulate additional research to assess the contribution of hitherto unknown pathogens to human obesity and possibly to prevent or treat obesity of infectious origins. I. INTRODUCTION The World Health Organization recently declared that we are experiencing an epidemic of obesity. In the past 20 years, the prevalence of obesity has increased by 30% in the United States and several developed as well as developing countries have reported increased prevalence (Astrup et al., 1998; Powledge, 2004; Rossner, 2005). In the best of hands, obesity treatment usually yields marginal and transient weight loss. More eVective and longer lasting strategies for prevention and treatment of obesity are urgently needed. Understanding contribution of various etiologic factors of obesity may lead to treatments directed specifically toward the cause, and consequently, its successful management. In addition to genetic, behavioral, endocrinal, and other causative factors of obesity, infectious etiology has been known for over two decades
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
63
(Sclafani, 1984) but largely ignored for the purpose of obesity prevention and treatment strategies. To date, adipogenic eVects of 10 pathogens have been described, which include human and nonhuman viruses, scrapie agents, bacteria, and gut microflora. A comprehensive understanding of their adipogenic role may facilitate further investigation in determining certain infections as an etiologic factor in human obesity. This chapter describes various adipogenic pathogens reported since the first report about obesitypromoting eVects of Canine distemper virus (CDV) in 1982 (Lyons et al., 1982). A summary of the effects of these adipogenic pathogens on the host and the potential mechanism involved is provided in Tables I and II.
II. CANINE DISTEMPER VIRUS A. CDV GENERAL INFORMATION
The first obesity-promoting pathogen reported (Lyons et al., 1982), CDV of the genus Morbillivirus, subgroup of paramyxoviruses, is a lymphotropic and neurotropic negative-stranded RNA virus (Rozenblatt et al., 1985; Vandevelde and Zurbriggen, 1995; Yamanouchi, 1980). CDV causes a frequently fatal disease that aVects dogs and a wide range of mammals (Leisewitz et al., 2001; Lyons et al., 1982; Raine, 1976; Summers and Appel, 1994; Vandevelde and Kristensen, 1977). CDV and Measles virus (MV) produce similar systemic disorders and are antigenically related (Hall et al., 1980). Although an association of CVD with other human diseases was suggested (Summers and Appel, 1994), CDV is not considered a human pathogen. CDV invades the nervous system and replicates in neurons and glial cells of the white mater subgroup (Vandevelde and Zurbriggen, 1995). Mice or dogs experimentally infected with CDV showed viral inclusions, giant cell formation, reactive gliosis, and myelin degradation (Lyons et al., 1982; Raine, 1976; Vandevelde and Kristensen, 1977). Bernard et al. (1993) suggest that CDV infection spreads by humoral and intracellular space pathways or by axonal transport. CDV infection results in acute encephalitis and death of 40–50% of the animals, followed by either motor impairment or obesity syndrome in a late phase in the survivors (Bernard et al., 1988, 1993). B. CDV-INDUCED OBESITY
Lyons et al. (1982) first reported that CDV induces obesity in Swiss albino mice. Results were confirmed later by Bernard et al. (1988, 1991, 1993). CDV produced significant increase in body weight and fat cell number as well as
64
TABLE I ADIPOGENIC PATHOGENS—AN OVERVIEW
Animal model used, age, and sex
Duration of onset of obesity
EVect of infection on body weight
EVect of infection on biochemical parameters
Association with human obesity
CDV
1982 (Lyons et al., 1982)
Swiss albino mice, male and female, 4–5 weeks old (Lyons et al., 1982)
Developed 6–10 weeks postinfection and reaches a plateau after 16–20 weeks (Lyons et al., 1982)
Mean weight of infected obese animals was 63.7 g versus 33.1 g in the uninfected group (Lyons et al., 1982)
Association with human multiple sclerosis (Summers and Appel, 1994)
RAV-7
1983 (Carter et al., 1983a)
10-day-old embryos— SC white leghorn chicken line (Carter et al., 1983a,b, 1984; Carter and Smith, 1983)
Stunting—14 days posthatching (Carter et al., 1983a) Obesity—3 weeks of age (Carter et al., 1983b)
Stunting " Visceral fat (Carter et al., 1983a,b)
BDV
1991 (Gosztonyi and Ludwig, 1995)
Weaning/adult Lewis rats (Gosztonyi and Ludwig, 1995; Herden et al., 2000)
2-month postinoculation (Gosztonyi and Ludwig, 1995)
Obesity with " visceral fat (Gosztonyi and Ludwig, 1995)
" Insulin (Bernard et al., 1988, 1999) No significant change in glucose (Bernard et al., 1988) # Leptin levels (Bernard et al., 1999) # MCH, NPY (GriVond et al., 2004) # Catecholamine (Lyons et al., 1982) # Neuropeptides (GriVond et al., 2004) Anemia Hyperlipidemia Immune suppression " Amylase " Insulin # Glucose # Thyroxine (Carter et al., 1983a,b, 1984) " Tryglyceride Moderate " blood glucose (Gosztonyi and Ludwig, 1995)
No
Transmission of BDV from animals to humans is possible (Ludwig and Bode, 2000)
M. PASARICA AND N. V. DHURANDHAR
Year first reported
1968 (Pattison and Jones, 1968)
6- to 9-week-old female mice SJL, C57NL, A2G, SAMP8, SAMR1, AKR, 22L (Kim et al., 1987, p. 91; Carp et al., 1998) 3-week-old white leghorn broilers (Dhurandhar et al., 1990, 1992)
12 weeks postinfection (Carp et al., 1984)
" Body weight due to fat accumulation (Carp et al., 1984, 1989)
" Blood glucose (Vorbrodt et al., 2001) # GLUT-4 density in certain brain areas (Vorbrodt et al., 2001)
Not reported
SMAM-1
1990 (Dhurandhar et al., 1990)
3 weeks postinoculation (Dhurandhar et al., 1990, 1992)
Stunting " Visceral fat (Dhurandhar et al., 1990, 1992)
# Cholesterol # Triglyceride (Dhurandhar et al., 1990, 1992)
2000 (Dhurandhar et al., 2000)
Chickens Mice Male rhesus and marmoset monkeys Rats (Dhurandhar et al., 2000, 2001, 2002; Pasarica et al., 2006)
4 weeks (Dhurandhar et al., 2000, 2001), 6- to 7-month postinoculation (Dhurandhar et al., 2002; Pasarica et al., 2006)
" Body weight " Visceral, epididymalinguinal, retroperitoneal fat (Dhurandhar et al., 2001; Pasarica et al., 2006)
2002 (Atkinson et al., 2002)
3-week-old white leghorn chickens (Atkinson et al., 2002)
4-weekpostinoculation (Atkinson et al., 2002)
No diVerence in body weight " Visceral fat (Atkinson et al., 2002)
# Cholesterol (Dhurandhar et al., 2000, 2001; Pasarica et al., 2006) # Triglyceride (Dhurandhar et al., 2000, 2001; Pasarica et al., 2006) # HOMA (" insulin sensitivity) (Pasarica et al., 2006) " Leptin (Pasarica et al., 2006) # Corticosterone and norepinephrine (Pasarica et al., 2006) # Triglycerides (Atkinson et al., 2002)
Yes. Seropositive obese subjects were heavier versus seronegative obese counterparts (Dhurandhar et al., 1997b) Yes. Greater prevalence of seropositivity in obese versus nonobese subjects. Seropositive subjects were heavier than seronegative counterparts (Atkinson et al., 2005)
Ad-36
Ad-37
Keratoconjunctivitis and genitourinary tract infections in humans (de Jong et al., 1981)
65
(continued)
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
Scrapie
66
TABLE I (continued) Animal model used, age, and sex
Duration of onset of obesity
EVect of infection on body weight
EVect of infection on biochemical parameters
Association with human obesity
Ad-5
2005 (So et al., 2005)
3-week-old female outbread CD1 mice (So et al., 2005)
22- to 13-week postinoculation (So et al., 2005)
–
Chlamydia pneumoniae
2000 (Ekesbo et al., 2000)
Humans (Dart et al., 2002; Ekesbo et al., 2000)
Association with increased BMI (Dart et al., 2002; Ekesbo et al., 2000)
" Body weight " Whole body adiposity (So et al., 2005) Significantly higher BMI (Dart et al., 2002; Ekesbo et al., 2000)
Gut microbiota
2004 (Backhed et al., 2004)
8- to 10-week-old germfree male B6/NMRI mice (Backhed et al., 2004)
After 14 days colonization (Backhed et al., 2004)
Respiratory tract infection in humans (Limbourg et al., 1996) Association with increased BMI 27.3 versus 25.8 kg/m2 (Ekesbo et al., 2000) 26.6 versus 25.5 kg/m2 (Dart et al., 2002) –
No diVerence in body weight " Whole body fat " Epididymal fat # Lean mass (Backhed et al., 2004)
Association with CHD (Danesh et al., 1997; Kuo et al., 1993; Saikku et al., 1988)
Insulin resistance # Metabolic rate " Hepatic triglyceride content " Expression of de novo fatty acid synthesis pathway # Expression Fiaf (Backhed et al., 2004)
M. PASARICA AND N. V. DHURANDHAR
Year first reported
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
67
TABLE II MECHANISM OF ACTION OF ADIPOGENIC PATHOGENS
Natural host
Organs/systems aVected
Mechanism of action
CDV
Dogs (Leisewitz et al., 2001; Summers and Appel, 1994)
Brain Pancreas Reproductive organs Kidneys Liver (Lyons et al., 1982)
RAV-7
Avian
BDV
Horses and sheep (Gosztonyi and Ludwig, 1995)
Scrapie
Sheep and goats (Hunter, 1972)
# Thymus weight # Bursa weight Fatty, yellow, enlarged livers Lymphoblastic infiltration of thyroid and pancreas (Carter et al., 1983a,b; Carter and Smith, 1983) Brain Hyperplasia islet of Langerhans (Gosztonyi and Ludwig, 1995) # Size—spleen, liver, kidney, brain, uterus " Adrenal weight (Carp et al., 1984; Kim et al., 1988)
Alters hypothalamic integrity (Bernard et al., 1993, 1999; Nagashima et al., 1992; Verlaeten et al., 2001) # Leptin long receptor and " leptin (Bernard et al., 1999) # MCH (Verlaeten et al., 2001) # Neuropeptides (GriVond et al., 2004) # Catecholamine (Lyons et al., 1982) " Cytokines production (Bencsik et al., 1996) Changes in lipid metabolism (Anderton et al., 1982, 1983a,b; Wild et al., 1986) # Thyroxine (Carter and Smith, 1983)
Inflammatory lesions and viral replication in hypothalamus (Herden et al., 2000) Brain function alteration (Kim et al., 1987; Vorbrodt et al., 2001) # GLUT-1 density, # glucose tolerance (Vorbrodt et al., 2001) " Adrenal weight disturbs hypothalamicpituitary-adrenal axis (Kim et al., 1988) (continued)
68
M. PASARICA AND N. V. DHURANDHAR
TABLE II (continued) Natural host
Organs/systems aVected
Mechanism of action
SMAM-1
Avian (Ajinkya, 1985)
Impaired liver function (Dhurandhar et al., 1992) Impaired lipogenesis (Dhurandhar et al., 1992) Glucagons deficiency (Dhurandhar et al., 1992)
Ad-36
Human (Wigand et al., 1980)
Liver—" size, congested, fatty, infiltrated with intranuclear inclusion bodies Kidney—" size # Size of bursae, thymus, spleen (Dhurandhar et al., 1990, 1992) –
Ad-37
–
Ad-5
Human (de Jong et al., 1981) Human (Limbourg et al., 1996)
Chlamydia pneumoniae
Humans (Hogan et al., 2004)
Respiratory tract (Kuo et al., 1995)
Gut microbiota
Human gut (Xu and Gordon, 2003)
–
–
Increased replication, diVerentiation, and lipid accumulation in preadipocytes (Pasarica et al., 2005; Vangipuram et al., 2004) " Insulin sensitivity (Yu and Dhurandhar, 2005) # Leptin secretion (Vangipuram et al., 2007) and expression (Yu and Dhurandhar, 2005) in fat cells Increased Increased preadipocyte diVerentiation (So et al., 2005) Anti-inflammatory response determined by infection (So et al., 2005) Mechanism unknown. Preponderance of seropositivity in obese subjects is not an eVect of obesity (Dart et al., 2002) Increased processing of polysaccharides Increased calories Increased ineYcient metabolism (Backhed et al., 2004)
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
69
moderate increase in fat cell size in mice surviving the infection (Lyons et al., 1982). Food intake was slightly but not significantly increased for the obese group (Bernard et al., 1988). Obese and lean animals had comparable titers of anti-CDV-neutralizing antibodies (Lyons et al., 1982). Obesity was observed in 26% of the animals after an intracerebral inoculation of CDV, while only 16% of animals become obese following an intraperitoneal inoculation. Body weights of the obese animals were comparable to those seen in genetic or hypothalamic models of obesity. When the body weight plateaued at 16–20 weeks postinoculation, mean weight of infected obese animals was 63.7 g versus 33.1 g in the uninfected group (Lyons et al., 1982). Obese animals had three times more lipid per cell and twice as many fat cells in the inguinal fat pads compared with the lean counterparts. A comparable change was observed in the gonadal and retroperitoneal fat pads (Lyons et al., 1982). Brains and reproductive organs were lighter and livers, kidneys, and pancreas were heavier in the obese animals, and this diVerence was statistically significant only for the females. There was no diVerence in the adrenal and pituitary gland weights. The increase in liver weight was mainly due to accumulation of triglyceride, while no change was detected in phospholipid composition. Obese mice had decreased lipogenesis in white adipose tissue with unaVected glycogenesis (Bernard et al., 1988). Prior to developing obesity, the CVD-infected group of mice showed increased insulin levels that attained statistical significance of 4–6 months postinfection, when they were six times greater than those in lean animal (Bernard et al., 1988, 1999). However, no significant diVerence in glucose levels was observed (Bernard et al., 1988). There was an initial increase, followed by a decrease in leptin long receptor and a dramatic increase in leptin levels accompanied by low levels of viral RNA in targeted CDV brain regions of infected animals (Bernard et al., 1999). Melanin-concentrating hormone precursor mRNA (ppMCH) was downregulated in the late stage of the acute phase CDV infection in mice (Verlaeten et al., 2001). In addition, GriVond et al. (2004) reported decreased expression of neuropeptide Y (NPY), melanin-concentrating hormone (MCH), and other neuropeptides in the obese animals. Catecholamine levels in the obese-infected mice were reduced significantly in forebrain, but not in the brain stem (Lyons et al., 1982). In substantia nigra, CDV infection downregulates tyrosine hydroxylase (TH), the ratelimiting enzyme of dopamine synthesis, which leads to motor impairment of infected animals (Bencsik et al., 1996).
70
M. PASARICA AND N. V. DHURANDHAR C. MECHANISMS OF CDV-INDUCED OBESITY
As described below, several possible pathways have been proposed to explain the mechanism involved in CDV-induced obesity. 1. CDV replication in the rain The occurrence of obesity was correlated with the neurovirulence of the virus strain (Bernard et al., 1999). Prior vaccination with a vaccinia recombinant coding for CDV surface antigens partially protected against acute encephalitis and obesity (Sixt et al., 1998; Wild et al., 1993). Neuroadapted CDV strain inoculation by other routes (intranasal, footpad, and subcutaneous) does not produce obesity, suggesting that viral replication in the brain is a prerequisite for development of obesity, as suggested by Bernard et al. (1999). 2. Hit-and-run eVect Oldstone et al. (1982) reported a novel way by which viruses may cause disease, ‘‘a hit-and-run’’ model. Virus replicates in the cells that make growth hormone, thereby disrupting homeostasis and decreasing growth hormone synthesis but surprisingly without producing any cell death or inflammation. Bernard et al. (1999) speculated that the initial impact of CDV on hypothalamus may initiate changes that would continue to promote obesity in animals even months after the acute infection, suggesting a ‘‘hit-and-run’’ eVect. Viral products are expressed in high levels in the acute stage of infection and at lower levels in the late stage (1 year after infection). Survivors of acute encephalitis complete the elimination of virus-producing cells or suppress expression of viral antigens within a few weeks postinfection (Nagashima et al., 1992). CDV nucleoprotein transcripts and F gene mRNA levels decrease with time, reaching low levels in the hypothalami of the infected rats 1 year postinoculation (Bernard et al., 1999). F surface protein of CDV has an essential role in infectivity, allowing viral spread. Defective expression of F gene, along with viral proteins M and HA, may produce viral persistence in brain cells, probably by escaping the host immune system (Liebert et al., 1986). There are no signs of inflammation in the hypothalamus (Bernard et al., 1999). Infected cells appear intact, despite vital presence (Bernard et al., 1993). Bernard et al. (1999) suggested that the hypothalamus acts as a reservoir for CDV, and this noncytolytic infection impedes specific hypothalamic functions like weight maintenance (Bray and York, 1971; Olney, 1969; Weingarten et al., 1985).
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
71
3. CDV alters hypothalamic integrity Hypothalamic nuclei, neuropeptides, and neurotransmitters integrate central and peripheral signals in order to regulate energy balance of the organism (Elmquist et al., 1999; Kalra et al., 1999; Sawchenko, 1998). Verlaeten et al. (2001) suggested that CDV alters hypothalamic integrity and subsequently modifies the homeostasis of the brain, which leads to obesity. Although CDV targets specific brain structures such as hypothalamic nuclei, thalamus, limbic system, substantia nigra, pars compacta, locus ceruleus, and raphe nuclei (Bernard et al., 1993), viral transcripts are only present in few structures, including hypothalamus (Bernard et al., 1999). Nagashima et al. (1992) reported that CDV produces a disorganization or destruction of hypothalamic nuclei, including the paraventricular nucleus. Furthermore, obese-infected animals lost pro-opiomelanocortin (POMC) and TH cell bodies (Nagashima et al., 1992). Loss of POMC bodies is shown to be associated with development of obesity (Scallet and Olney, 1986). These findings suggest a role for food intake disregulation in the CDV-infected animals. In agreement with these findings, Lyons et al. (1982) had reported that food intake of the infected group was greater, but did not attain statistical significance. Perhaps, the small additional energy intake over several weeks eventually contributed to biologically significant gain in body energy stores. 4. CDV downregulates long leptin receptor and increases leptin In the acute phase of infection, the expression of long leptin receptor was upregulated in all tissues targeted by CDV. With the exception of the hypothalamus, the same change was present in the late phase of the infection (Bernard et al., 1999). Long form of leptin receptor expression in the hypothalami was downregulated 70% and blood leptin levels were dramatically increased (53.4 mg/l vs 7.1 mg/l) in the late phase of infection when obesity occurred. Leptin, a protein mainly secreted by adipocytes, modulates food intake and energy metabolism (Paracchini et al., 2005). Downregulation of leptin receptor produces a state of leptin resistance. Consequentially, an increase in food intake and body weight may follow. 5. CDV downregulates melanin-concentrating hormone Melanin concentration hormone, synthesized in lateral hypothalamus and zona incerta (Bittencourt et al., 1992), is recognized to be a potent anorectic peptide that is involved in hypothalamic regulation of feeding behavior (Presse et al., 1996; Qu et al., 1996; Shimada et al., 1998). CDV causes an
72
M. PASARICA AND N. V. DHURANDHAR
initial downregulation of ppMCH in infected mice and this change is maintained in the late stages of infection only in the mice that become obese (Verlaeten et al., 2001). Verlaeten et al. (2001) speculated that either a disturbance in cAMP second messenger pathway or a strong induction in TNF-a is responsible for ppMCH downregulation. Expression of ppMCH mRNA is reduced in obese-infected mice by about 70% when compared to lean infected or uninfected mice. MCH protein expression is also decreased even in the absence of neuronal damage or reduction in cell number in hypothalamus, which suggests the ‘‘hit-and-run’’ eVect described by Oldstone et al. (1982). Verlaeten et al. (2001) suggested that this downregulation is related to CDV-induced obesity, rather than CDV infection itself. 6. CDV decreases expression of neuropeptides In the acute phase of infection, CDV decreases the expression of neuropeptides, in particular NPY, MCH, hypocretin, vasopressin, and tachykinins, disturbing homeostatic equilibrium. In the late stage of infection, the lean animals recover, while some of the obese animals surprisingly still have disturbed equilibrium. Interestingly, POMC, the precursors of anorexigenic a-MSH, is not modified, whereas orexigenic peptides like NPY, MCH, and hypocretin are downregulated (GriVond et al., 2004). NPY is involved in the control of hunger, satiation, and satiety (Ramos et al., 2005); MCH participates in food intake and energy expenditure modulation (Collins and Kym, 2003; Kawano et al., 2002); and hypocretins contribute to appetite and satiety regulation, energy equilibrium, arousal and sleep wakefulness, and vigilance and defense behaviors (Burdakov, 2004; Mazza et al., 2005; Sakurai, 2003). Implications of these findings are still unclear (GriVond et al., 2004). 7. CDV decreases catecholamine levels Changes in adrenergic system play a key role in regulating energy balance, and are associated with obesity (Clement et al., 1997; Fisher et al., 1998; Lipworth, 1996). Catecholamine levels were two to three times lower in CDV-infected mice (Lyons et al., 1982). Lyons et al. (1982) did not find significant lesions in the brain. Therefore, at the time, they considered reduced catecholamine levels as the cause of the obesity observed in CDV mice. 8. Increase cytokine production Cytokines produced in the brain play an important role in virus–host interaction that may influence viral spread and gene expression and consequently the functioning of neural cells (D’Arcangelo et al., 1991; Merrill and Chen, 1991;
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
73
Patterson and Nawa, 1993; Zalcman et al., 1994). TNF-a, IL-b, and IL-6 transcripts are selectively expressed in CDV-targeted brain structures, suggesting a possible participation of cytokine in CDV-induced changes. Cytokines are only expressed in brain regions permissive to CDV, suggesting that viral replication is necessary for cytokine expression (Bencsik et al., 1996). Upregulation of cytokine expression may alter neural cell function, which the author speculates could trigger the ensuing neurological disorders (Bencsik et al., 1996).
III. ROUS-ASSOCIATED VIRUS-7 Rous-associated virus-7 (RAV-7) was the second pathogen reported to cause obesity. In addition, it causes stunting and hyperlipidemia in chickens (Carter et al., 1983a). The following is a description of the adipogenic eVects of RAV-7. A. RAV-7 GENERAL INFORMATION
RAV-7, an avian leukosis virus (Carter and Smith, 1984), has an 8.2-kb RNA (Carter et al., 1983a). It is the most common naturally occurring avian retrovirus associated with neoplastic disease condition in domesticated poultry (Fadly, 1997). Avian leukosis viruses are RNA tumor viruses, a subfamily of the retroviridae (Vogt and Hu, 1977). All RNA tumor viruses carry three genes: gag (group-specific antigen), pol (directs the synthesis of the RNA-dependent DNA polymerase of the virion), and env (the gene for the envelope glycoprotein). The envelope glycoprotein of oncoviruses determines type-specific properties of the virion: host range, interaction with neutralizing antibodies, and viral interference. In the avian leukosis viruses, these specific properties are markers for virus classification into five subgroups: A, B, C, D, and F (Vogt and Hu, 1977). RAV-7 shares the least antigenic cross-reactivity within the subgroup C (DuV and Vogt, 1969). Avian retroviruses have also been classified into two groups based on the time required to produce tumors (Graf and Beug, 1978). However between these groups, there is another group that produces tumors like osteopetrosis after an intermediate latency time (Smith and Moscovici, 1969), immunosuppression (Smith and Van Eldik, 1978), stunting (Banes and Smith, 1977), and anemia (Paterson and Smith, 1978; Smith and Schmidt, 1982). Carter
74
M. PASARICA AND N. V. DHURANDHAR
showed that RAV-7 is classified as an avian retrovirus that causes disease at an intermediate time.
B. RAV-7-INDUCED OBESITY
Carter et al. (1983a) showed that RAV-7 induces obesity in chickens, which is characterized by stunting and hyperlipidemia. Birds, when infected as 10-day-old embryos, developed fat deposition around crop and abdominal fat pads. Whereas inoculation of 1-day-old hatched chickens did not produce stunting or obesity (Carter et al., 1983a). DiVerence in food intake was observed only after 3 weeks, when stunting and obesity developed (Carter et al., 1983b). Stunting of growth was the most striking eVect of RAV-7. Failure to grow became apparent 14 days posthatching, and the infected animals had grown four times slower than the uninfected controls (3.9 g/day vs 16.3 g/day). Fifty days posthatching, mean weight of RAV-7-infected chickens was 194 g compared to 515 g of the control group. RAV-7 infection caused a marked reduction in thymus weight, whereas the spleen size remained unchanged (Carter et al., 1983a). Fifty days after hatching, bursa weight was 0.2 g versus 3.1 g in the uninfected controls. Three weeks after hatching, infected chickens developed fatty, yellow colored livers, hepatomegaly, anemia, and immune suppression. Infected livers represented 6.2% of the body weight versus 2.4% in the uninfected controls. The liver cells from the 30-day-old RAV-7-infected chickens showed marked histological changes, with disorganization and swollen mitochondria with less cristae. RAV-7-infected chickens showed hyperlipidemia. The most striking eVect was observed in several 30-day-old infected chickens that had serum triglyceride levels greater than 2000 mg/dl and interestingly one greater than 14,000 mg/dl. There was no evidence of neoplastic transformation in the infected chickens, but lymphoblastoid infiltration of the thyroid and pancreas was present as early as 7 days posthatching, and the infiltration involved more tissue with time. Hypoglycemia was present in the infected animals 20 and 40 days after hatching. Serum amylase levels were increased for the infected animals, and this diVerence was significant 40 days posthatching. Carter et al. (1983a) suggested that increased amylase levels and decreased serum glucose values accompanied by histological alteration of the pancreas indicated pancreatic damage. Insulin levels in RAV-7-infected chickens were above normal all through 43 days posthatching and ranged from 114% to 352% of normal, with the exception of 3 days. Twenty and 30 days posthatching, glucagon
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
75
levels dropped to 34% and 44% of normal. This period also coincided with high mortality in RAV-7-infected chickens (Carter et al., 1983a). C. SPECIFICITY OF RAV-7-INDUCED OBESITY
Carter et al. (1983a,b) reported that the obesity-promoting eVects of RAV-7 are common for the subgroup C of avian leucosis viruses, but not for the other subgroups (A, B, D, or F). Chickens infected with subgroups A, B, D, E, and F showed osteopetrosis (predominant for MAV-1 and MAV-2), anemia, liver lesions, blood cysts, fibrosarcoma, or nephroblastoma (predominant for MAV-2), but did not develop adiposity (Carter and Smith, 1984). Subgroup C viruses tested (RAV-7, transformation-defective B77, transformation-defective Prague strain of Rous sarcoma virus, RAV-49) caused stunting, lymphoblastoid infiltration of the thyroid and pancreas, decreased thyroxine, and increased insulin and liver weight, with RAV-7 showing the greatest change. These results were obtained from 10-day-old embryos intravenously inoculated with diVerent types of viruses belonging to avian leukosis class. Subgroup C virus-infected chickens were significantly stunted 20, 30, or 40 days posthatching. The possibility that the envelope of avian leukosis virus is involved in the pathogenesis of disease was examined by comparing the changes induced by RAV-7, and other viruses in subgroups A, B, D, and F. Subgroup C viruses produced similar changes, which were not common to those from other subgroups. This suggested that the envelope may be involved in pathogenicity (Carter and Smith, 1984). RAV-7 shares the least antigenic cross-reactivity within the subgroup C viruses (DuV and Vogt, 1969), which may explain its greater pathogenicity compared to other viruses in the same subgroup. At 10 days posthatching, 25–75% of thyroid tissue from all subgroup C virus-infected chickens appeared to be lymphoblastoid and at 30 days posthatching, the eVect was more prominent, showing the presence of plasma cells. T4 levels in the serum were significantly lower for RAV-7- and tdB77-infected chickens at 10 days posthatching, while those for RAV-49infected chickens attained significantly lower levels after 20 days. T4 levels continued to decrease until 45 days posthatching, when all the viruses in subgroup C had significantly lower T4 levels. Infiltration of the pancreas varied at 10 days posthatching among the viruses, being the most severe for RAV-7 and RAV-49. However by 20–30 days posthatching, all the subgroup C viruses tested showed germinal center formation. Insulin levels were increased 10 days after hatching compared with the control group and by 45 days after hatching the diVerence was significant for all subgroup C viruses.
76
M. PASARICA AND N. V. DHURANDHAR
Livers from all infected chickens showed mild lymphocytic infiltration 10 days posthatching with slight enlargement of hepatocytes after 30 days, which the authors attribute to fat accumulation. Chickens infected with all subgroup C viruses had significantly increased relative liver weights at all times compared with the controls. Serum triglyceride levels in chickens infected with all subgroup C viruses were increased. The greatest change was induced by RAV-7 with a mean of 1500 mg/dl after 45 days compared with a range of 68.2–90.5 mg/dl in uninfected chickens. Cholesterol levels decreased initially followed by a significant increase, 45 days posthatching. Marked hyperlipidemia was present only in RAV-7-infected chickens. Histological examination of thyroid, pancreas, and liver showed no similarity between subgroup C-induced changes and those by Rous-associated viruses of other subgroups (A, B, D, and F). Fat accumulation as adipose tissue and fatty liver was apparent only for RAV-7-infected chickens. Relative liver weights were higher for all infected animals. MAV-1- and RAV-1infected chickens showed significant increase in insulin levels, but the increases were smaller compared to those induced by RAV-7. All avian leucosis virus-infected chickens showed decreased T4 levels, with a significant diVerence in RPV and RAV-61 (subgroup F). Changes in T4 levels in these chickens were smaller compared to the changes induced by RAV-7, which also showed thyroiditis. D. MECHANISM OF RAV-7-INDUCED CHANGES
A decrease in thyroid hormone levels is the major metabolic change that may explain adiposity and other changes induced in RAV-7-infected chickens (DuV and Vogt, 1969). Chicken embryos infected with RAV-7 showed alteration in thyroid tissue 2 days posthatching, lymphoblastoid infiltration 7 days posthatching, and extensive infiltration, loss of normal thyroid structure, and significantly lower levels of T3 and T4 16 days posthatching. Chickens with hypothyroidism induced by Tapazole have near normal growth characteristics after daily administration of T4 (Singh et al., 1968). When RAV-7-infected chickens received supplementation with Synthroid, the disease symptoms alleviated showing a decrease in body weight, relative liver weight, and insulin levels. Although an increased mortality in the group fed low-fat diet was noted, fat content of the diet did not influence stunting or obesity (Carter et al., 1983b). Levels of T4 were decreased for all avian leukosis virus-infected chickens and correlated with stunting of animals (Carter and Smith, 1984). The possibility of autoimmune thyroiditis was considered due to the similarity in thyroid infiltration and change of T4 levels (Carter and Smith, 1984) present in an obese chicken line and RAV-7-infected chickens. The obese chicken
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
77
line is a phenotypic expression of the genetically determined autoimmune thyroiditis (Wick et al., 1981). However, the possibility of autoimmune thyroiditis was excluded since no precipitating antithyroglobulin in the sera of RAV-7-infected chickens was observed. RAV-7-induced hyperlipidemia could be a result of hypothyroidism. Hyperlipidemia appears to be common in hypothyroid animals, where there is a decrease in lipid utilization or catabolism (Hoch, 1974). Similar etiology was suggested for increased insulin levels and localized lymphoblastoid infiltration of the pancreas (Carter and Smith, 1984) because it was observed that amelioration of thyroid function by Synthroid administration reduces insulin levels (Carter and Smith, 1983). Increased mortality that occurred 20 and 30 days posthatching may be the result of a severe drop in glucagon levels (Carter and Smith, 1983; Carter et al., 1983a), which determines severe hypoglycemia (Mikami and Ono, 1962).
IV. CHLAMYDIA PNEUMONIAE Chlamydia pneumoniae (CP) is the first bacteria reported to be associated with increased body mass index (BMI) in humans. Experimental inoculation of animals with CP to study the eVect on body weight has not been reported. A. CP GENERAL INFORMATION
Chlamydia is a eubacteria that causes widespread infection in humans (Hogan et al., 2004). CP respiratory infection occurs in almost all humans during lifetime (Hogan et al., 2004) and results in 10% of communityacquired pneumonia and 5% of bronchitis and sinusitis cases (Kuo et al., 1995). Association between CP and coronary heart disease (CHD) is equivocal. Some studies show an association between CP and CHD (Danesh et al., 1997; Kuo et al., 1993; Saikku et al., 1988), while others found none (Caligiuri et al., 2001; HoVmeister et al., 2000). HoVmeister et al. (2000) reported that indicators of atherogenic lipid profile, like decreased HDL-C, HDL-C to total cholesterol ratio, apoAI, and increased apoB, were associated with current infection with Helicobacter pylori, but not with CP or Cytomegalovirus (HoVmeister et al., 2001). B. CP ASSOCIATION WITH HIGHER BMI
Some studies reported an association between CP infection and increased BMI (Dart et al., 2002; Ekesbo et al., 2000), while others did not find any relation (Blanc et al., 2004; Falck et al., 2002; Muller et al., 2003).
78
M. PASARICA AND N. V. DHURANDHAR
Ekesbo et al. (2000) reported that a group of subjects with combined serology for CP and H. pylori had significantly higher BMI compared to the control group (27.3 kg/m2 vs 25.8 kg/m2). Greater age, lower socioeconomic status, and greater fasting levels of insulin also characterize the antibody positive subjects. The authors suggested that ‘‘Obesity might be a marker not only for lower social class but also for greater than normal susceptibility to such infections’’ (Ekesbo et al., 2000). Similar correlation was found in another study where subjects positive for IgG to CP had significantly higher mean BMI compared to the seronegative subjects 26.6 kg/m2 versus 25.5 kg/m2, respectively (Dart et al., 2002). There was no association between CHD or coronary artery stenosis and infection with CP. Antibody positive subjects had increased BMI, smaller LDL particle, and greater insulin levels. However, after multivariate analysis, only BMI continued to be associated with seropositivity (Dart et al., 2002). C. MECHANISM OF CP EFFECTS
Dart et al. (2002) postulated that CP infection is causally related to increased BMI, although the mechanism is completely unknown. Obesity is associated with impaired immunity (Fried et al., 1998; Tanaka et al., 1993; Visser et al., 1999) and as suggested by Ekesbo et al. (2000) obesity might be the indicator for increased susceptibility to H. pylori and CP infection (Ekesbo et al., 2000). However, Dart et al. (2002) found no preponderance of antibodies to Chlamydia trachomatis and Chlamydia pssittaci in the same subject population. Lack of relationship of BMI with prevalence of antibodies to C. trachomatis and C. pssittaci indicated that increased BMI did not necessarily predispose the subjects to ‘‘catch’’ infection. Experiments with animal models designed to investigate the adipogenic potential of CP and human sero-epidemiological data are needed to further determine the role of CP in obesity. V. SCRAPIE AGENT Scrapie agents have been reported to cause obesity in mice, and the eVect is dependent on the strain of scrapie. Relevance of the findings to humans has not been established. A. GENERAL INFORMATION
Scrapie is a neurodegenerative disease with a long incubation period, known to occur in sheep and goats, however, mice and other small rodents can be infected with it (Hunter, 1972). Certain scrapie strains induce obesity in
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
79
experimentally infected animals, although the main manifestation of scrapie infections is abnormal behavior and motor dysfunction in mice (Kim et al., 1987) and hamsters (Carp et al., 1990). Incubation period determined by the mouse gene Sinc and manifestation of disease varies with the scrapie and mouse strain (Dickinson and Meikle, 1971). B. SCRAPIE-INDUCED OBESITY
Weight increase in scrapie-infected animals was observed as a preclinical manifestation as early as 1968 by Pattison and Jones (1968) and was followed by Outram and Markovits in 1972 and 1981, respectively (Markovits et al., 1981; Outram, 1972). Mice infected with certain strains of scrapie determine a significant increase in body weight in the preclinical phase of the disease (Carp et al., 1984). Regardless of the mouse strain, the scrapie strain ME7 injected in the hypothalamus-induced obesity (Carp et al., 1984, 1998; Kim et al., 1987, 1988). This eVect was also observed for 22L scrapie strain injected in certain type of mice (Carp et al., 1984, 1998; Kim et al., 1987), but not for 139A (Carp et al., 1984, 1998; Kim et al., 1987, 1988) or 22A scrapie strains (Carp et al., 1984). Hypothalamic injection of ME7 injection induced obesity in SJL, C57NL, A2G, SAMP8, SAMR1, and AKR mice (Carp et al., 1984, 1998; Kim et al., 1987, 1988). Twelve weeks postinfection with ME7, SJL mice weighed significantly more than the control group and this diVerence reached maximum after 4 weeks. Infected animals showed 80% and 68% increase in body weight when injected in the hypothalamus or cortex, respectively, versus 41% in the control group. The weight increase was due to fat accumulation, and not due to edema (Carp et al., 1998; Outram, 1972). Surprisingly, spleen, liver, kidney, brain, and uterus weights were lower than those in the control (Carp et al., 1984; Kim et al., 1988). Adrenal gland was the only organ with significantly greater weight in the infected group. This increase was due to marked enlargement in zona fasciculate and slight enlargement in zona glomerulosa of the cortex, without any cytopathic changes (Kim et al., 1988). Weight gain in ME7-infected mice paralleled increase in food consumption (Kim et al., 1988). The weight gain appeared 67 days postinfection and continued throughout the preclinical phase of the disease (Kim et al., 1988). Unexpectedly, at the same time there was an increase in food consumption in scrapie strain 139A-infected SJL mice, which did not become obese. The author suggests a possibly separate mechanism for food consumption and weight gain (Kim et al., 1988). ME7 injected in the hypothalamus, but not in cortex, induces obesity in C57NL mice. ME7 produced the same pattern of vacuolation in nine
80
M. PASARICA AND N. V. DHURANDHAR
diVerent brain regions, regardless of the injection site (Kim et al., 1987). The only diVerence was in the brain region predominantly aVected: ME7 aVected the forebrain region, 22L aVected the cerebellum, and 139A the white matter (Kim et al., 1988). 22L strain of scrapie injected in the cortex or hypothalamus of SJL mice induced obesity (Carter and Smith, 1984; Kim et al., 1987). However when injected in SAMP8, SAMR1, AKR (Carp et al., 1998), and CBA mice (Carp et al., 1984), the scrapie strain did not produce any diVerences in body weight. SJL-infected mice showed 73% and 70% increase in body weights when injected in hypothalamus or cortex, respectively, versus 36% increase in the control group. Furthermore, the weight diVerence became significant earlier, compared to when inoculated with 22L (10 weeks vs 12 weeks postinjection) (Kim et al., 1987). A significant decrease of GLUT-1 in thalamus, cerebellum, and hippocampus along with reduced glucose tolerance and hyperglycemia in ME7infected mice suggested disregulation in function of the aVected brain regions (Carp et al., 1989; Kim et al., 1988). C. MECHANISM OF SCRAPIE-INDUCED OBESITY
Involvement of the brain is strongly implicated in scrapie-induced obesity. Kim et al. (1987) speculated that scrapie-induced obesity is related to changes in CNS and neuroendocrine dysfunction and that the condition was also dependent on the route of inoculation. ME7 induced obesity in C57NL mice only when injected in hypothalamus, but not cortex, whereas hypothalamic and not cortical route of inoculation was required for increasing body weight in SJL. Similar weight gain and patterns of vacuolation were obtained whether ME7 was injected unilaterally or bilaterally in the hypothalamus of SJL mice, suggesting that scrapie can spread to the opposite hemisphere after replication at the site of injection (Kim et al., 1987). Role of brain function alterations was further supported by the findings of Vorbrodt et al. (2001), who reported a decrease in GLUT-1 density in certain brain regions, reduced glucose tolerance and hyperglycemia in ME7infected mice. Glucose is of critical importance for normal functioning of the nervous system and impaired glucose transport could untimely lead to impaired brain function. The authors recommend further studies to elucidate the regional diVerence in GLUT-1 expression and the eVect on brain function (Vorbrodt et al., 2001). In addition to the role of higher centers, a hypothalamic-pituitary-adrenal axis-mediated mechanism for scrapie-induced obesity has been suggested (Kim et al., 1988). Adrenals in the scrapie-induced mice were significantly larger than controls and adrenalectomy performed before ME7 injection
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
81
prevented weight gain in mice, which support the hypothesis. Although one of the possible downstream eVects of impaired higher brain center functions is food intake dysregulation, increased food intake did not necessarily explain obesity in all models of scrapie strains. ME7- and 139A-infected SJL mice showed increase in food consumption, however only ME7 induced obesity (Kim et al., 1988). Kim et al. (1988) suggested that the pathways involved in increasing food consumption and weight gain may be separate in these models. Moreover, the duration of scrapie incubation does not seem to play a role in the development of obesity. Carp et al. (1984) showed that Sinc mouse gene, which determines the incubation period, is not involved in scrapieinduced obesity. 22L strain was injected into three mouse strains with the same s7s7 Sinc genotype, which resulted in obesity in SJL mice, but not the other two strains (Carp et al., 1984).
VI. BORNA DISEASE VIRUS A. GENERAL INFORMATION
Borna disease virus (BDV) is an enveloped, nonsegmented, negative-stranded RNA virus belonging to the Mononegavirales order (Kao et al., 1993; Rott and Becht, 1995; Stitz et al., 1995). Although it can produce a strong immune response and the disease can be fatal, BDV may persist in the nervous system with no major symptoms (Ludwig and Bode, 2000; Narayan et al., 1983; Solbrig et al., 1995). Experimental infection with BDV has been shown in chickens, mice, rats, rabbit, hamsters, and rhesus monkeys models (Ludwig et al., 1988; Richt et al., 1992). Rats infected with BDV showed behavior changes and learning deficits (Ludwig and Bode, 2000). BDV causes encephalopathy in a broad range of animals like horses, sheep, cattle, cats, and dogs (Ludwig and Bode, 2000). BDV incidence was reported worldwide: in UK (Thomas et al., 2005), Iran (Bahmani et al., 1996), Japan (Terayama et al., 2003), China (Yang et al., 2003), Germany (Bechter et al., 1987), and the United States (Kao et al., 1993). Ludwig and Bode (2000) postulated that a cross species transmission of BDV from animals to humans may be possible. BDV received considerable attention when de la Torre (1994) demonstrated that BDV can infect human brain, by detecting BDV-specific antigen in four autopsied human brains. Fifty BDV studies were reported in humans before the beginning of 2000, including case studies, serological, or viral prevalence studies. Chalmers et al. (2005) reported in their review that seroprevalence in humans varied from 0% to 48% and viral prevalence from 0% to 82%. Mental disorders like depression
82
M. PASARICA AND N. V. DHURANDHAR
and schizophrenia are associated with BDV-specific antibodies prevalence (Chen et al., 1999; Ferszt et al., 1999; Richt et al., 1997) and BDV RNA in the peripheral blood (Chen et al., 1999). Chen et al. (1999) provided some evidence for a possible human to human transmission of BDV infection, by showing that psychiatric patient’s family members and the mental health workers had higher prevalence of BDV antibodies than control. However, Ferszt et al. (1999) postulated that the higher prevalence of BDV antibodies in depressive patients may be a nonspecific aspect of immunosuppression. Although the BDV pathogenesis is not yet clear, a pathogen once thought to only infect animals certainly appears to infect humans as well. B. BORNA DISEASE VIRUS-INDUCED OBESITY
Gosztonyi et al. (1991) described an obesity syndrome induced by BDV in rats. Induction of obesity was dependent on age and genetic characteristics of animals and virus strain (Gosztonyi and Ludwig, 1995; Gosztonyi et al., 1991). Weanling or adult rats developed acute encephalitis 1–4 months postBDV infection. Two moths later, surviving animals developed marked obesity. Virus-specific antigen and inflammatory infiltrate were present in brains of obese rats, and decreased progressively with time, reaching very low levels 18–24 months postinfection (Gosztonyi and Ludwig, 1995; Gosztonyi et al., 1991). The lymphomonocytic inflammatory infiltration was found in the hypothalami of all infected rats. Progressive neural degeneration located mainly in the dentate gyrus was accompanied by marked hydrocephalus. Spongy degeneration foci were present in the cerebellum, followed by reactive astrocytosis. Obese rats had massive visceral fat deposition with increased triglyceride and hyperplasia of Islets of Langerhans, with moderate increase in blood glucose (Gosztonyi and Ludwig, 1995). C. MECHANISM OF BDV-INDUCED OBESITY
Herden et al. (2000) compared the eVect of two diVerent BDV variants, one that induces obesity (BDV-ob) and one that induces the biphasic course of the disease (BDV-bi) in order to determine the mechanism of BDV-induced obesity. No antigenic variation was present between the two diVerent phenotypes. Four-week-old Lewis rats were inoculated intracerebrally with the infectious brain homogenate of BDV-ob or BDV-bi representing the control group. Fifty-six days postinfection animals infected with BDV-ob reached significantly higher body weight (p < 0.0001) compared with the control group. No neurological signs were observed in the obese group, whereas the control group developed the biphasic form of infection with ataxia, hyperactivity, and weight loss followed by apathy and somnolence. Both groups
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
83
developed nonpurulent meningoencephalitis with mononuclear perivascular and parenchymal infiltration. These were generalized in the control group, but restricted to the ventromedial tuberal hypothalamus, septum, hypocampus, and amygdala in the obese group. Viral antigen expression presented a similar pattern of distribution. BDV-ob infection produced low levels of replication, in contrast with BDV-bi where replication was persistent for more than 210 days. Therefore, Herden et al. (2000) hypothesized that BDVinduced obesity may be due to inflammatory lesions and viral antigen expression in brain, especially in the hypothalamus, which is known to regulate body weight and food intake. VII. GUT MICROBIOTA A. GENERAL INFORMATION
Microbiota is a collection of microorganism, growing in the human gut. It is mostly composed of anaerobic bacteria, which are essential for processing dietary polysaccharides (Xu and Gordon, 2003). These bacteria act in a symbiotic relationship with the human gut, consuming as well as distributing energy by processing nutrients inaccessible to humans in other ways (Backhed et al., 2005). Moreover, it regulates human immune system (Braun-Fahrlander et al., 2002), fortifies the mucosal barrier, and stimulates angiogenesis (Hooper, 2001; Hooper et al., 2003; Stappenbeck et al., 2002). B. MICROBIOTA-INDUCED OBESITY
Backhed et al. (2004) reported that gut microbiota regulates fat storage. Fourteen days postconventionalization with normal microbiota, germfree mice developed more body fat and insulin resistance, with surprisingly lower food intake. These eVects were seen in male and females in two diVerent mouse strains (B6 and NMRI) (Backhed et al., 2004). Eight- to ten-week-old male germfree mice, which experience colonization for 14 days, showed 57% increase in total body fat with 61% increase in epididymal fat and 7% decrease in lean mass with no diVerence in body weight. Lipid profile did not change after colonization. A similar change was determined by colonization of germfree animals at birth or for diVerent amount of time; however, increasing colonization time did not amplify the eVect on adipose tissue (Backhed et al., 2004). Subsequently, germfree mice were colonized only with Bacteroides thetaiotaomicron, which is predominant in gut microbiota and has the ability to degrade plant polysaccharides (Hooper et al., 2001). B. thetaiotaomicron is
84
M. PASARICA AND N. V. DHURANDHAR
associated with induction of host monosaccharide transporters (Xu and Gordon, 2003). After a 14 days colonization period, these mice developed 23% more body fat than their germfree counterparts showing a similar change to the complete colonization eVect, but to a smaller extent (Backhed et al., 2004). Ley et al. (2005) reported that obesity correlates with a shift in microbiota composition. Obese mice showed 50% decrease in Bacteroides and significant increase in Firmicutes (p < 0.05), independent on kinship or gender. OVspring shared cecal microbiota with their mothers, independent of their ob phenotype. The authors suggest that changes in microbiota of ob/ob animals ‘‘may represent an unheralded contributing factor to their fuel partitioning’’ (Ley et al., 2005). C. MECHANISM OF MICROBIOTA-INDUCED OBESITY
Colonization for 14 days produced a 27% decrease (p < 0.01) in metabolic rate, whereas high energy phosphate stores remained unchanged. Thus, obese colonized animals consume more oxygen without increasing high energy phosphate stores, which suggest the presence of ineYcient metabolism (Backhed et al., 2004). The microbiota determined a 2.3-fold increase in hepatic triglyceride content, with no change in cholesterol, but significantly increased expression of de novo fatty acid synthesis pathway genes (Backhed et al., 2004). Moreover, colonization decreased the expression of fasting-induced adipocyte factor (Fiaf) (Backhed et al., 2004), also called angiopoietin-like protein 4, an inhibitor of lipoprotein lipase (LPL) in vitro (Yoshida et al., 2002). This eVect is not dependent on mature lymphocytes or PPAR-g (Backhed et al., 2004). The authors suggest that the microbiota act via Fiaf to increase hepatic lipogenesis as well as increase adipose tissue LPL. Thus, the extra energy harvested from the gut by microbiota is converted to lipids in the liver and LPL helps deposition of this lipid in adipocytes and adiposity ensues (Backhed et al., 2004). VIII. ADENOVIRUSES Four adipogenic pathogens are adenoviruses. Adenoviruses were first isolated in 1953 by investigators attempting to establish cell lines from the adenoidal tissue of children after tonsillectomy (Shen and Shenk, 1995). Adenoviruses are widespread in nature, infecting birds, mammals, and humans. In humans, adenoviruses are frequently associated with acute upper respiratory tract infections, enteritis, or conjunctivitis. Presence of serum antibodies
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
85
to adenovirus is common in the general population (Foy and Grayston, 1976). Adenoviral DNA is detected in adult human lymphocytes, and the number of positive cells increases with the age of the person (Horvath et al., 1986). There are six major subgroups among the 50 human adenoviruses maintained by the American Type Culture Collection (ATCC). Each subgroup has a number of specific serotypes. Adenoviruses are nonenveloped DNA viruses with icosahedral symmetry and a diameter of 65–80 nm (Pereira et al., 1963). All adenoviral genomes have the same general organization, that is the genes encoding specific functions are located at the same position on the viral chromosome (Shen and Shenk, 1995). The genome consists of a single linear, double-stranded DNA molecule consisting of five early transcription units (E1A, E1B, E2, E3, and E4), two delayed early units (IX and IVa2), and one major late unit which generates five families of mRNAs (L1–L5). Adenoviruses can be readily propagated in primary cell cultures or cell lines, replicate within the nucleus of the infected cells, and produce characteristic cytopathic changes in the cell. IX. SMAM-1 Avian adenovirus SMAM-1 causes adiposity in chickens and shows association with human obesity. It is the first virus to be linked with human obesity. Increased adiposity with hypolipidemia are the peculiar features of this syndrome. A. SMAM-1 GENERAL INFORMATION
Adenoviruses are responsible for approximately 8% of the viral infection worldwide (Rubin, 1993). Avian adenovirus SMAM-1 was discovered during a poultry epidemic in early 1980s (Ajinkya, 1985) and it is serologically related to avian adenovirus Chick Embryo Lethal Orphan virus (CELO). B. SMAM-1-INDUCED OBESITY
Three-week-old chickens experimentally inoculated with SMAM-1 developed excessive visceral fat compared to the uninfected controls 3 weeks postinoculation. Another group of chickens sharing the cage with the infected group (in-contact group) also developed significant visceral adiposity, suggesting a horizontal transmission of the virus in cage mates (Dhurandhar et al., 1990, 1992). Visceral fat was greater by 53% and 33% in the infected and in-contact group, respectively. Interestingly, SMAM-1-induced adiposity was accompanied by paradoxically lower serum cholesterol and triglyceride levels.
86
M. PASARICA AND N. V. DHURANDHAR
Food intake of the chickens could not explain the adiposity (Dhurandhar et al., 1990, 1992). At baseline, body weights were similar for all groups; however, after 5 weeks the infected group weighted significantly less than the control (924.8 102.1 g vs 995.7 97 g). Furthermore, weight gain between the third and sixth week was 473.8 90.7 versus 571.8 63.5 in the infected and control groups, respectively. The in-contact group tended to have lower body weight after 6 weeks, but the diVerence was not significant (Dhurandhar et al., 1992). One week postinoculation, the infected and in-contact group had significantly lower cholesterol and triglyceride levels when compared to the control. Cholesterol values were 46.1 10.3 mg/dl versus 56.5 10.8 mg/dl and triglycerides 19.9 7.9 mg/dl versus 67.1 18.5 mg/dl in the infected and control groups, respectively. After 2 weeks, cholesterol as well as triglycerides remained lower for the infected and the in-contact groups, but only cholesterol showed statistical significance 3 weeks postinoculation (Dhurandhar et al., 1992). Livers were significantly heavier for the infected and in-contact groups. Livers and kidneys of the infected animals were enlarged and pale brown. Histopathology of the livers showed severe congestion, fatty infiltration, and presence of intranuclear inclusion bodies. The in-contact group showed similar but less severe changes. Bursae, thymus, and spleen were atrophied in the infected and in-contact group (Dhurandhar et al., 1992). Subsequently, Dhurandhar et al. (1997a) reported an association between SMAM-1 seropositivity and human obesity. This was the first virus reported to be associated with human obesity. Using an agar gel precipitation assay, Dhurandhar et al. (1997a) reported 20% prevalence in 52 obese subjects from India screened for the presence of antibodies against SMAM-1. Similar to the syndrome caused by SMAM-1 in chickens, the seropositive human subjects had significantly higher body weight and BMI and significantly lower blood lipid levels. These subjects were men and women from an outpatient treatment program in Bombay, India, with a mean age of 39 and a mean BMI of 31.6 kg/m2. The antibody positive subjects had significantly greater BMI (35.3 1.5 kg/m2) compared to antibody negative subjects (30.7 0.6 kg/m2, p < 0.001). A similar diVerence was seen in body weight. The antibody positive subjects weighted significantly more than the antibody negative ones (95.1 2.1 kg vs 80.1 0.6 kg, p < 0.02). The diVerences were valid even within gender. Serum cholesterol was 15% lower (p < 0.02) and triglyceride 60% lower (p <001) in the antibody positive subjects compared to antibody negative counterparts (Dhurandhar et al., 1997a). In addition, two of the positive serum samples cross-reacted with each other, suggesting presence of active viremia. The findings were surprising as avian adenoviruses have been
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
87
thought to be serologically diVerent from human adenoviruses (Asch et al., 1979; McFerran et al., 1975), and therefore, unable to infect across species. C. MECHANISM OF SMAM-1-INDUCED OBESITY
Dhurandhar et al. (1992) suggested that SMAM-1 infection could impair normal liver function, causing fatty liver and decreasing cholesterol and triglyceride levels. Consequent to impaired hepatic lipogenesis, increased visceral fat accumulation may be due to either increased compensatory lipogenesis or reduced lipolysis in fat cells. Moreover, since chickens are very sensitive to glucagon, the authors expressed the possibility that glucagon deficiency could be responsible for greater accumulation of visceral fat due to reduced lipolysis (Dhurandhar et al., 1992). Both theories have not been tested. The authors postulated that high infectivity of SMAM-1 and the temporal association between the appearance of SMAM-1 in chickens in India and worldwide increase in obesity may suggest the role of SMAM-1 in human obesity (Dhurandhar et al., 1997a). However, further research is necessary to demonstrate such a role. X. ADENOVIRUS TYPE 36 Animals experimentally infected with Adenovirus type 36 (Ad-36) develop greater adiposity but a relative hypolipidemia. Sero-epidemiological studies show association of Ad-36 antibodies with human obesity. In vitro experiments in 3T3-L1 preadipocytes showed that Ad-36 promotes their proliferation, diVerentiation, and lipid accumulation. However, the exact mechanism of adipogenic action in vivo is yet unknown. Adipogenic eVects of Ad-36 are described below in detail. A. Ad-36 GENERAL INFORMATION
Ad-36 was first isolated in 1978 in Germany from the feces of a 6-year-old girl suVering from diabetes and enteritis (Wigand et al., 1980). Ad-36 infection was thought to occur rarely, but work indicates that 11–30% of the individuals screened in the United States are seropositive for Ad-36 antibodies (Atkinson et al., 2005). B. Ad-36-INDUCED ADIPOSITY
Ad-36 promotes adiposity in animals and shows association with human obesity.
88
M. PASARICA AND N. V. DHURANDHAR
1. Animal models In separate experiments, chickens, mice, or marmosets (nonhuman primates) inoculated with human adenovirus Ad-36 developed a syndrome of increased adipose tissue and paradoxically low levels of serum cholesterol and triglycerides (Dhurandhar et al., 1992, 2000, 2001). Food intake of the infected and the uninfected controls was not significantly diVerent. Using a capillary electrophoresis assay (Kolesar et al., 2000), Ad-36 DNA was detected in the adipose tissue of the infected animals but not in the skeletal muscle. The amount of Ad-36 DNA present in the visceral fat correlated with the amount of total visceral fat in the chickens (r ¼ 0.41, p ¼ 0.025). Sections of the brain and hypothalamus of Ad-36-inoculated animals did not show any overt histopathologic changes. Dhurandhar et al. (2001) demonstrated the transmissibility of adenovirus infection and adiposity in a chicken model by parenteral route. Four groups of 3-week-old chickens (infected donors and recipients, and control donors and recipients) were used. The infected and the control donors were inoculated with Ad-36 or media. Thirty-six hours postinoculation, blood from the infected or a control group was transfused intravenously in the respective recipient groups. Infected donors and recipient animals developed significantly greater total body fat than the control groups, despite similar food intake. The visceral fat depots in the infected donors and receivers were heavier (142% and 80% greater, respectively) compared to the control. When obesity was defined as body fat 85th percentile of that in the control group, 64% of the infected donors and 72% of the infected recipients were considered obese versus only 18% in control donors and recipients together. Serum cholesterol was significantly lower in the infected and infected-recipient animals compared to the control group, showing that Ad-36 infection and subsequent obesity was transmissible. Subsequently, two more studies were conducted to demonstrate the adipositypromoting eVect in nonhuman primates (Dhurandhar et al., 2002). The first study used stored plasma samples from adult male rhesus monkeys, which were collected every 6 months over a period of 84 months at the University of Wisconsin Regional Primate Research Center in Madison, Wisconsin. The results showed spontaneous appearance of Ad-36 antibodies followed by weight gain in the year following seroconversion versus the year preceding it (1.8 kg vs 0.1 kg, respectively). Lipid profile was improved, showing a decrease in serum cholesterol by 35 mg/dl. In the second study, male marmosets, separated into two weight- and age-matched groups, were inoculated intranasally with either Ad-36 or medium. Twenty-eight weeks postinoculation, the infected animals showed a fourfold gain in body weight and an increase in visceral fat (7.3 2.5 g vs 4.4 0.9 g, p ¼ 0.089).
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
89
Ad-36 inoculation induced adiposity in male Wistar rats despite similar food intake. Twenty-seven weeks postinoculation, Ad-36-infected rats attained greater body weight (628.3 þ 45.1 g vs 587.5 ¼ 30.6 g, p < 0.008). Their epididymal-inguinal, retroperitoneal, and visceral fat pads were 60%, 46%, and 86% greater, respectively (p < 0.0001). Paradoxically, Ad-36 group developed higher insulin sensitivity compared to the control (Yu and Dhurandhar, 2005). Leptin levels were greater and corticosterone and norepinephrine lower in the infected group, suggesting that Ad-36 may aVect the hypothalamo-pituitary-adrenal axis (Pasarica et al., 2006; Shin et al., 2004). 2. Association with human obesity Sera of 360 obese (BMI 30 kg/m2) and 142 nonobese (BMI < 30 kg/m2) subjects from Wisconsin, Florida, and New York were screened for the presence of Ad-36 antibodies using a constant-virus-decreasing-serum neutralization assay, a gold standard for detecting neutralizing antibodies. The eVect of Ad-36 seropositivity on the risk of obesity was highly significant (Atkinson et al., 2005), which was independent of age, sex, and the data collection site, Ad-36 antibodies were more prevalent in obese subjects (30%) than in nonobese subjects (11%). Seropositive obese as well as nonobese subjects had significantly greater BMI versus their respective seronegative counterparts (Atkinson et al., 2005). Prevalence of Ad-36 antibodies in human population may vary by the geographic locations. Only 5% of the subjects screened in Denmark had antibodies to Ad-36 (Raben et al., 2001). Ad-36 is the first human virus reported to show an association with human obesity. Due to ethical reasons, it is not possible to infect humans with a virus, which precludes unequivocal demonstration of causative role of Ad-36 in human obesity. Future experiments are likely to generate indirect and circumstantial evidence. C. MECHANISM OF Ad-36-INDUCED OBESITY
The adipogenic mechanism of Ad-36 is unclear, but several in vitro and in vivo studies provide some insight about the molecular eVect of Ad-36 on adipose tissue metabolism. Studies show that Ad-36 has similar eVects as thiozolinediones, a class of antidiabetic drugs. Ad-36 increases replication (Pasarica et al., 2005), diVerentiation (Vangipuram et al., 2004), lipid accumulation (Vangipuram et al., 2004), and insulin sensitivity (Yu and Dhurandhar, 2005) and reduces leptin secretion (Vangipuram et al., 2007) and expression (Yu and Dhurandhar, 2005) in fat cells. 3T3-L1 preadipocytes as well as human primary preadipocytes when infected with Ad-36 show increased levels of glycerol 3-phosphate dehydrogenase (GPDH), a diVerentiation specific
90
M. PASARICA AND N. V. DHURANDHAR
enzyme (Vangipuram et al., 2004). These eVects were not observed with Ad-2, a nonadipogenic human adenovirus. These findings suggest considerable involvement of the adipose tissue in adipogenic eVect of Ad-36. Increased diVerentiation of 3T3-L1 preadipocytes (Vangipuram et al., 2004) and upregulated expressions of adipogenic regulator genes (like PPAR-g, CEBP b and a, and GPDH) in visceral fat of infected animals (Yu et al., 2004) suggest an eVect of Ad-36 on fat cell diVerentiation. Moreover, Ad-36 increases proliferation of preadipocytes, generating more cells capable of accumulating lipids, which may explain the adipogenic eVect in vivo (Pasarica et al., 2005). Greater number of preadipocytes and adipocytes due to Ad-36 infection may also contribute to the enhanced insulin sensitivity in Ad-36-infected rats (Yu et al., 2004). As expected, adipose tissue of Ad-36-infected rats showed enhanced expression of genes of insulin-signaling pathway and de novo lipogenesis such as GLUT-4, insulin receptor, fatty acid synthetase (FAS), and acetyl CoA carboxylase (ACC-1) (Yu et al., 2004). Thus, it appears that Ad-36 increases number of fat cells, enhances glucose uptake by adipocytes, and promotes its conversion to lipids via de novo lipogenesis in 3T3-L1 cells. XI. ADENOVIRUS TYPE 5 A. Ad-5 GENERAL INFORMATION
Adenovirus type 5 (Ad-5) sequence was completely described in 1992 (Chroboczek et al., 1992). Ad-5 has been extensively used for gene therapy (Kanerva and Hemminki, 2005) because these vectors are safe and eYcient and can accommodate large antigen-encoding structures (Wu et al., 2005). Ad-5 causes respiratory tract infections in humans (Limbourg et al., 1996). B. Ad-5-INDUCED OBESITY
So et al. (2005) showed that Ad-5 induces adiposity in mice. Three-week-old female CD1 mice were injected intraperitoneally with either Ad-5 or saline solution. Ad libitum access at food and water was provided. After 22–23 weeks, infected animals attained significantly greater body weight compared to the control group (14.8 g vs 13.5 g; p < 0.05) despite similar food intake. The infected group had a mean adiposity of 6.7%, compared with 2.4% in the control group (p < 0.05) representing a 279% increase, as measured by in vivo 1H magnetic resonance spectroscopy (1H MRS), which is a new rapid and noninvasive technique used to determine body composition. Compared to the control group in the upper quartile for body weight, 66.7% of the infected animals were heavier versus only 16.7% in the control group. In vivo 1H MRS
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
91
showed that there was no diVerence in the intrahepatic lipid levels (So et al., 2005). Serum lipid levels were not reported in this study. C. MECHANISM OF Ad-5-INDUCED OBESITY
The infected group accumulated more body fat, which accounted for the increased body weight. The authors suggest that like Ad-36, increased preadipocyte diVerentiation by viral infection (Vangipuram et al., 2004) may be responsible for the increased body fat. Alternatively, the authors proposed the eVect of inflammation on lipid metabolism. PPAR-g is a pivotal transcription factor responsible for adipocyte diVerentiation and is also involved in modulating inflammatory response (Clark, 2002). The authors speculated that increased adiposity may be a side eVect of the anti-inflammatory response elicited by Ad-5 infection. XII. ADENOVIRUS TYPE 37 Human adenovirus type 37 (Ad-37) was discovered by de Jong et al. (1981). It causes keratoconjunctivitis and genitourinary tract infections in humans (de Jong et al., 1981). Ad-37 was shown to cause adiposity in chickens (Atkinson et al., 2002). Visceral fat pads were three times heavier for the Ad-37 group compared to the control (p < 0.0009). Interestingly, unlike Ad-36, it did not reduce serum cholesterol levels. Food intake of the animals could not explain the adiposity. No information is available about the possible mechanism involved. XIII. ADIPOGENIC POTENTIAL OF OTHER ADENOVIRUSES The adipogenic potential of Ad-36 is not shared by all adenoviruses. Avian adenovirus CELO or human adenoviruses type 2 or 31 did not promote adiposity in animal models (Atkinson et al., 2002; Dhurandhar et al., 2000). Unlike Ad-36, Ad-2 and Ad-31 did not show association with human obesity. For Ad-31 and Ad-2 the antibody prevalence between the obese and the nonobese subjects was similar (76% vs 81% for Ad-2 and 70% and 80% for Ad-31). BMIs and serum lipids were virtually identical for ABþ and AB subjects (Atkinson et al., 2005). Moreover, almost equal distribution of seropositivity among the obese and nonobese subjects for Ad-2 and Ad-31 suggested that the greater prevalence of Ad-36 antibodies in obese subjects is not a result of obesity. Of the 50 known serotypes of human adenovirus, Ad-36, Ad-37, and Ad-5 are adipogenic and Ad-2 and Ad-31 are not adipogenic. Adipogenic
92
M. PASARICA AND N. V. DHURANDHAR
potential of the remaining serotypes is unknown. Further information about the mode of action and elucidating the mechanism involved may help in screening the remaining serotypes for their adipogenic eVects. XIV. ROLE OF PATHOGENS IN HUMAN OBESITY Although some of the adipogenic pathogens are conventionally considered to be nonhuman pathogens, possible use of a human host by these pathogens cannot be ruled out. Such was the case with BDV, which was originally considered to be a virus of horses and sheep but now shows clear evidence of human infections (Chalmers et al., 2005; de la Torre, 1994; Gosztonyi and Ludwig, 1995; Ludwig and Bode, 2000). Similarly, humans showed antibodies to SMAM-1, the adipogenic avian adenovirus (Dhurandhar et al., 1997a). Moreover, human adenovirus Ad-36 appears to have little selectivity for species and infects chickens, mice, nonhuman primates, rats, and hamsters (Dhurandhar et al., 1997a, 2000, 2001, 2002; Pasarica et al., 2006). Changing of host by pathogens has been well documented. For instance, CDV changed species to infect feline species and considerably reduced Serengeti’s lion population (Morell, 1996). Therefore, nonhuman adipogenic pathogens cannot be ruled out as nonpathogenic for humans. Although several pathogens have been unequivocally shown to cause obesity in animal models, determining their contribution to human obesity is of greatest significance, but equally challenging. Unlike the animal models, human cannot be experimentally infected with these pathogens due to ethical reasons. This limitation precludes any direct demonstration of a cause and eVect relationship of a pathogen and adiposity and the evidence will have to be indirect and circumstantial. Moreover, insidious onset of obesity makes it diYcult to link it to a particular episode of infection experienced in the past. If an adipogenic pathogen uses ‘‘hit-and-run’’ mechanism to induce obesity, the pathogen may not even be detectable in the body, by the time adiposity is noticed. Therefore, elucidating the mechanism of adipogenic action of a pathogen is important. In addition to treatment, prevention could be a longterm goal of researchers investigating Infectobesity. Vaccines against adipogenic pathogens could be expected to provide protection against obesity due to that specific pathogen. XV. INFECTION, INFLAMMATION, AND OBESITY The rapid increase in obesity, its comorbidities, and the associated health care costs have prompted a search for newer and better approaches for its prevention and management (WHO, 2000). Such eVorts may be facilitated by
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
93
understanding the etiology of obesity. Of the nine etiologic factors (Sclafani, 1984), the viral etiology of obesity first reported in 1982 (Lyons et al., 1982) has been largely ignored. In the last two decades, 10 adipogenic pathogens were reported (Atkinson et al., 2002; Backhed et al., 2004, 2005; Carter et al., 1983a,b; Dart et al., 2002; Dhurandhar, 2004; Dhurandhar et al., 1990, 1992, 2000, 2001, 2002; Gosztonyi and Ludwig, 1995; Kim et al., 1987; Lyons et al., 1982; So et al., 2005). These astonishingly high number of reports include human and nonhuman viruses, scrapie agents, bacteria, and gut microflora. Some of these pathogens are associated with human obesity (Atkinson et al., 2005; Dart et al., 2002; Dhurandhar et al., 1997a), but their causative role has not been established. Although a causative role of certain infections in obesity is a relatively novel concept, adipose tissue involvement with modulators and mediators of immune response is well documented. For instance, Cousin et al. (1999) showed that preadipocytes function like macrophages and possess phagocytic and microbicidal activity. Leptin, an adipocyte-secreted hormone involved in body weight regulation, also enhances proliferation and activation of human circulating T lymphocytes and stimulates cytokine production (Martin-Romero et al., 2000). In addition, adipocytes themselves secrete various cytokines (Fried et al., 1998; Sewter et al., 1999) and, in turn, preadipocytes and adipocytes are subject to cytokine-directed modulations (Gregoire et al., 1992; Kras et al., 2000). With such an extensive interaction between the immune system and the adipose tissue, expansion of the latter in response to certain infections is conceivable. For instance, macrophage colony-stimulating factor (MCSF), which promotes the production of macrophages, is also secreted by adipocytes and when over expressed in vivo induces significant adipose tissue hyperplasia (Levine et al., 1998). It is unknown if the obesity-promoting pathogens stimulate MCSF production to increase the growth of adipose tissue. MCSF is an example of pro-inflammatory cytokine. Relationship of infections with inflammation is well known. Moreover, a recent body of evidence shows association of obesity with cytokines and markers of inflammation. Elevated levels of IL-6 (Roytblat et al., 2000) and C-reactive proteins (Visser et al., 1999) are observed in obese individuals. Interestingly, Duncan et al. (2000) showed that markers of inflammation can predict weight gain in middle-aged adults. It remains to be determined if inflammation is a cause or eVect of obesity. XVI. CONCLUSIONS In conclusion, Infectobesity or ‘‘Obesity of infectious origin’’ would be a relatively novel, yet extremely significant concept, if shown to be relevant to humans. An adequate understanding of such pathogens is needed for the
94
M. PASARICA AND N. V. DHURANDHAR
better management of obesity. A new perspective about the infectious etiology of obesity may stimulate additional research to assess the contribution of hitherto unknown pathogens in human obesity and possibly to prevent or treat obesity of infectious origins. ACKNOWLEDGMENTS This work was partly funded by NIH grant 1R01 DK066164-01 to NVD. REFERENCES Ajinkya, S. 1985. ICAR: ‘‘Final Technical Report.’’ Red and Blue Cross Publishing, Bombay, India. Anderton, P., Wild, T.F., and Zwingelstein, G. 1982. Phospholipids in a measles virus persistent infection: Modification of fatty acid metabolism and fatty acid composition of released virus. J. Gen. Virol. 62(Pt. 2), 249–258. Anderton, P., Wild, T.F., and Zwingelstein, G. 1983a. Accumulation of radiolabelled fatty acids in the neutral lipid fraction of measles virus persistently infected BGM cells. Biochem. Biophys. Res. Commun. 112, 29–34. Anderton, P., Wild, T.F., and Zwingelstein, G. 1983b. Measles-virus-persistent infection in BGM cells. Modification of the incorporation of [3H]arachidonic acid and [14C]stearic acid into lipids. Biochem. J. 214, 665–670. Asch, B.B., McCormick, K.J., and Trentin, J.J. 1979. Unusual features of the oncogenicity of chicken embryo lethal orphan (CELO) virus in hamsters. Prog. Exp. Tumor. Res. 23, 56–88. Astrup, A., Lundsgaard, C., and Stock, M.J. 1998. Is obesity contagious? Int. J. Obes. Relat. Metab. Disord. 22, 375–376. Atkinson, R., Whigham, L., Kim, Y., Israel, B., and Dhurandhar, N. 2002. Evaluation of human adenoviruses as an etiology of obesity in chickens. Am. J. Clin. Nutr. 75, 380S. Atkinson, R.L., Dhurandhar, N.V., Allison, D.B., Bowen, R.L., Israel, B.A., Albu, J.B., and Augustus, A.S. 2005. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int. J. Obes. Relat. Metab. Disord. 29, 281–286. Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F., and Gordon, J.I. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101, 15718–15723. Backhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., and Gordon, J.I. 2005. Host-bacterial mutualism in the human intestine. Science 307, 1915–1920. Bahmani, M.K., Nowrouzian, I., Nakaya, T., Nakamura, Y., Hagiwara, K., Takahashi, H., Rad, M.A., and Ikuta, K. 1996. Varied prevalence of Borna disease virus infection in Arabic, thoroughbred and their cross-bred horses in Iran. Virus Res. 45, 1–13. Banes, A.J. and Smith, R.E. 1977. Biological characterization of avian osteopetrosis. Infect. Immun. 16, 876–884. Bechter, K., Herzog, S., Fleischer, B., Schuttler, R., and Rott, R. 1987. Findings with nuclear magnetic resonance tomography in psychiatric patients with and without serum antibodies to the virus of Borna disease. Nervenarzt 58, 617–624. Bencsik, A., Malcus, C., Akaoka, H., Giraudon, P., Belin, M.F., and Bernard, A. 1996. Selective induction of cytokines in mouse brain infected with canine distemper virus: Structural, cellular and temporal expression. J. Neuroimmunol. 65, 1–9.
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
95
Bernard, A., Zwingelstein, G., Meister, R., and Wild, T.F. 1988. Hyperinsulinemia induced by canine distemper virus infection of mice and its correlation with the appearance of obesity. Comp. Biochem. Physiol. B 91, 691–696. Bernard, A., Fevre-Montange, M., Giraudon, P., Hardin, H., Wild, T.F., and Belin, M.F. 1991. Demonstration of viral proteins and RNA in hypothalamus of mice infected by canine distemper virus. C. R. Acad. Sci. III 313, 545–551. Bernard, A., Fevre-Montange, M., Bencsik, A., Giraudon, P., Wild, T.F., Confavreux, C., and Belin, M.F. 1993. Brain structures selectively targeted by canine distemper virus in a mouse model infection. J. Neuropathol. Exp. Neurol. 52, 471–480. Bernard, A., Cohen, R., Khuth, S.T., Vedrine, B., Verlaeten, O., Akaoka, H., Giraudon, P., and Belin, M.F. 1999. Alteration of the leptin network in late morbid obesity induced in mice by brain infection with canine distemper virus. J. Virol. 73, 7317–7327. Bittencourt, J.C., Presse, F., Arias, C., Peto, C., Vaughan, J., Nahon, J.L., Vale, W., and Sawchenko, P.E. 1992. The melanin-concentrating hormone system of the rat brain: An immuno- and hybridization histochemical characterization. J. Comp. Neurol. 319, 218–245. Blanc, P., Corsi, A.M., Gabbuti, A., Peduzzi, C., Meacci, F., Olivieri, F., Lauretani, F., Francesco, M., and Ferrucci, L. 2004. Chlamydia pneumoniae seropositivity and cardiovascular risk factors: The InCHIANTI Study. J. Am. Geriatr. Soc. 52, 1626–1631. Braun-Fahrlander, C., Riedler, J., Herz, U., Eder, W., Waser, M., Grize, L., Maisch, S., Carr, D., Gerlach, F., Bufe, A., Lauener, R.P., Schierl, R., et al. 2002. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 347, 869–877. Bray, G.A. and York, D.A. 1971. Genetically transmitted obesity in rodents. Physiol. Rev. 51, 598–646. Burdakov, D. 2004. Electrical signaling in central orexin/hypocretin circuits: Tuning arousal and appetite to fit the environment. Neuroscientist 10, 286–291. Caligiuri, G., Rottenberg, M., Nicoletti, A., Wigzell, H., and Hansson, G.K. 2001. Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 103, 2834–2838. Carp, R.I., Callahan, S.M., Sersen, E.A., and Moretz, R.C. 1984. Preclinical changes in weight of scrapie-infected mice as a function of scrapie agent-mouse strain combination. Intervirology 21, 61–69. Carp, R.I., Kim, Y.S., and Callahan, S.M. 1989. Scrapie-induced alterations in glucose tolerance in mice. J. Gen. Virol. 70(Pt. 4), 827–835. Carp, R.I., Kim, Y.S., and Callahan, S.M. 1990. Pancreatic lesions and hypoglycemiahyperinsulinemia in scrapie-injected hamsters. J. Infect. Dis. 161, 462–466. Carp, R.I., Meeker, H., Sersen, E., and Kozlowski, P. 1998. Analysis of the incubation periods, induction of obesity and histopathological changes in senescence-prone and senescence-resistant mice infected with various scrapie strains. J. Gen. Virol. 79(Pt. 11), 2863–2869. Carter, J.K. and Smith, R.E. 1983. Rapid induction of hypothyroidism by an avian leukosis virus. Infect. Immun. 40, 795–805. Carter, J.K. and Smith, R.E. 1984. Specificity of avian leukosis virus-induced hyperlipidemia. J. Virol. 50, 301–308. Carter, J.K., Ow, C.L., and Smith, R.E. 1983a. Rous-associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity. Infect. Immun. 39, 410–422. Carter, J.K., Garlich, J.D., Donaldson, W.E., and Smith, R.E. 1983b. Influence of diet on a retrovirus-induced obesity and stunting syndrome. Avian Dis. 27, 317–322. Chalmers, R.M., Thomas, D.R., and Salmon, R.L. 2005. Borna disease virus and the evidence for human pathogenicity: A systematic review. QJM 98, 255–274. Chen, C.H., Chiu, Y.L., Shaw, C.K., Tsai, M.T., Hwang, A.L., and Hsiao, K.J. 1999. Detection of Borna disease virus RNA from peripheral blood cells in schizophrenic patients and mental health workers. Mol. Psychiatry 4, 566–571.
96
M. PASARICA AND N. V. DHURANDHAR
Chroboczek, J., Bieber, F., and Jacrot, B. 1992. The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186, 280–285. Clark, R.B. 2002. The role of PPARs in inflammation and immunity. J. Leukoc. Biol. 71, 388–400. Clement, K., Manning, B.S., Basdevant, A., Strosberg, A.D., Guy-Grand, B., and Froguel, P. 1997. Gender eVect of the Trp64Arg mutation in the beta 3 adrenergic receptor gene on weight gain in morbid obesity. Diabetes Metab. 23, 424–427. Collins, C.A. and Kym, P.R. 2003. Prospects for obesity treatment: MCH receptor antagonists. Curr. Opin. Investig. Drugs 4, 386–394. Cousin, B., Munoz, O., Andre, M., Fontanilles, A.M., Dani, C., Cousin, J.L., Laharrague, P., Casteilla, L., and Penicaud, L. 1999. A role for preadipocytes as macrophage-like cells. FASEB J. 13, 305–312. Danesh, J., Collins, R., and Peto, R. 1997. Chronic infections and coronary heart disease: Is there a link? Lancet 350, 430–436. D’Arcangelo, G., Grassi, F., Ragozzino, D., Santoni, A., Tancredi, V., and Eusebi, F. 1991. Interferon inhibits synaptic potentiation in rat hippocampus. Brain Res. 564, 245–248. Dart, A.M., Martin, J.L., and Kay, S. 2002. Association between past infection with Chlamydia pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin. Int. J. Obes. Relat. Metab. Disord. 26, 464–468. de Jong, J.C., Wigand, R., Wadell, G., Keller, D., Muzerie, C.J., Wermenbol, A.G., and Schaap, G.J. 1981. Adenovirus 37: Identification and characterization of a medically important new adenovirus type of subgroup D. J. Med. Virol. 7, 105–118. de la Torre, J.C. 1994. Molecular biology of Borna disease virus: Prototype of a new group of animal viruses. J. Virol. 68, 7669–7675. Dhurandhar, N.V. 2004. Contribution of pathogens in human obesity. Drug News Perspect. 17, 307–313. Dhurandhar, N., Kulkarni, P., Ajinkya, S., and Sherikar, A. 1990. Avian adenovirus leading to pathognomonic obesity in chicken. J. Bombay Vet. Coll. 2, 131–132. Dhurandhar, N.V., Kulkarni, P., Ajinkya, S.M., and Sherikar, A. 1992. EVect of adenovirus infection on adiposity in chicken. Vet. Microbiol. 31, 101–107. Dhurandhar, N.V., Augustus, A.S., and Atkinson, R.L. 1997a. Evidence of an association of a virus with obesity in humans. FASEB J. 3, A230. Dhurandhar, N.V., Kulkarni, P.R., Ajinkya, S.M., Sherikar, A.A., and Atkinson, R.L. 1997b. Association of adenovirus infection with human obesity. Obes. Res. 5, 464–469. Dhurandhar, N.V., Israel, B.A., Kolesar, J.M., Mayhew, G.F., Cook, M.E., and Atkinson, R.L. 2000. Increased adiposity in animals due to a human virus. Int. J. Obes. Relat. Metab. Disord. 24, 989–996. Dhurandhar, N.V., Israel, B.A., Kolesar, J.M., Mayhew, G., Cook, M.E., and Atkinson, R.L. 2001. Transmissibility of adenovirus-induced adiposity in a chicken model. Int. J. Obes. Relat. Metab. Disord. 25, 990–996. Dhurandhar, N.V., Whigham, L.D., Abbott, D.H., Schultz-Darken, N.J., Israel, B.A., Bradley, S.M., Kemnitz, J.W., Allison, D.B., and Atkinson, R.L. 2002. Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J. Nutr. 132, 3155–1360. Dickinson, A.G. and Meikle, V.M. 1971. Host-genotype and agent eVects in scrapie incubation: Change in allelic interaction with diVerent strains of agent. Mol. Gen. Genet. 112, 73–79. DuV, R.G. and Vogt, P.K. 1969. Characteristics of two new avian tumor virus subgroups. Virology 39, 18–30. Duncan, B.B., Schmidt, M.I., Chambless, L.E., Folsom, A.R., Carpenter, M., and Heiss, G. 2000. Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults—the ARIC study. Atherosclerosis risk in communities. Obes. Res. 8, 279–286.
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
97
Ekesbo, R., Nilsson, P.M., Lindholm, L.H., Persson, K., and Wadstrom, T. 2000. Combined seropositivity for H. pylori and C. pneumoniae is associated with age, obesity and social factors. J. Cardiovasc. Risk 7, 191–195. Elmquist, J.K., Elias, C.F., and Saper, C.B. 1999. From lesions to leptin: Hypothalamic control of food intake and body weight. Neuron 22, 221–232. Fadly, A.M. 1997. Avian retroviruses. Vet. Clin. North Am. Food Anim. Pract. 13, 71–85. Falck, G., Gnarpe, J., Hansson, L.O., Svardsudd, K., and Gnarpe, H. 2002. Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: Respiratory morbidity and the metabolic syndrome. Chest 122, 1587–1593. Ferszt, R., Severus, E., Bode, L., Brehm, M., Kuhl, K.P., Berzewski, H., and Ludwig, H. 1999. Activated Borna disease virus in aVective disorders. Pharmacopsychiatry 32, 93–98. Fisher, M.H., Amend, A.M., Bach, T.J., Barker, J.M., Brady, E.J., Candelore, M.R., Carroll, D., Cascieri, M.A., Chiu, S.H., Deng, L., Forrest, M.J., Hegarty-Friscino, B., et al. 1998. A selective human b3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys. J. Clin. Invest. 101, 2387–2393. Foy, H.M. and Grayston, J.T. Adenoviruses. In ‘‘Viral Infection of Human: Epidemiology and Control’’ (S. Evans Alfred, ed.), pp. 53–69. Plenum Medical, New York. Fried, S.K., Bunkin, D.A., and Greenberg, A.S. 1998. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot diVerence and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83, 847–850. Gosztonyi, G. and Ludwig, H. 1995. Borna disease—neuropathology and pathogenesis. Curr. Top. Microbiol. Immunol. 190, 39–73. Gosztonyi, G., Kao, M., Bode, L., and Ludwig, H. 1991. Obesity syndrome in experimental infection of rats with Borna disease virus. Clin. Neuropathol. 10, 33–34. Graf, T., and Beug, H. 1978. Avian leukemia viruses: Interaction with their target cells in vivo and in vitro. Biochim. Biophys. Acta 516, 269–299. Gregoire, F., De Broux, N., Hauser, N., Heremans, H., Van Damme, J., and Remacle, C. 1992. Interferon-gamma and interleukin-1 beta inhibit adipoconversion in cultured rodent preadipocytes. J. Cell. Physiol. 151, 300–309. GriVond, B., Verlaeten, O., Belin, M.F., Risold, P.Y., and Bernard, A. 2004. Specific alteration of the expression of selected hypothalamic neuropeptides during acute and late mouse brain infection using a morbillivirus: Relevance to the late-onset obesity? Brain Res. 1022, 173–181. Hall, W.W., Lamb, R.A., and Choppin, P.W. 1980. The polypeptides of canine distemper virus: Synthesis in infected cells and relatedness to the polypeptides of other morbilliviruses. Virology 100, 433–449. Herden, C., Herzog, S., Richt, J.A., Nesseler, A., Christ, M., Failing, K., and Frese, K. 2000. Distribution of Borna disease virus in the brain of rats infected with an obesity-inducing virus strain. Brain Pathol. 10, 39–48. Hoch, F.L. 1974. Metabolic eVects of thyroid hormones. In ‘‘Handbook of Physiology, Section 7: Endocrinology’’ (M.A. Greer and D.H. Solomon, eds), pp. 391–412. American Physiological Society, Washington, DC. HoVmeister, A., Rothenbacher, D., Wanner, P., Bode, G., Persson, K., Brenner, H., Hombach, V., and Koenig, W. 2000. Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: Negative results of a case-control study. J. Am. Coll. Cardiol. 35, 112–118. HoVmeister, A., Rothenbacher, D., Bode, G., Persson, K., Marz, W., Nauck, M.A., Brenner, H., Hombach, V., and Koenig, W. 2001. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler. Thromb. Vasc. Biol. 21, 427–432.
98
M. PASARICA AND N. V. DHURANDHAR
Hogan, R.J., Mathews, S.A., Mukhopadhyay, S., Summersgill, J.T., and Timms, P. 2004. Chlamydial persistence: Beyond the biphasic paradigm. Infect. Immun. 72, 1843–1855. Hooper, L. 2001. Survey of UK dietetic departments: Diet in secondary prevention of myocardial infarction. J. Hum. Nutr. Diet. 14, 307–318. Hooper, L.V., Wong, M.H., Thelin, A., Hansson, L., Falk, P.G., and Gordon, J.I. 2001. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881–884. Hooper, L.V., Stappenbeck, T.S., Hong, C.V., and Gordon, J.I. 2003. Angiogenins: A new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4, 269–273. Horvath, J., Palkonyay, L., and Weber, J. 1986. Group C adenovirus DNA sequences in human lymphoid cells. J. Virol. 59, 189–192. Hunter, G.D. 1972. Scrapie: A prototype slow infection. J. Infect. Dis. 125, 427–440. Kalra, S.P., Dube, M.G., Pu, S., Xu, B., Horvath, T.L., and Kalra, P.S. 1999. Interacting appetiteregulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20, 68–100. Kanerva, A. and Hemminki, A. 2005. Adenoviruses for treatment of cancer. Ann. Med. 37, 33–43. Kao, M., Hamir, A.N., Rupprecht, C.E., Fu, Z.F., Shankar, V., Koprowski, H., and Dietzschold, B. 1993. Detection of antibodies against Borna disease virus in sera and cerebrospinal fluid of horses in the USA. Vet. Rec. 132, 241–244. Kawano, H., Honma, S., Honma, A., Horie, M., Kawano, Y., and Hayashi, S. 2002. Melaninconcentrating hormone neuron system: The Wide Web that controls the feeding. Anat. Sci. Int. 77, 149–160. Kim, Y.S., Carp, R.I., Callahan, S.M., and Wisniewski, H.M. 1987. Scrapie-induced obesity in mice. J. Infect. Dis. 156, 402–405. Kim, Y.S., Carp, R.I., Callahan, S.M., and Wisniewski, H.M. 1988. Adrenal involvement in scrapieinduced obesity. Proc. Soc. Exp. Biol. Med. 189, 21–27. Kolesar, J.M., Miller, J.A., Dhurandhar, N.V., and Atkinson, R.L. 2000. Direct quantification of AD-36 adenovirus DNA by capillary electrophoresis with laser-induced fluorescence. J. Chromatogr. B Biomed. Sci. Appl. 744, 1–8. Kras, K.M., Hausman, D.B., and Martin, R.J. 2000. Tumor necrosis factor-alpha stimulates cell proliferation in adipose tissue-derived stromal-vascular cell culture: Promotion of adipose tissue expansion by paracrine growth factors. Obes. Res. 8, 186–193. Kuo, C.C., Shor, A., Campbell, L.A., Fukushi, H., Patton, D.L., and Grayston, J.T. 1993. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167, 841–849. Kuo, C.C., Jackson, L.A., Campbell, L.A., and Grayston, J.T. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8, 451–461. Leisewitz, A.L., Carter, A., van Vuuren, M., and van Blerk, L. 2001. Canine distemper infections, with special reference to South Africa, with a review of the literature. J. S. Afr. Vet. Assoc. 72, 127–136. Levine, J.A., Jensen, M.D., Eberhardt, N.L., and O’Brien, T. 1998. Adipocyte macrophage colonystimulating factor is a mediator of adipose tissue growth. J. Clin. Invest. 101, 1557–1564. Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., and Gordon, J.I. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102, 11070–11075. Liebert, U.G., Baczko, K., Budka, H., and ter Meulen, V. 1986. Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J. Gen. Virol. 67(Pt. 11), 2435–2444. Limbourg, F.P., Stadtler, H., Chinnadurai, G., Baeuerle, P.A., and Schmitz, M.L. 1996. A hydrophobic region within the adenovirus E1B 19 kDa protein is necessary for the transient inhibition of NF-kB activated by diVerent stimuli. J. Biol. Chem. 271, 20392–20398. Lipworth, B.J. 1996. Clinical pharmacology of beta 3-adrenoceptors. Br. J. Clin. Pharmacol. 42, 291–300.
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
99
Ludwig, H. and Bode, L. 2000. Borna disease virus: New aspects on infection, disease, diagnosis and epidemiology. Rev.-OV. Int. Epizoot. 19, 259–288. Ludwig, H., Bode, L., and Gosztonyi, G. 1988. Borna disease: A persistent virus infection of the central nervous system. Prog. Med. Virol. 35, 107–151. Lyons, M.J., Faust, I.M., Hemmes, R.B., Buskirk, D.R., Hirsch, J., and Zabriskie, J.B. 1982. A virally induced obesity syndrome in mice. Science 216, 82–85. Markovits, P., Dormont, D., Delpech, B., Court, L., and Latarjet, R. 1981. Trials of in vitro propagation of the scrapie agent in mouse nerve cells. C. R. Seances Acad. Sci. III 293, 413–417. Martin-Romero, C., Santos-Alvarez, J., Goberna, R., and Sanchez-Margalet, V. 2000. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell. Immunol. 199, 15–24. Mazza, M., Della Marca, G., Paciello, N., Mennuni, G., Bria, P., and Mazza, S. 2005. Orexin, sleep and appetite regulation: A review. Clin. Ter. 156, 93–96. McFerran, J.B., Adair, B., and Connor, T.J. 1975. Adenoviral antigens (CELO, QBV, GAL). Am. J. Vet. Res. 36, 527–529. Merrill, J.E. and Chen, I.S. 1991. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 5, 2391–2397. Mikami, S.I. and Ono, K. 1962. Glucagon deficiency induced by extirpation of alpha islets of the fowl pancreas. Endocrinology 71, 464–473. Morell, V. 1996. New virus variant killed Serengeti cats. Science 271, 596. Muller, J., Moller, D.S., Kjaer, M., Nyvad, O., Larsen, N.A., and Pedersen, E.B. 2003. Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertension. Scand. J. Infect. Dis. 35, 704–712. Nagashima, K., Zabriskie, J.B., and Lyons, M.J. 1992. Virus-induced obesity in mice: Association with a hypothalamic lesion. J. Neuropathol. Exp. Neurol. 51, 101–109. Narayan, O., Herzog, S., Frese, K., Scheefers, H., and Rott, R. 1983. Behavioral disease in rats caused by immunopathological responses to persistent borna virus in the brain. Science 220, 1401–1403. Oldstone, M.B., Sinha, Y.N., Blount, P., Tishon, A., Rodriguez, M., von Wedel, R., and Lampert, P.W. 1982. Virus-induced alterations in homeostasis: Alteration in diVerentiated functions of infected cells in vivo. Science 218, 1125–1127. Olney, J.W. 1969. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164, 719–721. Outram, G.W. 1972. Changes in drinking and feeding habits of mice with experimental scrapie. J. Comp. Pathol. 82, 415–427. Paracchini, V., Pedotti, P., and Taioli, E. 2005. Genetics of leptin and obesity: A HuGE review. Am. J. Epidemiol. 162, 101–114. Pasarica, M., Holland, T., and Dhurandhar, N. 2005. Enhanced cell cycle activation by adenovirus 36 contributes to increased lipid accumulation in 3T3-L1 cells. FASEB J. 19, A91. Pasarica, M., Shin, A.C., Yu, M., Ou Yang, H.-M., Rathod, M., Jen, K.-L.C., Mohankumar, S., Mohankumar, P.S., Markward, N., and Dhurandhar, N.V. 2006. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity 14, 1905–1913. Patterson, P.H. and Nawa, H. 1993. Neuronal diVerentiation factors/cytokines and synaptic plasticity. Cell 72(Suppl.), 123–137. Paterson, R.W. and Smith, R.E. 1978. Characterization of anemia induced by avian osteopetrosis virus. Infect. Immun. 22, 891–900. Pattison, I.H. and Jones, K.M. 1968. Modification of a strain of mouse-adapted scrapie by passage through rats. Res. Vet. Sci. 9, 408–410.
100
M. PASARICA AND N. V. DHURANDHAR
Pereira, H.G., Huebner, R.J., Ginsberg, H.S., and Van Der Veen, J. 1963. A short description of the adenovirus group. Virology 20, 613–620. Powledge, T.M. 2004. Is obesity an infectious disease? Lancet Infect. Dis. 4, 599. Presse, F., Sorokovsky, I., Max, J.P., Nicolaidis, S., and Nahon, J.L. 1996. Melanin-concentrating hormone is a potent anorectic peptide regulated by food-deprivation and glucopenia in the rat. Neuroscience 71, 735–745. Qu, D., Ludwig, D.S., Gammeltoft, S., Piper, M., Pelleymounter, M.A., Cullen, M.J., Mathes, W.F., Przypek, R., Kanarek, R., and Maratos-Flier, E. 1996. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380, 243–247. Raben, A., Haulrik, N., Dhurandhar, N., Atkinson, R., and Astrup, A. 2001. Minor role of human adenovirus 36 in the obesity epidemic in Denmark. Int. J. Obes. 25(Suppl. 2), S46. Raine, C.S. 1976. On the development of CNS lesions in natural canine distemper encephalomyelitis. J. Neurol. Sci. 30, 13–28. Ramos, E.J., Meguid, M.M., Campos, A.C., and Coelho, J.C. 2005. Neuropeptide Y, alpha-melanocytestimulating hormone, and monoamines in food intake regulation. Nutrition 21, 269–279. Richt, J.A., VandeWoude, S., Zink, M.C., Clements, J.E., Herzog, S., Stitz, L., Rott, R., and Narayan, O. 1992. Infection with Borna disease virus: Molecular and immunobiological characterization of the agent. Clin. Infect. Dis. 14, 1240–1250. Richt, J.A., PfeuVer, I., Christ, M., Frese, K., Bechter, K., and Herzog, S. 1997. Borna disease virus infection in animals and humans. Emerg. Infect. Dis. 3, 343–352. Rossner, S. 2005. Can obesity be an infectious disease? Lakartidningen 102, 1896–1898. Rott, R. and Becht, H. 1995. Natural and experimental Borna disease in animals. Curr. Top. Microbiol. Immunol. 190, 17–30. Roytblat, L., Rachinsky, M., Fisher, A., Greemberg, L., Shapira, Y., Douvdevani, A., and Gelman, S. 2000. Raised interleukin-6 levels in obese patients. Obes. Res. 8, 673–675. Rozenblatt, S., Eizenberg, O., Ben-Levy, R., Lavie, V., and Bellini, W.J. 1985. Sequence homology within the morbilliviruses. J. Virol. 53, 684–690. Rubin, B.A. 1993. Clinical picture and epidemiology of adenovirus infections (a review). Acta Microbiol. Hung. 40, 303–323. Saikku, P., Leinonen, M., Mattila, K., Ekman, M.R., Nieminen, M.S., Makela, P.H., Huttunen, J.K., and Valtonen, V. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2, 983–986. Sakurai, T. 2003. Orexin: A link between energy homeostasis and adaptive behaviour. Curr. Opin. Clin. Nutr. Metab. Care 6, 353–360. Sawchenko, P.E. 1998. Toward a new neurobiology of energy balance, appetite, and obesity: The anatomists weigh in. J. Comp. Neurol. 402, 435–441. Scallet, A.C. and Olney, J.W. 1986. Components of hypothalamic obesity: Bipiperidyl-mustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia. Brain Res. 374, 380–384. Sclafani, A. 1984. Animal models of obesity: Classification and characterization. Int. J. Obes. 8, 491–508. Sewter, C.P., Digby, J.E., Blows, F., Prins, J., and O’Rahilly, S. 1999. Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. J. Endocrinol. 163, 33–38. Shen, Y. and Shenk, T.E. 1995. Viruses and apoptosis. Curr. Opin. Genet. Dev. 5, 105–111. Shimada, M., Tritos, N.A., Lowell, B.B., Flier, J.S., and Maratos-Flier, E. 1998. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396, 670–674. Shin, A., Mohankumar, P., Dhurandhar, N., and Mohankumar, S. 2004. Adipogenic Human adenovirus ad-36 modulates the rat hypothalamo pituitary adrenal (HPA) Axis. Obes. Res. 12, 393–P. Singh, A., Reineke, E.P., and Ringer, R.K. 1968. Influence of thyroid status of the chick on growth and metabolism, with observations on several parameters of thyroid function. Poult. Sci. 47, 212–219.
INFECTOBESITY: OBESITY OF INFECTIOUS ORIGIN
101
Sixt, N., Cardoso, A., Vallier, A., Fayolle, J., Buckland, R., and Wild, T.F. 1998. Canine distemper virus DNA vaccination induces humoral and cellular immunity and protects against a lethal intracerebral challenge. J. Virol. 8472–8476. Smith, R.E. and Moscovici, C. 1969. The oncogenic eVects of nontransforming viruses from avian myeloblastosis virus. Cancer Res. 29, 1356–1366. Smith, R.E. and Schmidt, E.V. 1982. Induction of anemia by avian leukosis viruses of five subgroups. Virology 117, 516–518. Smith, R.E. and Van Eldik, L.J. 1978. Characterization of the immunosuppression accompanying virus-induced avian osteopetrosis. Infect. Immun. 22, 452–461. So, P.W., Herlihy, A.H., and Bell, J.D. 2005. Adiposity induced by adenovirus 5 inoculation. Int. J. Obes. Relat. Metab. Disord. 29, 603–606. Solbrig, M.V., Fallon, J.H., and Lipkin, W.I. 1995. Behavioral disturbances and pharmacology of Borna disease. Curr. Top. Microbiol. Immunol. 190, 93–101. Stappenbeck, T.S., Hooper, L.V., and Gordon, J.I. 2002. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells.